This is a Validated Antibody Database (VAD) review about human CD8A, based on 898 published articles (read how Labome selects the articles), using CD8A antibody in all methods. It is aimed to help Labome visitors find the most suited CD8A antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD8A synonym: CD8; Leu2; p32

others
domestic rabbit monoclonal (SP57)
  • immunohistochemistry; mouse; 1:1000; loading ...
CD8A antibody (Roche, 790-4460) was used in immunohistochemistry on mouse samples at 1:1000. Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (SP57)
  • immunohistochemistry - paraffin section; human
CD8A antibody (Roche, 790-4460) was used in immunohistochemistry - paraffin section on human samples . Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (SP57)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2c
CD8A antibody (Roche, 790-4460) was used in immunohistochemistry - paraffin section on human samples (fig 2c). Aging Cell (2020) ncbi
domestic rabbit monoclonal (SP57)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; fig s5a
CD8A antibody (Roche, SP57) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig s5a). Acta Neuropathol Commun (2019) ncbi
Invitrogen
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...
Invitrogen CD8A antibody (eBioscience, 12-0089-42) was used in flow cytometry on human samples . J Immunother Cancer (2022) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...
Invitrogen CD8A antibody (eBioscience, 25-0088-42) was used in flow cytometry on human samples . J Immunother Cancer (2022) ncbi
mouse monoclonal (AMC908)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 7a
Invitrogen CD8A antibody (eBioscience -Thermo Fisher Scientific, 50-0008-80) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 7a). Nat Commun (2022) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s4a
Invitrogen CD8A antibody (Invitrogen, 46-0087-42) was used in flow cytometry on human samples (fig s4a). Mol Cancer (2022) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s4a
Invitrogen CD8A antibody (Invitrogen, 17-0088-42) was used in flow cytometry on human samples (fig s4a). Mol Cancer (2022) ncbi
mouse monoclonal (AMC908)
  • immunohistochemistry; human; loading ...; fig 4e
Invitrogen CD8A antibody (eBioscience, AMC908) was used in immunohistochemistry on human samples (fig 4e). Front Immunol (2021) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 3
Invitrogen CD8A antibody (Thermo, MA5-14548) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 3). J Cell Mol Med (2022) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 3b
Invitrogen CD8A antibody (Thermo Fisher, MA5-14548) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3b). Cell Rep (2021) ncbi
mouse monoclonal (OKT8 (OKT-8))
  • flow cytometry; human; 1:200; loading ...; fig s3a
Invitrogen CD8A antibody (Invitrogen, 47-0086-42) was used in flow cytometry on human samples at 1:200 (fig s3a). Nature (2021) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:50; fig 1
Invitrogen CD8A antibody (Thermo Fisher Scientific, C8/144B) was used in immunohistochemistry on human samples at 1:50 (fig 1). Ann Med (2021) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 1c
Invitrogen CD8A antibody (Invitrogen, MA5-13473) was used in immunohistochemistry on mouse samples at 1:50 (fig 1c). J Autoimmun (2021) ncbi
mouse monoclonal (OKT8 (OKT-8))
  • flow cytometry; human; loading ...; fig s3
Invitrogen CD8A antibody (Invitrogen, 47-0086-42) was used in flow cytometry on human samples (fig s3). Nature (2021) ncbi
mouse monoclonal (OKT8 (OKT-8))
  • flow cytometry; human; 1:200; fig e4a
Invitrogen CD8A antibody (Invitrogen, 47-0086-42) was used in flow cytometry on human samples at 1:200 (fig e4a). Nature (2021) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:20; fig 5b
Invitrogen CD8A antibody (Thermo Fisher Scientific, RPA-T8) was used in flow cytometry on human samples at 1:20 (fig 5b). Science (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...
Invitrogen CD8A antibody (ThermoFisher, 25-0087-42) was used in flow cytometry on human samples . Cell (2021) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
Invitrogen CD8A antibody (Lab Vision/Thermo Scientific, SP16) was used in immunohistochemistry - paraffin section on human samples (fig 4a). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 5a
Invitrogen CD8A antibody (Invitrogen, 17-0088-42) was used in flow cytometry on human samples (fig 5a). Cancer Sci (2021) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; fig 4g
Invitrogen CD8A antibody (ThermoFisher Scientific, C8/144B) was used in immunohistochemistry on human samples (fig 4g). Nat Commun (2020) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 4a
Invitrogen CD8A antibody (eBioscience, RPA-T8) was used in flow cytometry on human samples (fig 4a). BMC Immunol (2020) ncbi
mouse monoclonal (3B5)
  • flow cytometry; African green monkey; loading ...; fig 3b
Invitrogen CD8A antibody (Invitrogen, MHCD0817) was used in flow cytometry on African green monkey samples (fig 3b). PLoS Pathog (2020) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1e
Invitrogen CD8A antibody (Thermo Fisher, SP16) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1e). BMC Cancer (2020) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 10b, 12b
Invitrogen CD8A antibody (eBioscience, 46-0087-42) was used in flow cytometry on human samples (fig 10b, 12b). Hum Vaccin Immunother (2020) ncbi
mouse monoclonal (OKT8 (OKT-8))
  • flow cytometry; human; loading ...; fig s1c
Invitrogen CD8A antibody (eBioscience, 17-0086-41) was used in flow cytometry on human samples (fig s1c). Cell (2019) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig s7a
Invitrogen CD8A antibody (eBiosciences, 12-0089-42) was used in flow cytometry on human samples (fig s7a). Nat Commun (2019) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s1b
Invitrogen CD8A antibody (eBioscience, 46-0087-42) was used in flow cytometry on human samples (fig s1b). BMC Cancer (2019) ncbi
mouse monoclonal (OKT8 (OKT-8))
  • flow cytometry; human; loading ...; fig 7c
Invitrogen CD8A antibody (Ebioscience, 17-0086-42) was used in flow cytometry on human samples (fig 7c). Oncoimmunology (2019) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry; human; loading ...; fig 4d
Invitrogen CD8A antibody (Invitrogen, SP16) was used in immunohistochemistry on human samples (fig 4d). Cell (2019) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2d
Invitrogen CD8A antibody (Thermo Scientific, MA5-14548) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2d). Cancer Cell (2019) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry; human; loading ...
Invitrogen CD8A antibody (Thermo Fisher, MA5-14548) was used in immunohistochemistry on human samples . Cell (2019) ncbi
mouse monoclonal (Hit8a)
  • immunocytochemistry; human; loading ...; fig s2d
Invitrogen CD8A antibody (eBioscience, 12-0089-41) was used in immunocytochemistry on human samples (fig s2d). Cell (2019) ncbi
mouse monoclonal (OKT8 (OKT-8))
  • flow cytometry; rhesus macaque; 1:200; loading ...; fig 3g
Invitrogen CD8A antibody (Invitrogen, 47-0086-42) was used in flow cytometry on rhesus macaque samples at 1:200 (fig 3g). Nature (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 4a
Invitrogen CD8A antibody (eBioscience, RPA-T8) was used in flow cytometry on human samples (fig 4a). J Exp Med (2019) ncbi
mouse monoclonal (OKT8 (OKT-8))
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD8A antibody (eBioscience, OKT8) was used in flow cytometry on human samples (fig 1a). Front Immunol (2019) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s4a
Invitrogen CD8A antibody (Thermofisher, MA5-13473) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s4a). Cancer Cell (2019) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; 1:200; loading ...; fig 3e
Invitrogen CD8A antibody (eBioscience, 17-0087-42) was used in flow cytometry on mouse samples at 1:200 (fig 3e). Nat Commun (2019) ncbi
mouse monoclonal (OKT8 (OKT-8))
  • flow cytometry; human; loading ...; fig s3c
Invitrogen CD8A antibody (ThermoFisher Scientific, OKT8) was used in flow cytometry on human samples (fig s3c). Transl Oncol (2019) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; 1:300; loading ...; fig s1a
Invitrogen CD8A antibody (eBioscience, 3B5) was used in flow cytometry on human samples at 1:300 (fig s1a). Nat Commun (2018) ncbi
mouse monoclonal (4B11)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4c
Invitrogen CD8A antibody (Thermo Fisher Scientific, MA1-80231) was used in immunohistochemistry - paraffin section on human samples (fig 4c). Neurosurgery (2018) ncbi
mouse monoclonal (4B11)
  • immunohistochemistry - paraffin section; human; loading ...; fig 7g
Invitrogen CD8A antibody (Thermo fisher, 4B11) was used in immunohistochemistry - paraffin section on human samples (fig 7g). J Clin Invest (2018) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 3a
Invitrogen CD8A antibody (Life Technologies, 3B5) was used in flow cytometry on human samples (fig 3a). J Exp Med (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD8A antibody (eBioscience, RPA-T8) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 5c
Invitrogen CD8A antibody (eBioscience, HIT8a) was used in flow cytometry on human samples (fig 5c). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; tbl s1
In order to investigate the effect of Shigella infection on human lymphocytes, Invitrogen CD8A antibody (eBioscience, 12-0088-73) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:200; loading ...; fig 1a
In order to study the interaction between CD100 and CD72 and its role in T cell proliferation, Invitrogen CD8A antibody (eBiosciences, RPA-T8) was used in flow cytometry on human samples at 1:200 (fig 1a). Front Immunol (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 3a
In order to investigate the effectiveness of a neoantigen vaccine against melanoma, Invitrogen CD8A antibody (eBioscience, SK1) was used in flow cytometry on human samples (fig 3a). Nature (2017) ncbi
mouse monoclonal (OKT8 (OKT-8))
  • flow cytometry; human; loading ...; tbl 1
In order to investigate infiltrating T cells in liver cancer through single-cell sequencing, Invitrogen CD8A antibody (eBioscience, 17-0086-41) was used in flow cytometry on human samples (tbl 1). Cell (2017) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry; human; loading ...; fig 3a
In order to investigate the tumor microenvironment in tertiary lymphoid organs of prostate cancer patients, Invitrogen CD8A antibody (Thermo Fisher Scientific, SP16) was used in immunohistochemistry on human samples (fig 3a). Front Immunol (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1b
In order to characterize CD8 T cells isolated patients with stage IV melanoma before and after treatment with pembrolizumab, Invitrogen CD8A antibody (eBioscience, RPA-T8) was used in flow cytometry on human samples (fig 1b). Nature (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 3e
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Invitrogen CD8A antibody (Thermo Fisher Scientific, 25-0088) was used in flow cytometry on human samples (fig 3e). Cell Res (2017) ncbi
domestic rabbit monoclonal (SP16)
  • flow cytometry; human; 1:200; loading ...; fig 3f
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Invitrogen CD8A antibody (Thermo Fischer Scientific, MA5-14548) was used in flow cytometry on human samples at 1:200 (fig 3f). Cell Res (2017) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 5
In order to elucidate the effects of pathogen recognition receptors on dendritic cell maturation, HIV infection, and on the quality of HIV-specific cytotoxic T-cell activation, Invitrogen CD8A antibody (Invitrogen, MHCD0826) was used in flow cytometry on human samples (fig 5). Eur J Immunol (2017) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...
In order to assess the effects of targeting the chimeric antigen receptors to the TRAC locus, Invitrogen CD8A antibody (eBioscience, HIT8a) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 3b
Invitrogen CD8A antibody (eBioscience, RPA-T8) was used in flow cytometry on human samples (fig 3b). J Immunol (2017) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 3a
In order to examine the impact of recruited CD8+ T cells on BPH epithelial cells under a low androgen level, Invitrogen CD8A antibody (Thermo Fischer Scientific, RM-9116-S1) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3a). Sci Rep (2017) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1a
In order to use CD49a expression to define subsets of tissue-resident memory T cells in the skin, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1a). Immunity (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1c
In order to characterize the periferal blood lymphocytes phenotype in tacrolimus-treated liver transplanted patients., Invitrogen CD8A antibody (eBioscience, SK1) was used in flow cytometry on human samples (fig 1c). Med Princ Pract (2017) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1h
In order to examine a potential prognostic relevance of CTLA-4 expression in extrahepatic bile duct cancer, Invitrogen CD8A antibody (Thermo Fisher Scientific, MA5-14548) was used in immunohistochemistry - paraffin section on human samples (fig 1h). Target Oncol (2017) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 3
In order to develop a functional assay to assess the risk of developing acute graft-versus-host disease, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 3). J Immunol Res (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1e
In order to study the restoration of immune function in chronic HIV infection, Invitrogen CD8A antibody (eBioscience, SK1) was used in flow cytometry on human samples (fig 1e). J Clin Invest (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:100; loading ...; fig 1b
In order to explore the role of thrombopoietin signaling in the human primitive hematopoietic stem cell compartment, Invitrogen CD8A antibody (eBiosciences, RPA-T8) was used in flow cytometry on human samples at 1:100 (fig 1b). Cell Transplant (2017) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; loading ...; fig 7a
In order to study the efficacy of nanoparticle adjuvants for inducing protective immunity against simian immunodeficiency virus, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples (fig 7a). J Virol (2017) ncbi
mouse monoclonal (3B5)
  • flow cytometry; mouse; loading ...; fig 5c
In order to determine the role of IL-17A in airway fibrosis, Invitrogen CD8A antibody (Thermo Fisher, 3B5) was used in flow cytometry on mouse samples (fig 5c). Am J Physiol Lung Cell Mol Physiol (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 5c
In order to propose that female sex protects against systemic inflammation-induced endothelial dysfunction, Invitrogen CD8A antibody (eBioscience, 45-00988-42) was used in flow cytometry on human samples (fig 5c). J Clin Invest (2017) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...
In order to explore how HIV-1 alters immunity during latent tuberculosis, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . Tuberculosis (Edinb) (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 4b
In order to demonstrate that neonatal CD8 positive T cells have a specific genetic program biased toward the innate immune response, Invitrogen CD8A antibody (Life Technologies, MHCD0826) was used in flow cytometry on human samples (fig 4b). Cell Rep (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; fig 4a
In order to examine the contribution of HIV-derived conserved elements in vaccination, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples (fig 4a). J Immunol (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1a
In order to evaluate the predictive values of the protective T-cell response for human cytomegalovirus disease, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1a). New Microbiol (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 6
In order to assess receptor for hyaluronic acid-mediated motility specific dendritic cell responses, Invitrogen CD8A antibody (Thermo Fisher, MHCD0828) was used in flow cytometry on human samples (fig 6). Oncotarget (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 3
Invitrogen CD8A antibody (eBioscience, 17-0088) was used in flow cytometry on human samples (fig 3). Stem Cell Reports (2016) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...
In order to determine the S. Typhi, S. Paratyphi A, and S. Paratyphi B cross-reactive CD4 positive T cell responses elicited by immunization with Ty21a, Invitrogen CD8A antibody (Invitrogen, HIT8A) was used in flow cytometry on human samples . Clin Immunol (2016) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human
In order to assess programmed cell death 1 and programmed cell death ligand 1 expression in patients with extranodal natural killer/T cell lymphoma, Invitrogen CD8A antibody (Thermo Scientific, SP16) was used in immunohistochemistry - paraffin section on human samples . Virchows Arch (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig st9
In order to characterize American patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, Invitrogen CD8A antibody (ThermoFisher, 3B5) was used in flow cytometry on human samples (fig st9). JCI Insight (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; 1:40; loading ...; fig 7b
In order to use flow cytometry and barcoded peptide-major histocompatibility complex multimers to screen for T cell specificities, Invitrogen CD8A antibody (Invitrogen, MHCD0831) was used in flow cytometry on human samples at 1:40 (fig 7b). Nat Biotechnol (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to optimize the generation of therapeutic extracellular vesicles and identify molecules involved in their clearance, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . Biomaterials (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 5a
In order to investigate the contribution of the PD-1 pathway in allogeneic stem cell transplantation, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 5a). Biol Blood Marrow Transplant (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1a
In order to elucidate the mechanisms by which DRibbles induce T-cell activation, Invitrogen CD8A antibody (Invitrogen, MHCD0801) was used in flow cytometry on human samples (fig 1a). Cell Death Dis (2016) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, Invitrogen CD8A antibody (Thermofisher, SP16) was used in immunohistochemistry - frozen section on human samples at 1:100 (tbl s2). Nat Immunol (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 3
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 3). PLoS Pathog (2016) ncbi
mouse monoclonal (RPA-T8)
In order to assess how ABCG1 loss in T cells affects atherosclerosis, Invitrogen CD8A antibody (eBioscience, RPA-T8) was used . J Clin Invest (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 1
Invitrogen CD8A antibody (eBioscience, RPA-T8) was used in flow cytometry on human samples (fig 1). Clin Cancer Res (2017) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; mouse; fig 6b
In order to utilize humanized major histocompatibility class I- and class II-deficient NOG mice to assess the antitumor effect of an anti-programmed death-1 antibody, Invitrogen CD8A antibody (Thermo Fisher, C8/144B) was used in immunohistochemistry on mouse samples (fig 6b). Clin Cancer Res (2017) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:25; fig 1
In order to gain insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade by analysis of immune signatures in longitudinal tumor samples, Invitrogen CD8A antibody (Thermo Scientific, MA5-13473) was used in immunohistochemistry - paraffin section on human samples at 1:25 (fig 1). Cancer Discov (2016) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry; human; 1:50; fig 3
In order to characterize anti-GABAB receptor limbic encephalitis and evidence of a pathogenic role for CD8(+) T cells, Invitrogen CD8A antibody (Thermo, MA5-14548) was used in immunohistochemistry on human samples at 1:50 (fig 3). Neurol Neuroimmunol Neuroinflamm (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...
In order to study the role of T regulatory cells in patients with immune thrombocytopenic purpura, Invitrogen CD8A antibody (eBioscience, 15-0088) was used in flow cytometry on human samples . Turk J Haematol (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig s2b
In order to test if the two hematopoietic systems in patients with mixed chimerism remain functional and study immunological differences, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig s2b). PLoS ONE (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 6
In order to discover cell-intrinsic division and differentiation differences in neonatal CD8+ T cells, Invitrogen CD8A antibody (eBiosciences, 48-0088-42) was used in flow cytometry on human samples (fig 6). Immunol Cell Biol (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig s1
Invitrogen CD8A antibody (eBioscience, SK1) was used in flow cytometry on human samples (fig s1). Cell Rep (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; rhesus macaque; fig 1g
Invitrogen CD8A antibody (eBiosciences, RPA-T8) was used in flow cytometry on rhesus macaque samples (fig 1g). J Immunol (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...
In order to assess if statins modulate the monocyte phenotype and function associated with HIV-1 neuropathogenesis, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . J Neurovirol (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1a
In order to determine if HIV-specific CD8 T cells are present in cerebrospinal fluid of HIV controllers, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1a). AIDS Res Hum Retroviruses (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1a
In order to measure DR3 expression on peripheral blood mononuclear cells of patients with inflammatory bowel disease, Invitrogen CD8A antibody (eBiosciences, SK1) was used in flow cytometry on human samples (fig 1a). Cytometry B Clin Cytom (2017) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 2a
In order to compare the immune compartmentalization between ileum and colon in healthy and inflamed mucosa, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 2a). J Crohns Colitis (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 1
In order to determine mucosal characteristics of lymphocytic and collagenous colitis, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1). J Crohns Colitis (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 2b
In order to Targeting CD8(+) T cells prevents psoriasis development, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 2b). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 4c
In order to study the role of human head and neck squamous cell carcinoma-associated semaphorin 4d in myeloid-derived suppressor cells, Invitrogen CD8A antibody (eBioscience, 25-0088-42) was used in flow cytometry on human samples (fig 4c). J Immunol (2016) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess how proportional balance of tumor associated macrophages and tumor infiltrating lymphocytes in microsatellite-unstable gastric carcinoma is a prognostic indicator of M2 macrophages, Invitrogen CD8A antibody (Neomarkers, SP16) was used in immunohistochemistry - paraffin section on human samples at 1:100. PLoS ONE (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 1
In order to analyze the difference in immune profiles at the pandemic epicenter in two pandemic Influenza A (H1N1) pdm09 virus waves, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1). Arch Med Res (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 1
In order to analyze HIV progression traits of a selective loss of early differentiated and highly functional PD1high CD4 T cells, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to study nontuberculous mycobacterial infection with mutual IgG4-related lymphadenopathy, Invitrogen CD8A antibody (Thermo Fisher, SP16) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). APMIS (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...
In order to perform an antigenic analysis of Bla g 2 using antibodies, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . J Biol Chem (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; loading ...; fig 5a
In order to study the CD8+ non-cytolytic antiviral response in SIV infected rhesus macaques, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples (fig 5a). PLoS ONE (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 2a
In order to develop an antigen presenting cell/T-cell platform to study intrathecal CD4 positive and CD8 positive T-cell responses to candidate MS-associated autoantigens, Invitrogen CD8A antibody (eBiosciences, RPA-T8) was used in flow cytometry on human samples (fig 2a). Eur J Immunol (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; mouse
In order to study immune escape from CD8+ T cell killing mediated by PD-L1 expression on retrovirus-infected cells, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on mouse samples . PLoS Pathog (2015) ncbi
mouse monoclonal (OKT8 (OKT-8))
  • flow cytometry; human; fig 7
In order to characterize a bispecific scFv antibody targeting of human melanoma made in transgenic cattle called r28M, Invitrogen CD8A antibody (eBioscience, 12?C0086) was used in flow cytometry on human samples (fig 7). PLoS ONE (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig s1a
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig s1a). J Immunol (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; mouse; loading ...
In order to assess the effects of allosteric inhibitors on different mutant forms of isocitrate dehydrogenase 1 in leukemia, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on mouse samples . Nat Chem Biol (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human
In order to examine the histopathological patterns and their associations with clinical characteristics in Chinese patients with nasal inverted papilloma, Invitrogen CD8A antibody (Thermo, C8/144B) was used in immunohistochemistry - paraffin section on human samples . Laryngoscope (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig e3b
In order to discuss the importance of IL-5 positive Th2 cells to allergies, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig e3b). J Allergy Clin Immunol (2016) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human; 1:150; fig 1
In order to elucidate the prognosis of gastric cancer by tumor-infiltrating immune cells, Invitrogen CD8A antibody (Thermo Scientific, SP16) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 1). Medicine (Baltimore) (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 2
In order to assess the CD4/CD8 ratio as a marker for CD4+ T cell dysfunction in chronic HIV infection, Invitrogen CD8A antibody (Life Technologies, Clone 3B5) was used in flow cytometry on human samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; fig 2
In order to characterize Chinese nasal polyp, Invitrogen CD8A antibody (Thermo Scientific, C8/144B) was used in immunohistochemistry - paraffin section on human samples (fig 2). Int Forum Allergy Rhinol (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 2
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, Invitrogen CD8A antibody (Life Technologies, 3B5) was used in flow cytometry on human samples (fig 2). PLoS Pathog (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
Invitrogen CD8A antibody (eBioscience, SK1) was used in flow cytometry on human samples . Science (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; loading ...; fig 1a
In order to use lymph node fine-needle aspiration to examine the dynamics of T-follicular helper cells during SIV infection, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples (fig 1a). J Med Primatol (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 3d
In order to examine the effects of immunosuppressive agents on Polyomavirus BKV-specific T cells, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 3d). Kidney Int (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to study the dynamics of Ag-specific CD4(+) T cells during antiretroviral therapy, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 4
In order to discuss the role of T cells in Rasmussen encephalitis, Invitrogen CD8A antibody (eBioscience, RPA-T8) was used in flow cytometry on human samples (fig 4). J Neuroinflammation (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; African green monkey; loading ...; fig 6e
In order to elucidate the role of the adenosine pathway in human immunodeficiency virus type 1/simian immunodeficiency virus infection, Invitrogen CD8A antibody (Life Technologies, 3B5) was used in flow cytometry on African green monkey samples (fig 6e). J Virol (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; mouse
In order to compare the initial systemic Env-specific B cell responses of AGMs and rhesus macaques, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on mouse samples . J Virol (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
In order to study T cell subtypes in breast cancer patients with and without high levels of autoimmune thyroid antibodies, Invitrogen CD8A antibody (eBioscience, 15-0088) was used in flow cytometry on human samples . Cent Eur J Immunol (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 4
In order to investigate the role of VAMP8 in exocytosis, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 4). J Cell Biol (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 2
In order to discuss using the infiltrate to diagnosis B-cell lymphomas, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 2). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; fig 1
In order to elucidate how CD8 positive T cells suppress virus replication during simian immunodeficiency virus infection, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples (fig 1). J Virol (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to elucidate regulation of gamma-globin expression in F-cells, Invitrogen CD8A antibody (Life Technologies, 3B5) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; baboon
  • flow cytometry; pigtail macaque
  • flow cytometry; common marmoset
  • flow cytometry; crab eating macaque
  • flow cytometry; chimpanzee
  • flow cytometry; green monkey
  • flow cytometry; sooty mangabey
  • flow cytometry; orang utan
  • flow cytometry; White-cheeked Gibbon
  • flow cytometry; human; loading ...
  • flow cytometry; gorilla
  • flow cytometry; rhesus macaque
  • flow cytometry; bonobo
  • flow cytometry; Bolivian squirrel monkey
In order to analyze the expression of alpha4beta7-integrin in primate lymphocites., Invitrogen CD8A antibody (ebioscience, 25-0087) was used in flow cytometry on baboon samples , in flow cytometry on pigtail macaque samples , in flow cytometry on common marmoset samples , in flow cytometry on crab eating macaque samples , in flow cytometry on chimpanzee samples , in flow cytometry on green monkey samples , in flow cytometry on sooty mangabey samples , in flow cytometry on orang utan samples , in flow cytometry on White-cheeked Gibbon samples , in flow cytometry on human samples , in flow cytometry on gorilla samples , in flow cytometry on rhesus macaque samples , in flow cytometry on bonobo samples and in flow cytometry on Bolivian squirrel monkey samples . J Immunol (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1c
In order to develop feasible methods to generate cytomegalovirus-specific T cells from naive cells for T cell therapy, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1c). Sci Transl Med (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to optimize detection of IL-2 from live cells, Invitrogen CD8A antibody (Life Sciences/Invitrogen, Q10059) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human
In order to describe the clinicopathological features of 15 patients with Epstein-Barr virus-positive nodal T/NK-cell lymphoma, Invitrogen CD8A antibody (Thermo Scientific, SP16) was used in immunohistochemistry - paraffin section on human samples . Hum Pathol (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...
In order to assess intrahepatic delivery of anti-CEA chimeric antigen receptor-modified T cells through percutaneous hepatic artery infusions, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . Clin Cancer Res (2015) ncbi
mouse monoclonal (C8/144B)
  • immunoprecipitation; human; fig 4
In order to investigate the assembly of glycoprotein complexes by human cytomegalovirus, Invitrogen CD8A antibody (Thermo Scientific, 14-4b) was used in immunoprecipitation on human samples (fig 4). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; rhesus macaque; fig 1
  • flow cytometry; human; fig 1
In order to examine the role of lymphocyte activation gene-3 during HIV infection, Invitrogen CD8A antibody (eBioscience, RPA-T8) was used in flow cytometry on rhesus macaque samples (fig 1) and in flow cytometry on human samples (fig 1). J Immunol (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; tbl s1
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 3
In order to evaluate the potency of program death ligand 1 and 2-silenced dendritic cell vaccines for ex vivo priming and in vivo boosting of minor histocompatibility antigen-specific CD8 positive T cell responses, Invitrogen CD8A antibody (Life Technologies, 3B5) was used in flow cytometry on human samples (fig 3). Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to show that intermediate DNA methylation is a conserved signature of gene regulation and exon usage, Invitrogen CD8A antibody (Invitrogen, MHCD0806) was used in flow cytometry on human samples . Nat Commun (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:20
Invitrogen CD8A antibody (Thermo Fisher, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:20. J Dermatol Sci (2015) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry; human
Invitrogen CD8A antibody (Thermo Fischer Scientific, SP16) was used in immunohistochemistry on human samples . Lung Cancer (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig s1
Invitrogen CD8A antibody (eBioscience, RPA-T8) was used in flow cytometry on human samples (fig s1). J Autoimmun (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...
In order to ascertain the impact of cell-intrinsic immunity on the latent reservoir of HIV, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . AIDS (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to discuss methods to measure cytokine production by Th1 and Th17 cells, Invitrogen CD8A antibody (Life Technologies, Q10059) was used in flow cytometry on human samples . Curr Protoc Cytom (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:50; fig 2
In order to characterize location and tumor infiltration patterns as key prognostic factors when analyzing CD8+ T-cells and FoxP3+ T-regulatory cells in ovarian carcinoma, Invitrogen CD8A antibody (LAB Vision, MS 457) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2). PLoS ONE (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1a
In order to discuss the therapeutic use of ex vivo-generated Akt-inhibited minor histocompatibility antigen-specific CD8+ T cells, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1a). Blood (2014) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human
Invitrogen CD8A antibody (Thermo Scientific, SP16) was used in immunohistochemistry - paraffin section on human samples . Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (3B5)
  • chromatin immunoprecipitation; human
In order to characterize the coincidence detection with cell differentiation using a microfluidic impedance biochip, Invitrogen CD8A antibody (Life Technologies, MHCD0800) was used in chromatin immunoprecipitation on human samples . Lab Chip (2014) ncbi
mouse monoclonal (3B5)
  • immunocytochemistry; human; fig 2
In order to compare five SIV vaccine platforms, Invitrogen CD8A antibody (Invitroge, clone MHCD0826) was used in immunocytochemistry on human samples (fig 2). Clin Immunol (2014) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human; 1:100
In order to study the prognostic significance of the infiltration of tumor associate macrophages in patients with triple negative breast cancer, Invitrogen CD8A antibody (Lab Vision, RM-9116) was used in immunohistochemistry - paraffin section on human samples at 1:100. Onco Targets Ther (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 5
In order to study the role of plasmacytoid dendritic cells in human immunodeficiency virus type 1 infection and pathogenesis, Invitrogen CD8A antibody (Invitrogen, MHCD0817) was used in flow cytometry on human samples (fig 5). PLoS Pathog (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 4a
In order to test if proteasome-inhibition complements the effects of corticosteroids to improve outcomes in chronic graft-versus-host disease, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 4a). Biol Blood Marrow Transplant (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
In order to study the cell mediated immune response to JCV T-Ag in patients with colorectal adenomatous polyps or cancers, Invitrogen CD8A antibody (eBioscience, 12-0088-42) was used in flow cytometry on human samples . Gut Microbes (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to developed a strategy to expand umbilical cord blood T cells and test their effects after transplantation, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . Leukemia (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2a
Invitrogen CD8A antibody (eBioscience, 12-0088-42) was used in flow cytometry on human samples (fig 2a). Oncotarget (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; loading ...; fig 1b
In order to assess early changes in CD4 and CD8 T cells in rhesus macaques infected with SIVMAC251, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples (fig 1b). J Virol (2014) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:50
Invitrogen CD8A antibody (Thermo Fisher Scientific, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:50. Br J Dermatol (2015) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 3c
In order to elucidate the relationship between female genital schistosomiasis and HIV infection, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 3c). PLoS ONE (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to find Munc13-4 is highly expressed in differentiated human natural killer cells and effector CD8(+) T lymphocytes, Invitrogen CD8A antibody (Invitrogen, noca) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque
In order to determine if vaccination with a rhesus macaque-derived adenoviral vector simian adenovirus 7 enhances mucosal T cell activation, Invitrogen CD8A antibody (Invitrogen, noca) was used in flow cytometry on rhesus macaque samples . J Virol (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; mouse
In order to study the role of human endogenous retrovirus (HERV) envelope proteins in the uptake of exosomes, Invitrogen CD8A antibody (Invitrogen, MHCD0826) was used in flow cytometry on mouse samples . FASEB J (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to investigate the anti-influenza responses of T cell subsets, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to study virus-specific human memory T-cell activation in response to Dribble-mediated cross-presentation of viral antigens, Invitrogen CD8A antibody (Invitrogen, MHCD0804) was used in flow cytometry on human samples . J Transl Med (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 3
In order to assess how invariant natural killer T cells distribute, differentiate, and function in fetal peripheral lymphoid and non-lymphoid organs, Invitrogen CD8A antibody (Invitrogen, QDot605) was used in flow cytometry on human samples (fig 3). Mucosal Immunol (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; African green monkey; loading ...; fig 2a
In order to examine the role of IL-15 in HIV-infected chimpanzees, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on African green monkey samples (fig 2a). Cell Immunol (2014) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human
Invitrogen CD8A antibody (Thermo Fisher Scientific, SP16) was used in immunohistochemistry - paraffin section on human samples . Circ Arrhythm Electrophysiol (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to investigate the cellular sources of cytokines and chemokines associated with severe malaria, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry; human; 1:50
Invitrogen CD8A antibody (Labvision/Thermo Scientific, SP16) was used in immunohistochemistry on human samples at 1:50. PLoS Pathog (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque
In order to compare vaccination with highly conserved gag elements verses full-length gag DNA, Invitrogen CD8A antibody (Invitrogen, MHCD0826) was used in flow cytometry on rhesus macaque samples . PLoS ONE (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; loading ...; fig 3
In order to develop a newborn/infant model to study infection with Mycobacterium tuberculosis, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples (fig 3). Tuberculosis (Edinb) (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 4
In order to develop microfluidic biochips that count CD4(+) and CD8(+) lymphocytes in whole blood samples to use in third world countries, Invitrogen CD8A antibody (Life Technologies, MHCD0800) was used in flow cytometry on human samples (fig 4). Sci Transl Med (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; African green monkey; 1:100; fig s6
In order to decipher how susequent acute infection is supressed in T cell responses after exposure to subinfectious hepatitis C virus, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on African green monkey samples at 1:100 (fig s6). Nat Med (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 2b
In order to assess the effect of delayed administration of the BCG vaccine on the induced immune response in Ugandan children, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 2b). J Infect Dis (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...
In order to investigate cellular restriction of HIV-1, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . Retrovirology (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 5
In order to elucidate chimeric antigen receptor-mediated T cell activation, Invitrogen CD8A antibody (Life Technologies, 3B5) was used in flow cytometry on human samples (fig 5). Clin Exp Immunol (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the roles of TCR-gamma/delta T cells and natural killer cells in the mycobacterial-specific immune response, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; fig 2
  • western blot; rhesus macaque; fig 2
In order to investigate how chronic morphine exposure affects T cell numbers and functions, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples (fig 2) and in western blot on rhesus macaque samples (fig 2). J Neuroimmunol (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; African green monkey; loading ...; fig 1a
In order to examine changes in intestinal T cells during SIV infection, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on African green monkey samples (fig 1a). J Virol (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...
In order to examine surface molecules involved in plasmacytoid dendritic-natural killer cell cross-talk, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . J Immunol (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; 1:400; loading ...; fig 3d
In order to report the associations among host restriction factors, other established immunological parameters, and HLA type in HIV-1-seronegative individuals, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples at 1:400 (fig 3d). J Leukoc Biol (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 4
In order to examine tumor-infiltrating lymphocytes derived from liver and lung metastases from patients with gastrointestinal cancers or melanoma, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 4). J Immunol (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; loading ...; fig 2a
In order to infect chimpanzee adenovirus-immunized rhesus macaques with simian immunodeficiency virus, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples (fig 2a). J Virol (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; African green monkey; loading ...; fig 1a
In order to test if the increased plasma viral load in ethanol-treated, SIV-infected macaques negatively correlates with antigen-specific immune responses, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on African green monkey samples (fig 1a). J Acquir Immune Defic Syndr (2013) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 1
Invitrogen CD8A antibody (eBioscience, RPA-T8) was used in flow cytometry on human samples (fig 1). Ann Rheum Dis (2014) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; loading ...
In order to use Tat, Env, and Tat/Env regimens to induce and immune response and then assess protective efficacy using clade C Env, alum adjuvant, and a heterologous intrarectal SHIV1157ipd3N4 challenge, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples . Virology (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to study defective cellular immune response to pandemic H1N1 influenza A virus in obese and overweight adult humans, Invitrogen CD8A antibody (Invitrogen, noca) was used in flow cytometry on human samples . Obesity (Silver Spring) (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 3
In order to perform a phase I study in subjects with steroid-refractory chronic graft-versus-host disease using an anti-CD52 antibody, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 3). Biol Blood Marrow Transplant (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 1
In order to test if impaired human neonatal CD4(+) T cell immunity is due to reduced signaling by naive CD4(+) T cells following engagement of the alphabeta-TCR/CD3 complex and CD28, Invitrogen CD8A antibody (Invitrogen, clone 3B5) was used in flow cytometry on human samples (fig 1). J Immunol (2013) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; African green monkey; loading ...; fig s2c
In order to investigate mucosal dysfunction in relation to HIV/SIV pathogenesis, Invitrogen CD8A antibody (eBioscience, RPA-T8) was used in flow cytometry on African green monkey samples (fig s2c). J Immunol (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; African green monkey; loading ...; fig s2c
In order to investigate mucosal dysfunction in relation to HIV/SIV pathogenesis, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on African green monkey samples (fig s2c). J Immunol (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 4
In order to assess the effects of trichosanthin treatment, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 4). J Investig Allergol Clin Immunol (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 6g
In order to report the detrimental effects observed in patients treated with autologous anti-MAGE-A3 T-cell receptor-engineered T cells, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 6g). J Immunother (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; 1:50; loading ...; fig 1b
In order to compare the dose-dependent effects of hVEGF(165) and mVEGF(164) in skeletal muscle of severe combined immune deficient mice, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples at 1:50 (fig 1b). Hum Gene Ther Methods (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig s5a
In order to elucidate how HIV impacts natural killer cell responses during primary HIV-1 infection, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig s5a). PLoS ONE (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1b
In order to examine the role of Cd96 in HIV-1 pathogenesis, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1b). PLoS ONE (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 2
In order to assess the functionality of virus-specific CD8+ T cells in older individuals acutely infected with West Nile virus and chronically infected with Epstein Barr virus and Cytomegalovirus, Invitrogen CD8A antibody (noca, 3B5) was used in flow cytometry on human samples (fig 2). PLoS Pathog (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate CD161+ T cell recovery during graft-versus-host disease, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1a). PLoS ONE (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 1
In order to identify integrin alpha2 as a novel stem cell marker, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1). Stem Cells (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; loading ...; fig 2a
In order to test if vaccination alters the activation state of T cells within the gastrointestinal mucosa, inguinal lymph nodes, and peripheral blood, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples (fig 2a). Hum Vaccin Immunother (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 2
In order to study the roles of the decidua-derived CCL2 in the Th2 predominance found at the maternal-fetal interface, Invitrogen CD8A antibody (CALTAG, MHCD0818) was used in flow cytometry on human samples (fig 2). Clin Immunol (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 2b
In order to test if low immune activation contributes to the viremic slow progressor phenotype, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 2b). AIDS Res Hum Retroviruses (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; fig 4
In order to study the use of an IL-12 adjuvant when vaccinating rhesus macaques, Invitrogen CD8A antibody (Invitrogen, MHCD0826) was used in flow cytometry on rhesus macaque samples (fig 4). Hum Vaccin Immunother (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 2b
In order to test if bortezomib inhibits graft-versus-host disease after T-cell-replete HLA-mismatched transplantation, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 2b). J Clin Oncol (2012) ncbi
mouse monoclonal (OKT8 (OKT-8))
  • flow cytometry; human; 1:75; fig 1
In order to determine the localization of CD4 positive T cells subsets in the healthy intestine, Invitrogen CD8A antibody (eBioscience, OKT8) was used in flow cytometry on human samples at 1:75 (fig 1). PLoS ONE (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to analyze the regulation of Amphiregulin expression in human T cell subsets, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; fig 1a
In order to characterize macaque innate lymphoid cells, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on rhesus macaque samples (fig 1a). Mucosal Immunol (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 3a
In order to assess the effect of having ataxia-telangiectasia and age on CD95 and IL-7 expression, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 3a). J Immunol (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; loading ...; fig s3i
In order to report that the composition of the host immune system before infection with simian immunodeficiency virus influences the course of disease, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples (fig s3i). Sci Transl Med (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque
In order to study alterations in mucosal immunity during SIV infection, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples . Mucosal Immunol (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1c
In order to test if B and T lymphocyte attenuator contributes to the functional impairment of minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantation, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1c). J Immunol (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 1
In order to study influenza-specific CD4 T cells respond to vaccination using Ki67 as a marker, Invitrogen CD8A antibody (Invitrogen, clone 3B5) was used in flow cytometry on human samples (fig 1). Vaccine (2012) ncbi
mouse monoclonal (3B5)
In order to test if low levels of IFN-I signaling prevent chronic immune activation and disease progression in SIV-infected sooty mangabeys, Invitrogen CD8A antibody (Invitrogen, 3B5) was used . Blood (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1
In order to elucidate the role of CD4 T cell support on the quality of CD8 T cell memory, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1). J Immunol (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to analyze the proliferation and functional profile of circulating double positive T cells from acutely HIV-infected individuals and chronically HIV-infected viral controllers, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . J Immunol (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 2a
In order to discuss the link between interleukin 7 and lymphopenia, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 2a). J Infect Dis (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; tbl 3
In order to explore the importance of vitamin B6 in the recipients of allogeneic kidney graft, Invitrogen CD8A antibody (Caltag, clone 3B5) was used in flow cytometry on human samples (tbl 3). J Ren Nutr (2013) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; loading ...; fig 4a
In order to optimize a DNA vaccine to boost cellular immune responses induced by Ad5 prime, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples (fig 4a). Vaccine (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1a
In order to examine epitope-specific T cell responses in subjects with primary or secondary dengue virus infection, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1a). Sci Rep (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 5
In order to develop and validate a novel system for high throughput quantitation of autophagy in primary human leukocytes, Invitrogen CD8A antibody (Invitrogen, MHCD0828) was used in flow cytometry on human samples (fig 5). Autophagy (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 2a
In order to investigate leukocyte-endothelial interactions at the blood brain barrier, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 2a). Sci Transl Med (2012) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry; human; 1:100; fig 3
In order to test if damage to the lymphoid tissue fibroblastic reticular cell network contributes to naive T cell loss during HIV-1 infection, Invitrogen CD8A antibody (Neomarkers, RM-9116-s) was used in immunohistochemistry on human samples at 1:100 (fig 3). PLoS Pathog (2012) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry; human; 1:100
In order to evaluate the prognostic value of tumor-infiltrating lymphocytes in the anthracycline-based chemotherapy, Invitrogen CD8A antibody (Lab Vision, RM-9116) was used in immunohistochemistry on human samples at 1:100. Breast Cancer Res (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 2d
In order to test if low-dose interleukin-2 enhances T regulatory cells and suppresses chronic graft-versus-host disease, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 2d). N Engl J Med (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; loading ...; fig 1
In order to compare CD69 expression on T cells from the intestine, spleen, lymph nodes, and blood of normal and SIV-infected macaques, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on rhesus macaque samples (fig 1). PLoS ONE (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1
In order to assess memory T cells in cases of persistent Epstein-Barr virus infection, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1). J Med Virol (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; loading ...; fig 2a
In order to test if CCR5 signaling suppression reduces HIV-associated chronic immune activation, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples (fig 2a). J Med Primatol (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; fig 1
In order to characterize different macaque NK cell subpopulations, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples (fig 1). Immunology (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1a
In order to elucidate relationships among MAPK pathway function, HIV-1-induced activation, and exhaustion markers in circulating CD8+ T cells, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1a). J Virol (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...
In order to characterize two pathogenic, noncoding aberrations of UNC13D in patients with familial hemophagocytic lymphohistiocytosis, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . Blood (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 2b
In order to study the role of T regulatory cells in HIV infection, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 2b). J Virol (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 2
In order to discuss the live attenuated yellow fever vaccines, Invitrogen CD8A antibody (Caltag, 3B.5) was used in flow cytometry on human samples (fig 2). J Infect Dis (2011) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry; human; 1:50
In order to report the immune responses in the parietal pleura of patients with tuberculous pleurisy and compare them with nonspecific pleuritis, Invitrogen CD8A antibody (Thermo-scientific, RM-91160) was used in immunohistochemistry on human samples at 1:50. PLoS ONE (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig S2
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen CD8A antibody (Invitrogen, Q10009) was used in flow cytometry on human samples (fig S2). Proc Natl Acad Sci U S A (2012) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig S2
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen CD8A antibody (eBioscience, 47-0088-42) was used in flow cytometry on human samples (fig S2). Proc Natl Acad Sci U S A (2012) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:100; fig 5I
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen CD8A antibody (Thermo Scientific, MS-457-S1) was used in immunohistochemistry on human samples at 1:100 (fig 5I). Proc Natl Acad Sci U S A (2012) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 3
In order to characterize the new organic dye Krome Orange, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 3). J Immunol Methods (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1
In order to characterize activated T cells using flow cytometry, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1). Cytometry A (2011) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to identify biomarkers to distinguish between true recurrence and new primary cases of ipsilateral breast tumor recurrence, Invitrogen CD8A antibody (Lab vision, RM-9116) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Breast Cancer (Auckl) (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; loading ...
In order to assess second-generation Plasmodium vivax vaccine formulations to identify novel combinations of adjuvants, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples . Infect Immun (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; 1:500
In order to investigate memory B cell proliferation during SIV infection, Invitrogen CD8A antibody (Invitrogen, MHCD0817) was used in flow cytometry on rhesus macaque samples at 1:500. Clin Immunol (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1b
In order to test if anti-IgE therapy attenuates allergen specific T helper 2 cell responses, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1b). Clin Mol Allergy (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...
In order to study the relationship between plasmacytoid dendritic cells and HIV-1 pathogenesis, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . Blood (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 1, 2
In order to examine the impact of Tregs on CAR-modified T cells in the SCID-Beige xenotransplant model, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples (fig 1, 2). Cancer Res (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 3
In order to report that CD248 controls CD8(+) human T cell proliferation, Invitrogen CD8A antibody (Invitrogen, MHCD0830) was used in flow cytometry on human samples (fig 3). Immunology (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; tbl 2
In order to characterize peripheral blood lymphocyte subsets during the 12 months following low dose rabbit antithymocyte globulin therapy, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (tbl 2). Transplant Proc (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; fig 4
In order to identify and characterize memory B cells in normal rhesus macaques, Invitrogen CD8A antibody (Invitrogen, MHCD0817) was used in flow cytometry on rhesus macaque samples (fig 4). PLoS ONE (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; 1:200; loading ...; tbl 1
In order to use antibodies to examine LFA-1 conformational changes, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples at 1:200 (tbl 1). J Immunol Methods (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 1
In order to identify immunological/virological biomarkers associated with sleep quality in patients with chronic hepatitis C, Invitrogen CD8A antibody (Caltag, MHCD0801) was used in flow cytometry on human samples (fig 1). Scand J Immunol (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 1
In order to examine human cross-reactive T cells against a pandemic virus, Invitrogen CD8A antibody (Invitrogen, clone 3B5) was used in flow cytometry on human samples (fig 1). Vaccine (2011) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 2a
In order to assess the effects on cell signaling networks upon blockade of cytotoxic T lymphocyte-associated antigen-4 in patients with metastatic melanoma, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 2a). PLoS ONE (2010) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; fig 1
In order to determine the gene expression profile of Mtb isolated from non-primate granuloma, Invitrogen CD8A antibody (Caltag, MHCD0817) was used in flow cytometry on rhesus macaque samples (fig 1). PLoS ONE (2010) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; 1:40; fig 2a
In order to investigate molecules that stimulate IFN-gamma secretion by tumor-infiltrating T lymphocytes, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples at 1:40 (fig 2a). Cancer Res (2010) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; fig 2
In order to investigate immune mechanisms responsible for viral control in Indian rhesus macaques infected SIV, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on rhesus macaque samples (fig 2). J Immunol (2010) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; fig 2f
In order to use flow cytometry to characterize rhesus macaque lymphocyte, monocyte and dendritic cell subsets, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples (fig 2f). J Immunol Methods (2010) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 1
In order to report that HSP70 activates human NK cells to kill target cells expressing MICA in a natural killer group 2 member D-dependent manner, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples (fig 1). J Cell Mol Med (2010) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 2a
In order to characterize natural killer cells from HIV-infected patients, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 2a). AIDS (2010) ncbi
mouse monoclonal (3B5)
  • flow cytometry; mouse; fig 3
In order to compare the therapeutic efficacy of CD19-specific human primary T cells that constitutively express gamma(c)-cytokines, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on mouse samples (fig 3). Blood (2010) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; fig 3
In order to compare the therapeutic efficacy of CD19-specific human primary T cells that constitutively express gamma(c)-cytokines, Invitrogen CD8A antibody (eBioscience, RPA-T8) was used in flow cytometry on mouse samples (fig 3). Blood (2010) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 2d
In order to use flow cytometry to characterize human lymphocyte, monocyte, and DC subsets, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 2d). Cytometry A (2010) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; loading ...; fig 2d
In order to develop a coinfection animal model and test if HTLV-2 impacts simian immunodeficiency virus SIV(mac251)-induced disease, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on rhesus macaque samples (fig 2d). J Virol (2010) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...
In order to explore the effects of long-term BLyS inhibition in human systemic lupus erythematosus, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples . Arthritis Rheum (2010) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 1
In order to investigate how anti-CD3 monoclonal antibodies alter human immune responses in type 1 diabetes, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples (fig 1). Clin Immunol (2010) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1
In order to examine the effects of flt3 ligand and IL-15 on CD56(bright) natural killer cells, Invitrogen CD8A antibody (Caltag Laboratories/Invitrogen, 3B5) was used in flow cytometry on human samples (fig 1). Cytometry A (2009) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 2a
In order to test if delaying bacillus Calmette-Guerin vaccination from birth to 10 weeks of age enhances vaccine-induced immune responses, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples (fig 2a). Vaccine (2009) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; 1:200; fig 3
In order to develop a method to detect different T-cell populations in humans, Invitrogen CD8A antibody (Caltag, MHCD0829) was used in flow cytometry on human samples at 1:200 (fig 3). Nat Methods (2009) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to develop a xenotransplantation system using human hematopoietic stem cells and mice, Invitrogen CD8A antibody (Caltag/Invitrogen, 3B5) was used in flow cytometry on human samples . Nat Protoc (2008) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 1
In order to characterize lymphocyte subgroups in peripheral blood of advanced stage lung cancer patients, Invitrogen CD8A antibody (eBioscience, 15-0088) was used in flow cytometry on human samples (fig 1). Med Oncol (2010) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; 1:1000; fig 2
In order to show that suberoylanilide hydroxamic acid reactivates HIV from latency in chronically infected cell lines and primary cells, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples at 1:1000 (fig 2). J Biol Chem (2009) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry; human; 1:100; fig 1
In order to study autoantibodies and tumor-infiltrating T cells in epithelial ovarian cancer, Invitrogen CD8A antibody (Lab Vision, RM-9116) was used in immunohistochemistry on human samples at 1:100 (fig 1). PLoS ONE (2008) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to study low frequency antigen-specific CD8+ T cells with peptide-major histocompatibility complex class 1 tetramers and techniques to improve the direct ex vivo detection, Invitrogen CD8A antibody (noco, noca) was used in flow cytometry on human samples . Cytometry A (2008) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; fig 1
In order to examine the functional and immunophenotypic characteristics of CD4+ CD8+ T cells from 6 different neonatal rhesus macaques tissues, Invitrogen CD8A antibody (Caltag, MHCD0817) was used in flow cytometry on rhesus macaque samples (fig 1). Blood (2008) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to suggest that CXCR6 helps to retain T cells within the lung, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . Immunobiology (2008) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 3c
In order to correlate Notch receptor expression and the severity of systemic lupus erythematosus disease, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples (fig 3c). Lupus (2008) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 5a
In order to assess WT1 as an immunotherapeutic target, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples (fig 5a). Blood (2008) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to assess the efficacy of a multigenic DNA prime/modified vaccinia Ankara boost vaccine approach, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . Viral Immunol (2008) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; 1:1000; fig 1
In order to examine the changes in signaling pathways of human CD4(+) and CD8(+) T cells from HIV-infected patients, Invitrogen CD8A antibody (Invitrogen, 3B5) was used in flow cytometry on human samples at 1:1000 (fig 1). J Immunol (2008) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to test if the normally discarded bone marrow collection kits are a convenient source of large numbers of mesenchymal stem cells, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . Transplantation (2007) ncbi
mouse monoclonal (3B5)
  • immunohistochemistry; human; 1:100; fig 1
In order to investigate the spatiotemporal dynamics of CD8 T cells during infection with herpes simplex virus, Invitrogen CD8A antibody (Caltag, MHCD0821) was used in immunohistochemistry on human samples at 1:100 (fig 1). J Exp Med (2007) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque; fig 4
In order to examine HIV/SIV-derived peptide vaccines, Invitrogen CD8A antibody (Caltag, MHCD0817) was used in flow cytometry on rhesus macaque samples (fig 4). Vaccine (2006) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 3A
In order to characterize filoviral glycoproteins and study their contribution to infection, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples (fig 3A). FASEB J (2006) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to detect the JAK2 V617F mutation in hematopoietic stem cells and their progeny in patients with polycythemia vera, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2006) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque
In order to characterize double positive intestinal rhesus macaque T cells, Invitrogen CD8A antibody (Caltag, MHCD0817) was used in flow cytometry on rhesus macaque samples . Eur J Immunol (2006) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to develop methods to establish long-term, antigen-specific T-cell lines and clones, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . Immunol Lett (2006) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to examine the immunogenicity of the ESAT-6-CFP-10 complex, Invitrogen CD8A antibody (Caltag, MHCD0806) was used in flow cytometry on human samples . Int Immunol (2005) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to develop an assay to quantitate the number of latently infected cells carrying replication competent HIV-1, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . Methods Mol Biol (2005) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to elucidate the lineage of central memory T cells and effector memory T cells, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . J Immunol (2005) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 4
In order to study T cell homing in skin infected with Haemophilus ducreyi, Invitrogen CD8A antibody (CalTag, 3B5) was used in flow cytometry on human samples (fig 4). Infect Immun (2005) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; tbl 2
In order to study human cytomegalovirus-specific CD4+ and CD8+ T cells, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples (tbl 2). Eur J Immunol (2005) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to discuss methods to distinguish natural killer cells from natural killer T cells, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . Cytometry A (2005) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque
In order to test if the impaired ability of CD4+ T cells to upregulate CD154 contributes to the immune dysregulation that occurs during human immunodeficiency virus infection, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on rhesus macaque samples . J Virol (2005) ncbi
mouse monoclonal (3B5)
  • flow cytometry; mouse; loading ...; fig 2b
In order to investigate CpG-OVA complex-mediated CD8 T cell immunity in response to vaccination, Invitrogen CD8A antibody (Caltag Laboratories, 3B5) was used in flow cytometry on mouse samples (fig 2b). J Immunol (2005) ncbi
mouse monoclonal (3B5)
  • flow cytometry; African green monkey; fig 1
In order to discuss available reagents for studying the neotropical primate squirrel monkey, Invitrogen CD8A antibody (Caltag Laboratories, 3B5) was used in flow cytometry on African green monkey samples (fig 1). J Immunol Methods (2005) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to show that T cell expansion and contractions in persistent viral infections is not limited to the acute phase of infection, but continues in latent infection, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . Eur J Immunol (2005) ncbi
mouse monoclonal (3B5)
  • flow cytometry; baboons; tbl 4
In order to describe the epidemiologic and clinical presentation of zinc toxicosis in baboons in captivity, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on baboons samples (tbl 4). J Med Primatol (2004) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to study the life-cycle events of HIV-1 in primary cultures of human uterine epithelial cells and stromal fibroblasts, Invitrogen CD8A antibody (Caltag, MHCD0801) was used in flow cytometry on human samples . J Infect Dis (2004) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 5
In order to report the adaptive T cell responses to Japanese encephalitis virus in a naturally exposed healthy virus-immune human cohort, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples (fig 5). Arch Virol (2003) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to test if CD103 has a regulatory role in the microenvironment of the epithelial cell layer, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to ask if flow cytometry can be used for the detection of bone marrow involvement in the different types of B-cell malignant neoplasms, Invitrogen CD8A antibody (Zymed, 3B5) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; loading ...; fig 1a
In order to evaluate the use of recipient Epstein-Barr virus-transformed lymphoblastoid cell lines as stimulators to activate donor alloreactive T cells, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples (fig 1a). Blood (2003) ncbi
mouse monoclonal (3B5)
  • flow cytometry; mouse; fig 4a
In order to elucidate how keratinocyte growth factor and FGFR2IIIb signaling affect the development and function of thymic epithelium, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on mouse samples (fig 4a). Blood (2002) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 1
In order to identify and characterize immature CD2(-/low) T cells in peripheral blood, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples (fig 1). J Immunol (2002) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to report how to isolate highly purified hematopoietic intermediates, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2002) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 1
In order to describe a new flow cytometric method to identify TNF-alpha-secreting cells, Invitrogen CD8A antibody (Caltag Laboratories, clone 3B5) was used in flow cytometry on human samples (fig 1). J Immunol Methods (2002) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to use herpes simplex virus type 2 as a model system to investigate CD8(+) T cell trafficking to the skin in humans, Invitrogen CD8A antibody (Caltag, MHCD0801) was used in flow cytometry on human samples . J Clin Invest (2002) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to report differential expression of chemokine receptors among NKT cell subsets, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . Blood (2002) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to discuss methods to assess adenosine deaminase expression in hematopoietic cells, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . Hum Gene Ther (2002) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to determine how CCR5 expression is reduced in cells from ccr5Delta32 heterozygotes, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . J Biol Chem (2002) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to characterize CCR5 truncations, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . J Biol Chem (2001) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque
In order to assess the effect of IL-18 on a lentiviral infection, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on rhesus macaque samples . J Interferon Cytokine Res (2001) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 3
In order to assess cryptomonad-derived phycobiliproteins for their applicability to flow cytometry, Invitrogen CD8A antibody (Caltag Laboratories, clone 3B5) was used in flow cytometry on human samples (fig 3). Cytometry (2001) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 2
In order to characterize the localization and function of STRL33/Bonzo, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples (fig 2). Blood (2000) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 2
In order to investigate the role Th1 cells and their relationship with Th2 cells in human systemic lupus erythematosus, Invitrogen CD8A antibody (Caltag, MHCD0806) was used in flow cytometry on human samples (fig 2). Haematologica (2000) ncbi
mouse monoclonal (3B5)
  • flow cytometry; rhesus macaque
In order to examine the innate and adaptive immune responses of rhesus macaques infected with SIVmac251, Invitrogen CD8A antibody (BioSource, 3B5) was used in flow cytometry on rhesus macaque samples . J Virol (2000) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to characterize the cells present in the cutaneous blister fluid patients with toxic epidermal necrolysis, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . Clin Exp Immunol (2000) ncbi
mouse monoclonal (3B5)
  • flow cytometry; mouse
In order to elucidate role of SOD-1 overexpression in thymocyte biology, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on mouse samples . J Immunol (1999) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to determine the number of CD4, CCR5, and CXCR4 antibody-binding sites on various T cells and macrophages, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (1999) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human
In order to study responses of peripheral blood T cells to malaria antigens, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples . Infect Immun (1998) ncbi
mouse monoclonal (3B5)
  • flow cytometry; human; fig 4
In order to determine the functional properties of CK beta-11/MIP-3 beta/ELC, Invitrogen CD8A antibody (Caltag, 3B5) was used in flow cytometry on human samples (fig 4). J Immunol (1998) ncbi
BioLegend
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:50; loading ...
BioLegend CD8A antibody (BioLegend, 301028) was used in flow cytometry on human samples at 1:50. Life Sci Alliance (2022) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...
BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples . J Exp Med (2022) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:1000; loading ...
BioLegend CD8A antibody (Biolegend, 344722) was used in flow cytometry on human samples at 1:1000. J Hematol Oncol (2022) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; fig 2b
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on mouse samples (fig 2b). Mol Ther Oncolytics (2022) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s3a, 3a
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig s3a, 3a). Proc Natl Acad Sci U S A (2022) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD8A antibody (BioLegend, 300908) was used in flow cytometry on human samples (fig 1c). Sci Adv (2022) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; loading ...; fig 4a
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD8A antibody (BioLegend, 344718) was used in flow cytometry on mouse samples (fig 4a) and in flow cytometry on human samples (fig 1c). Sci Adv (2022) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig s5e, 5e
BioLegend CD8A antibody (BioLegend, 344722) was used in flow cytometry on human samples (fig s5e, 5e). Sci Adv (2022) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on human samples (fig 1b). Oncoimmunology (2022) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2e, 6d
BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on human samples (fig 2e, 6d). PLoS ONE (2022) ncbi
mouse monoclonal (SK1)
  • mass cytometry; human; loading ...; fig 2d
BioLegend CD8A antibody (Biolegend, 344727) was used in mass cytometry on human samples (fig 2d). Biomark Res (2022) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2e
BioLegend CD8A antibody (Biolegend, 301006) was used in flow cytometry on human samples (fig 2e). Biomark Res (2022) ncbi
mouse monoclonal (SK1)
  • flow cytometry; rhesus macaque; ; fig 9a
BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on rhesus macaque samples at (fig 9a). Front Immunol (2022) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; 1:100; loading ...; fig 1b
BioLegend CD8A antibody (Biolegend, HTT8a) was used in flow cytometry on human samples at 1:100 (fig 1b). Signal Transduct Target Ther (2022) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 5a
BioLegend CD8A antibody (BioLegend, 300922) was used in flow cytometry on human samples (fig 5a). Front Mol Biosci (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:100; fig 5b
BioLegend CD8A antibody (BioLegend, 344718) was used in flow cytometry on human samples at 1:100 (fig 5b). Sci Transl Med (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:100; loading ...; fig 6b
BioLegend CD8A antibody (BioLegend, 344709) was used in flow cytometry on human samples at 1:100 (fig 6b). Nat Nanotechnol (2022) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 4c
BioLegend CD8A antibody (Biolegend, 344722) was used in flow cytometry on human samples (fig 4c). Cell Rep Med (2021) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:200; loading ...; fig 4h
BioLegend CD8A antibody (BioLegend, 301008) was used in flow cytometry on human samples at 1:200 (fig 4h). J Immunother Cancer (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 5e
BioLegend CD8A antibody (Biolegend, 980904) was used in flow cytometry on human samples (fig 5e). Cell (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples (fig 1a). Front Immunol (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; 1:1000; loading ...; fig 7l
BioLegend CD8A antibody (Biolegend, 344716) was used in flow cytometry on mouse samples at 1:1000 (fig 7l). Cell Rep Med (2021) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; 1:1000; loading ...
BioLegend CD8A antibody (Biolegend, 301031) was used in flow cytometry on mouse samples at 1:1000. Cell Rep Med (2021) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD8A antibody (Biolegend, 301016) was used in flow cytometry on human samples (fig 1a). Cell Host Microbe (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s2
BioLegend CD8A antibody (Biolegend, 344722) was used in flow cytometry on human samples (fig s2). Mucosal Immunol (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 4
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig 4). Aging Cell (2021) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...
BioLegend CD8A antibody (BioLegend, 301044) was used in flow cytometry on human samples . Cell Rep Med (2021) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on human samples (fig 1b). Acta Neuropathol (2021) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human
BioLegend CD8A antibody (Biolegend, HIT8a) was used in flow cytometry on human samples . Immunity (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples . Immunity (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s6e
BioLegend CD8A antibody (BioLegend, 344722) was used in flow cytometry on human samples (fig s6e). Sci Transl Med (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BioLegend CD8A antibody (BioLegend, 344742) was used in flow cytometry on human samples . Science (2021) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; 1:100
BioLegend CD8A antibody (Biolegend, 300922) was used in flow cytometry on human samples at 1:100. Science (2021) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; 1:1000; loading ...
BioLegend CD8A antibody (BioLegend, 301035) was used in flow cytometry on mouse samples at 1:1000. Clin Cancer Res (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 8i
BioLegend CD8A antibody (Biolegend, 344748) was used in flow cytometry on human samples (fig 8i). Sci Rep (2021) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; fig 2f
BioLegend CD8A antibody (Biolegend, 300908) was used in flow cytometry on human samples (fig 2f). Sci Rep (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 3:50; loading ...; fig 3a
BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples at 3:50 (fig 3a). elife (2020) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 2a, s2, 3a
BioLegend CD8A antibody (Biolegend, 300929) was used in flow cytometry on human samples (fig 2a, s2, 3a). Am J Respir Crit Care Med (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 2a, s2, 3a
BioLegend CD8A antibody (Biolegend, 344707) was used in flow cytometry on human samples (fig 2a, s2, 3a). Am J Respir Crit Care Med (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...
BioLegend CD8A antibody (BioLegend, 344732) was used in flow cytometry on human samples . Cell (2021) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig s3-1
BioLegend CD8A antibody (Biolegend, 301053) was used in flow cytometry on human samples (fig s3-1). elife (2020) ncbi
mouse monoclonal (SK1)
  • immunohistochemistry; human; loading ...; fig 3c
BioLegend CD8A antibody (Biolegend, 344726) was used in immunohistochemistry on human samples (fig 3c). elife (2020) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend CD8A antibody (Biolegned, 344710) was used in flow cytometry on mouse samples (fig 3f). Nat Commun (2020) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples . elife (2020) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:100; loading ...; fig 2j
BioLegend CD8A antibody (BioLegend, 301050) was used in flow cytometry on human samples at 1:100 (fig 2j). elife (2020) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s3a
BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples (fig s3a). Aging (Albany NY) (2020) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s2
BioLegend CD8A antibody (Biolegend, 301042) was used in flow cytometry on human samples (fig s2). Cell (2020) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:400; loading ...; fig s1i
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples at 1:400 (fig s1i). J Clin Invest (2020) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1a, 1b
BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples (fig 1a, 1b). elife (2020) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; 1:200; loading ...; fig 3b
BioLegend CD8A antibody (Biolegend, HIT8a) was used in flow cytometry on human samples at 1:200 (fig 3b). Sci Signal (2020) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...
BioLegend CD8A antibody (BioLegend, HIT8a) was used in flow cytometry on human samples . Sci Adv (2020) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; 3:50; loading ...; fig 1c
BioLegend CD8A antibody (Biolegend, HIT8a) was used in flow cytometry on human samples at 3:50 (fig 1c). Science (2020) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD8A antibody (BioLegend, HIT8a) was used in flow cytometry on human samples (fig s1a). Sci Adv (2020) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...
BioLegend CD8A antibody (BioLegend, 344718) was used in flow cytometry on human samples . Nature (2020) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 0.5 ug/ml; loading ...; fig 1d
BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples at 0.5 ug/ml (fig 1d). Science (2019) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s20
BioLegend CD8A antibody (Biolegend, 344716) was used in flow cytometry on human samples (fig s20). Science (2019) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; 1:200; loading ...; fig 7b
BioLegend CD8A antibody (BioLegend, 300913) was used in flow cytometry on human samples at 1:200 (fig 7b). elife (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD8A antibody (Biolegend, 301016) was used in flow cytometry on human samples (fig 3c). Cell Rep (2019) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig e1a, 3h
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig e1a, 3h). Nature (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on human samples (fig 3c). elife (2019) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig s1). Aging Cell (2020) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; 1:100; loading ...; fig 7s1a
BioLegend CD8A antibody (Biolegend, 300920) was used in flow cytometry on human samples at 1:100 (fig 7s1a). elife (2019) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 3d
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig 3d). Nature (2019) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:200; loading ...; fig 1s1a
BioLegend CD8A antibody (BioLegend, 344710) was used in flow cytometry on human samples at 1:200 (fig 1s1a). elife (2019) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD8A antibody (BioLegend, HIT8a) was used in flow cytometry on human samples (fig 1a). Arthritis Res Ther (2019) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig s6c
BioLegend CD8A antibody (Biolegend, HIT8a) was used in flow cytometry on human samples (fig s6c). Science (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD8A antibody (BioLegend, 301053) was used in flow cytometry on human samples (fig s1a). Cell (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; loading ...; fig s5b
BioLegend CD8A antibody (BioLegend, 301041) was used in flow cytometry on mouse samples (fig s5b). Nat Immunol (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:200; loading ...; fig 1a
BioLegend CD8A antibody (Biolegend, 301023) was used in flow cytometry on human samples at 1:200 (fig 1a). Nat Commun (2019) ncbi
mouse monoclonal (RPA-T8)
  • mass cytometry; human; loading ...
BioLegend CD8A antibody (Biolegend, RPA-T8) was used in mass cytometry on human samples . PLoS Pathog (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:200; loading ...; fig 1s1a
BioLegend CD8A antibody (Biolegend, 301042) was used in flow cytometry on human samples at 1:200 (fig 1s1a). elife (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 3f, 3g
BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on human samples (fig 3f, 3g). Brain Pathol (2020) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 6
BioLegend CD8A antibody (BioLegend, 300913) was used in flow cytometry on human samples (fig 6). Gastroenterol Res Pract (2019) ncbi
mouse monoclonal (RPA-T8)
  • other; human; loading ...; fig 4a
BioLegend CD8A antibody (BioLegend, 301067) was used in other on human samples (fig 4a). Cell (2019) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD8A antibody (BioLegend, 300906) was used in flow cytometry on human samples (fig 4a). Diagn Pathol (2019) ncbi
mouse monoclonal (SK1)
  • mass cytometry; human; loading ...; fig s1
BioLegend CD8A antibody (BioLegend, SK1) was used in mass cytometry on human samples (fig s1). J Exp Med (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig 1a). BMC Res Notes (2019) ncbi
mouse monoclonal (RPA-T8)
  • mass cytometry; human; loading ...; fig 2b
BioLegend CD8A antibody (Biolegend, 301002) was used in mass cytometry on human samples (fig 2b). Cell (2019) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig s8
BioLegend CD8A antibody (BioLegend, HiT8a) was used in flow cytometry on human samples (fig s8). Nat Commun (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig ex5e
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig ex5e). Nat Med (2019) ncbi
mouse monoclonal (Hit8a)
  • immunohistochemistry - frozen section; human; loading ...; fig 2c
BioLegend CD8A antibody (BioLegend, HIT8a) was used in immunohistochemistry - frozen section on human samples (fig 2c). J Clin Invest (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig s1a). Eur J Immunol (2019) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig s1). Nat Immunol (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig s1a). Aging (Albany NY) (2019) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples (fig 3a). Cell Stem Cell (2019) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig s1b). J Immunol (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD8A antibody (Biolegend, 344702) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig 1b). J Clin Invest (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s4b
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig s4b). Sci Immunol (2018) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD8A antibody (BioLegend, HIT8a) was used in flow cytometry on human samples (fig 1a). Int J Infect Dis (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on mouse samples (fig 2b). Mucosal Immunol (2018) ncbi
mouse monoclonal (RPA-T8)
  • immunohistochemistry; human; 5,000 ug/ml; loading ...; fig s1b
BioLegend CD8A antibody (Biolegend, RPTA-T8) was used in immunohistochemistry on human samples at 5,000 ug/ml (fig s1b). Curr Biol (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 4f
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig 4f). J Clin Invest (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD8A antibody (BioLegend, 344708) was used in flow cytometry on human samples (fig 3a). Biol Reprod (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig 1c). J Clin Invest (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig s2e
BioLegend CD8A antibody (BioLegend, 344731) was used in flow cytometry on human samples (fig s2e). Cell (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 2c
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig 2c). J Virol (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples (fig 3a). Antimicrob Agents Chemother (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig 4b). J Clin Invest (2017) ncbi
mouse monoclonal (SK1)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend CD8A antibody (BioLegend, SK1) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s5a
In order to detail MAIT cell responses to various microorganisms and cytokines, BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig s5a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; tbl s3
In order to conduct a phenotypical investigation of clear cell renal cell carcinoma, BioLegend CD8A antibody (biolegend, RPA-T8) was used in flow cytometry on human samples (tbl s3). Cell (2017) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 6a
BioLegend CD8A antibody (Biolegend, HIT8a) was used in flow cytometry on human samples (fig 6a). Oncoimmunology (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; African green monkey; fig s4
In order to optimize the dosing regimen of neutralizing anti-HIV-1 antibodies, BioLegend CD8A antibody (biolegend, RPA-T8) was used in flow cytometry on African green monkey samples (fig s4). Nature (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD8A antibody (BioLegend, 301049) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BioLegend CD8A antibody (BioLegend, 301012) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; rhesus macaque; loading ...; fig 1d
In order to examine the kinetics of SIV-specific CD8+ T cell cytolytic factor expression in peripheral blood, lymph node, spleen, and gut mucosa from early acute infection through chronic infection, BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on rhesus macaque samples (fig 1d). PLoS Pathog (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; fig s3b
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on mouse samples (fig s3b). Nat Commun (2016) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; mouse; loading ...; fig 2f
In order to study the impact of modulating IFN-I signaling during suppressive combined antiretroviral therapy, BioLegend CD8A antibody (BioLegend, HIT8a) was used in flow cytometry on mouse samples (fig 2f). J Clin Invest (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:100; loading ...; fig 1
In order to report the effect of antiretroviral treatment initiation and different antiretroviral treatment regimens on the reconstitution of mucosal T cells within the gut associated lymphoid tissue, BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on human samples at 1:100 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:50; loading ...; fig 2a
In order to measure CD11d expression on lymphocyte subsets using flow cytometry, BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples at 1:50 (fig 2a). J Leukoc Biol (2017) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 1c
In order to profile the infiltration levels of immune cell populations in 19 cancer types, BioLegend CD8A antibody (Biolegend, 300926) was used in flow cytometry on human samples (fig 1c). Genome Biol (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; fig 3i
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on mouse samples (fig 3i). J Exp Med (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s1c
In order to demonstrate that neonatal CD8 positive T cells have a specific genetic program biased toward the innate immune response, BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples (fig s1c). Cell Rep (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize CD8 positive alpha beta gamma delta T cells, BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1a
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on human samples (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s8
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig s8). Science (2016) ncbi
mouse monoclonal (RPA-T8)
In order to characterize CD8 positive T cell subsets in dengue patients from India and Thailand, BioLegend CD8A antibody (Biolegend, 301048) was used . J Virol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig 1). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD8A antibody (BioLegend, HIT8a) was used in flow cytometry on human samples (fig 3a). Sci Rep (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 6e
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig 6e). J Clin Invest (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:50; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples at 1:50 (tbl s2). Nat Immunol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig s4a
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig s4a). J Immunol (2016) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 4
BioLegend CD8A antibody (Biolegend, HIT8a) was used in flow cytometry on human samples (fig 4). J Immunol Res (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; rhesus macaque; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BioLegend CD8A antibody (BioLegend, 301048) was used in flow cytometry on rhesus macaque samples . Nat Med (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s3
BioLegend CD8A antibody (Biolegend, RPAT8) was used in flow cytometry on human samples (fig s3). Nature (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; rhesus macaque; loading ...; fig 8b
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on rhesus macaque samples (fig 8b). PLoS ONE (2016) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...
In order to explore the role of the JAK/STAT pathway in controlling Foxp3 in regulatory T cells, BioLegend CD8A antibody (Biolegend, HIT8a) was used in flow cytometry on human samples . PLoS ONE (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2b
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig 2b). Am J Transplant (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:50; fig 6
BioLegend CD8A antibody (Biolegend, RPA T8) was used in flow cytometry on human samples at 1:50 (fig 6). PLoS ONE (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 10 ug/ml
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples at 10 ug/ml. Nat Commun (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; tbl s1
In order to explore how junctional adhesion molecule family members differentially regulate CXCR4 function and CXCL12 secretion in the bone marrow niche, BioLegend CD8A antibody (Biolegend, 301010) was used in flow cytometry on human samples (tbl s1). Stem Cells (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1b
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend CD8A antibody (biolegend, RPA-T8) was used in flow cytometry on human samples (fig 1b). J Immunol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; rhesus macaque; fig 3
In order to assess the ability of HIV-1 envelope glycoprotein-specific broadly neutralizing monoclonal antibodies to suppress acute simian-human immunodeficiency virus replication in rhesus macaques, BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on rhesus macaque samples (fig 3). J Virol (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; rhesus macaque; loading ...; fig s2
In order to study the CD8+ non-cytolytic antiviral response in SIV infected rhesus macaques, BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on rhesus macaque samples (fig s2). PLoS ONE (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:20
In order to describe the CD161(hi)TRAV1-2(+) TCR repertoire, BioLegend CD8A antibody (Biolegend, 344707) was used in flow cytometry on human samples at 1:20. Hum Immunol (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig s1
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on human samples (fig s1). PLoS Pathog (2015) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human
BioLegend CD8A antibody (BioLegend, HIT8a) was used in flow cytometry on human samples . Thromb Res (2015) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; 1:200; fig s3
BioLegend CD8A antibody (Biolegend, HIT8a) was used in flow cytometry on human samples at 1:200 (fig s3). Nat Commun (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; rhesus macaque; fig 1
In order to elucidate how CD8 positive T cells suppress virus replication during simian immunodeficiency virus infection, BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on rhesus macaque samples (fig 1). J Virol (2015) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; tbl 4
In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, BioLegend CD8A antibody (BioLegend, HIT8a) was used in flow cytometry on human samples (tbl 4). Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
In order to determine if HIV elite controllers have exhausted T cells, BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; tbl s1
BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples (tbl s1). PLoS ONE (2015) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 4c
BioLegend CD8A antibody (Biolegend, HIT8a) was used in flow cytometry on human samples (fig 4c). J Immunol Res (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BioLegend CD8A antibody (Biolegend, 301026) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig 2
BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples (fig 2). Cancer Immunol Res (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples . Clin Immunol (2015) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, BioLegend CD8A antibody (BioLegend, HIT8a) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; 1:40
BioLegend CD8A antibody (BioLegend, HIT8 alpha) was used in flow cytometry on human samples at 1:40. Nat Med (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human
BioLegend CD8A antibody (Biolegend, HIT8a) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; fig 1
In order to study the role of plasmacytoid dendritic cells in human immunodeficiency virus type 1 infection and pathogenesis, BioLegend CD8A antibody (Biolegend, 300914) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2014) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human
BioLegend CD8A antibody (BioLegend, HIT8a) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human
BioLegend CD8A antibody (BioLegend, HIT8alpha) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (RPA-T8)
BioLegend CD8A antibody (BioLegend, RPA-T8) was used . J Leukoc Biol (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples . Cell Immunol (2014) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend CD8A antibody (Biolegend, HIT8a) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; rhesus macaque
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BioLegend CD8A antibody (Biolegend, clone RPA-T8) was used in flow cytometry on human samples . Mol Ther (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
mouse monoclonal (SK1)
  • immunocytochemistry; human
BioLegend CD8A antibody (BioLegend, SK1) was used in immunocytochemistry on human samples . J Cell Physiol (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 2
In order to assess how different concentrations of IFN-gamma affect dendritic cells, BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig 2). J Leukoc Biol (2014) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:250; loading ...; fig 6e
Abcam CD8A antibody (Abcam, ab4055) was used in immunohistochemistry - paraffin section on mouse samples at 1:250 (fig 6e). Nat Commun (2022) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; fig 7a
Abcam CD8A antibody (Abcam, ab209775) was used in immunohistochemistry - paraffin section on mouse samples (fig 7a). J Int Med Res (2022) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry; mouse; 1:1000; fig 2h
Abcam CD8A antibody (ABCAM, ab209775) was used in immunohistochemistry on mouse samples at 1:1000 (fig 2h). J Immunol Res (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5e
Abcam CD8A antibody (Abcam, 4055) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5e). Mol Cancer Ther (2022) ncbi
domestic rabbit monoclonal (EP1150Y)
  • immunohistochemistry; human; 1:500; loading ...; fig 3f
Abcam CD8A antibody (Abcam, ab93278) was used in immunohistochemistry on human samples at 1:500 (fig 3f). Nat Commun (2022) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig s2
Abcam CD8A antibody (Abcam, ab209775) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig s2). Development (2022) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 3b
Abcam CD8A antibody (Abcam, EPR20305) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 3b). Med Oncol (2022) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; fig 4b
Abcam CD8A antibody (Abcam, ab209775) was used in immunohistochemistry - paraffin section on mouse samples (fig 4b). Gastric Cancer (2022) ncbi
mouse monoclonal (144B)
  • immunohistochemistry; human; 1:50; loading ...; fig 6a
Abcam CD8A antibody (Abcam, ab17147) was used in immunohistochemistry on human samples at 1:50 (fig 6a). Int J Biol Sci (2021) ncbi
domestic rabbit monoclonal (EP1150Y)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig s1a
Abcam CD8A antibody (Abcam, ab93278) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig s1a). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1h
Abcam CD8A antibody (Abcam, ab209775) was used in immunohistochemistry - paraffin section on mouse samples (fig 1h). Adv Sci (Weinh) (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:200; fig 1g
Abcam CD8A antibody (Abcam, ab4055) was used in immunohistochemistry on human samples at 1:200 (fig 1g). Aging (Albany NY) (2021) ncbi
mouse monoclonal (C8/468 + C8/144B)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6q
Abcam CD8A antibody (Abcam, ab199016) was used in immunohistochemistry - paraffin section on mouse samples (fig 6q). Signal Transduct Target Ther (2021) ncbi
domestic rabbit monoclonal (SP239)
  • immunohistochemistry - paraffin section; African green monkey; 4 ug/ml; loading ...; fig s1b
Abcam CD8A antibody (Abcam, ab178089) was used in immunohistochemistry - paraffin section on African green monkey samples at 4 ug/ml (fig s1b). Commun Biol (2021) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry; mouse; loading ...; fig 8c
Abcam CD8A antibody (Abcam, ab209775) was used in immunohistochemistry on mouse samples (fig 8c). Neoplasia (2021) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6f
Abcam CD8A antibody (Abcam, ab209775) was used in immunohistochemistry - paraffin section on mouse samples (fig 6f). Sci Adv (2021) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - frozen section; mouse; fig 5c
Abcam CD8A antibody (Abcam, EPR20305) was used in immunohistochemistry - frozen section on mouse samples (fig 5c). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (EP1150Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig 7c
Abcam CD8A antibody (Abcam, EP1150Y) was used in immunohistochemistry - paraffin section on human samples (fig 7c). Cell Death Dis (2020) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; 1:2000; loading ...; fig 4a
Abcam CD8A antibody (Abcam, ab209775) was used in immunohistochemistry - paraffin section on mouse samples at 1:2000 (fig 4a). BMC Cancer (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 1a
Abcam CD8A antibody (Abcam, ab4055) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1a). BMC Cancer (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human
Abcam CD8A antibody (Abcam, ab4055) was used in immunohistochemistry - paraffin section on human samples . Aging (Albany NY) (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s4
Abcam CD8A antibody (Abcam, ab4055) was used in immunohistochemistry - paraffin section on mouse samples (fig s4). Mol Ther Nucleic Acids (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig 2d
Abcam CD8A antibody (Abcam, ab4055) was used in immunohistochemistry - paraffin section on human samples (fig 2d). Aging Cell (2020) ncbi
domestic rabbit monoclonal (EP1150Y)
  • flow cytometry; mouse; loading ...; fig 2a
Abcam CD8A antibody (Abcam, EP1150Y) was used in flow cytometry on mouse samples (fig 2a). J Immunother Cancer (2020) ncbi
domestic rabbit monoclonal (EP1150Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2d
Abcam CD8A antibody (Abcam, ab93278) was used in immunohistochemistry - paraffin section on human samples (fig 2d). BMC Immunol (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 7
Abcam CD8A antibody (Abcam, ab4055) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 7). Food Sci Nutr (2020) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6
Abcam CD8A antibody (Abcam, ab209775) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Oncoimmunology (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; loading ...; fig s6c
Abcam CD8A antibody (Abcam, ab4055) was used in immunohistochemistry - frozen section on mouse samples (fig s6c). Sci Adv (2019) ncbi
mouse monoclonal (144B)
  • immunohistochemistry - paraffin section; human; loading ...; fig s7d
Abcam CD8A antibody (Abcam, ab17147) was used in immunohistochemistry - paraffin section on human samples (fig s7d). Cell (2019) ncbi
domestic rabbit monoclonal (EP1150Y)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1c
Abcam CD8A antibody (Abcam, ab93278) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1c). J Immunother Cancer (2019) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 8c
Abcam CD8A antibody (Abcam, EPR20305) was used in immunohistochemistry - paraffin section on mouse samples (fig 8c). J Exp Med (2019) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry; human; 1:100; loading ...
Abcam CD8A antibody (Abcam, EPR20305) was used in immunohistochemistry on human samples at 1:100. Nature (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig 1c
Abcam CD8A antibody (Abcam, ab4055) was used in immunohistochemistry - paraffin section on human samples (fig 1c). Cancer Med (2019) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry; mouse; 1:750; loading ...; fig s4b
Abcam CD8A antibody (Abcam, ab209775) was used in immunohistochemistry on mouse samples at 1:750 (fig s4b). Breast Cancer Res (2018) ncbi
domestic rabbit monoclonal (EP1150Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1e
Abcam CD8A antibody (Abcam, ab93278) was used in immunohistochemistry - paraffin section on human samples (fig s1e). Nat Commun (2018) ncbi
domestic rabbit monoclonal (EP1150Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5a
Abcam CD8A antibody (Abcam, ab93278) was used in immunohistochemistry - paraffin section on human samples (fig 5a). Int J Cancer (2018) ncbi
mouse monoclonal (144B)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 1
In order to investigate infiltrating T cells in liver cancer through single-cell sequencing, Abcam CD8A antibody (Abcam, ab17147) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Cell (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; loading ...; fig 1d
In order to use CD49a expression to define subsets of tissue-resident memory T cells in the skin, Abcam CD8A antibody (AbCAM, AB4055) was used in immunohistochemistry on human samples (fig 1d). Immunity (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; African green monkey; loading ...
In order to perform an enhanced embryo-fetal development investigation using pateclizumab in cynomolgus monkeys, Abcam CD8A antibody (Abcam, ab4055) was used in immunohistochemistry - paraffin section on African green monkey samples . Reprod Toxicol (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; fig 3
Abcam CD8A antibody (Abcam, ab4055) was used in immunohistochemistry on mouse samples (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (MEM-31)
  • flow cytometry; human
Abcam CD8A antibody (Abcam, ab26004) was used in flow cytometry on human samples . Traffic (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (32-M4)
  • immunohistochemistry; human; loading ...; fig 1a
Santa Cruz Biotechnology CD8A antibody (Santa Cruz, SC-1177) was used in immunohistochemistry on human samples (fig 1a). J Immunother Cancer (2022) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3c
Santa Cruz Biotechnology CD8A antibody (Santa Cruz, 53212) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3c). Arthritis Res Ther (2022) ncbi
mouse monoclonal (D-9)
  • immunohistochemistry; mouse; loading ...; fig 2g
Santa Cruz Biotechnology CD8A antibody (Santa Cruz, sc-7970) was used in immunohistochemistry on mouse samples (fig 2g). Theranostics (2021) ncbi
mouse monoclonal (D-9)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 11b
Santa Cruz Biotechnology CD8A antibody (Santa Cruz Biotechnology, sc 7970) was used in immunohistochemistry on mouse samples at 1:500 (fig 11b). Int J Mol Sci (2020) ncbi
mouse monoclonal (32-M4)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 9d
Santa Cruz Biotechnology CD8A antibody (Santa Cruz, sc-1177) was used in immunohistochemistry on mouse samples at 1:50 (fig 9d). J Neuroinflammation (2020) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:40; fig s7g
Santa Cruz Biotechnology CD8A antibody (SantaCruz, sc-53212) was used in immunohistochemistry on human samples at 1:40 (fig s7g). Nature (2018) ncbi
mouse monoclonal (UCH-T4)
  • immunohistochemistry - paraffin section; human; 1:100; fig s3
Santa Cruz Biotechnology CD8A antibody (Santa Cruz, sc-1181) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s3). Oncotarget (2016) ncbi
mouse monoclonal (6A242)
  • flow cytometry; mouse; fig 1
Santa Cruz Biotechnology CD8A antibody (Santa Cruz, 6A242) was used in flow cytometry on mouse samples (fig 1). Sci Rep (2016) ncbi
Miltenyi Biotec
human monoclonal (REA734)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s6
Miltenyi Biotec CD8A antibody (Miltenyi Biotec, 130-110-677) was used in immunohistochemistry - frozen section on mouse samples (fig s6). Sci Rep (2022) ncbi
mouse monoclonal (BW135/80)
  • flow cytometry; human; 1:100; fig 2f
Miltenyi Biotec CD8A antibody (Miltenyi, 130-113-155) was used in flow cytometry on human samples at 1:100 (fig 2f). Nat Med (2021) ncbi
mouse monoclonal (BW135/80)
  • flow cytometry; human; loading ...; fig s1a
Miltenyi Biotec CD8A antibody (Miltenyi Biotec, BW135/80) was used in flow cytometry on human samples (fig s1a). Oncoimmunology (2020) ncbi
mouse monoclonal (BW135/80)
  • flow cytometry; human; loading ...; fig 3b
Miltenyi Biotec CD8A antibody (Miltenyi Biotec, BW135/80) was used in flow cytometry on human samples (fig 3b). Front Immunol (2018) ncbi
mouse monoclonal (BW135/80)
  • flow cytometry; human; fig 1
Miltenyi Biotec CD8A antibody (Miltenyi Biotec, BW135/80) was used in flow cytometry on human samples (fig 1). Biosci Rep (2017) ncbi
mouse monoclonal (BW135/80)
  • flow cytometry; human; loading ...; fig 5a
Miltenyi Biotec CD8A antibody (Miltenyi Biotec, BW135/80) was used in flow cytometry on human samples (fig 5a). FEBS Lett (2017) ncbi
mouse monoclonal (BW135/80)
  • flow cytometry; human; loading ...; fig 1a, 4a
Miltenyi Biotec CD8A antibody (Miltenyi Biotec, BW135/80) was used in flow cytometry on human samples (fig 1a, 4a). Front Immunol (2017) ncbi
mouse monoclonal (BW135/80)
  • flow cytometry; human; loading ...; fig 5a
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, Miltenyi Biotec CD8A antibody (Miltenyi Biotec, BW135/80) was used in flow cytometry on human samples (fig 5a). J Exp Med (2016) ncbi
mouse monoclonal (BW135/80)
  • flow cytometry; human; loading ...; fig 1
In order to elucidate Th17 cell polarization, depletion, and restoration in response to HIV infection and antiretroviral therapy, Miltenyi Biotec CD8A antibody (Miltenyi, BW135/80) was used in flow cytometry on human samples (fig 1). Retrovirology (2015) ncbi
Bio-Rad
mouse monoclonal (38.65)
  • flow cytometry; domestic sheep; loading ...; fig 2a
Bio-Rad CD8A antibody (BioRad, 38.65) was used in flow cytometry on domestic sheep samples (fig 2a). BMC Vet Res (2020) ncbi
mouse monoclonal (LT8)
  • immunohistochemistry - frozen section; human; 1:50; loading ...; fig 2a-i
Bio-Rad CD8A antibody (AbD-Serotec, LT8) was used in immunohistochemistry - frozen section on human samples at 1:50 (fig 2a-i). Ann Clin Transl Neurol (2020) ncbi
mouse monoclonal (12.C7)
  • flow cytometry; human; loading ...; fig 1a
Bio-Rad CD8A antibody (Serotec, MCA1576F) was used in flow cytometry on human samples (fig 1a). J Virol (2018) ncbi
mouse monoclonal (4B11)
  • immunohistochemistry - paraffin section; human; tbl s7
In order to conduct a phenotypical investigation of clear cell renal cell carcinoma, Bio-Rad CD8A antibody (Bio-Rad, 4B11) was used in immunohistochemistry - paraffin section on human samples (tbl s7). Cell (2017) ncbi
mouse monoclonal (11-39)
  • flow cytometry; chicken; loading ...; fig 2b
Bio-Rad CD8A antibody (AbD Serotec, MCA2166PE) was used in flow cytometry on chicken samples (fig 2b). Vet Res (2017) ncbi
mouse monoclonal (38.65)
  • flow cytometry; domestic sheep; fig 3
Bio-Rad CD8A antibody (AbD Serotec, MCA2216GA) was used in flow cytometry on domestic sheep samples (fig 3). PLoS ONE (2016) ncbi
rat monoclonal (YTC182.20)
  • immunohistochemistry; African green monkey; loading ...
In order to perform an enhanced embryo-fetal development investigation using pateclizumab in cynomolgus monkeys, Bio-Rad CD8A antibody (AbD Serotec, MCA351G) was used in immunohistochemistry on African green monkey samples . Reprod Toxicol (2016) ncbi
mouse monoclonal (LT8)
  • flow cytometry; marmosets; loading ...; fig 4a
In order to test a therapeutic antibody against CD127 in a mouse model of experimental autoimmune encephalomyelitis, Bio-Rad CD8A antibody (Serotec, LT-8) was used in flow cytometry on marmosets samples (fig 4a). J Neuroimmune Pharmacol (2016) ncbi
mouse monoclonal (12.C7)
  • flow cytometry; domestic rabbit; fig 8
Bio-Rad CD8A antibody (AbD Serotec, MCA1576GA) was used in flow cytometry on domestic rabbit samples (fig 8). PLoS ONE (2015) ncbi
mouse monoclonal (LT8)
  • immunocytochemistry; human; 1:200; loading ...; fig 5
Bio-Rad CD8A antibody (Serotec, MCA1226A488) was used in immunocytochemistry on human samples at 1:200 (fig 5). elife (2014) ncbi
mouse monoclonal (RPA-T8)
  • immunohistochemistry; African green monkey; 1:100
In order to study the neurotoxicity of AAV9-mediated expression of a non-self protein in nonhuman primates, Bio-Rad CD8A antibody (AbD-Serotec, MCA4609T) was used in immunohistochemistry on African green monkey samples at 1:100. Mol Ther (2014) ncbi
mouse monoclonal (LT8)
  • immunohistochemistry - frozen section; rhesus macaque; loading ...
Bio-Rad CD8A antibody (AbD Serotec, MCA1226F) was used in immunohistochemistry - frozen section on rhesus macaque samples . Mol Ther (2014) ncbi
Novus Biologicals
rat monoclonal (YTS105.18)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 5c
Novus Biologicals CD8A antibody (Novus, NB200-578) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 5c). Sci Transl Med (2022) ncbi
domestic rabbit polyclonal (A103)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6q
Novus Biologicals CD8A antibody (Novus, NBP2-29475) was used in immunohistochemistry - paraffin section on mouse samples (fig 6q). Signal Transduct Target Ther (2021) ncbi
domestic rabbit polyclonal (A103)
  • immunohistochemistry; human; 1:100; loading ...; fig 4i
Novus Biologicals CD8A antibody (Novus Biologicals, NBP2-29475) was used in immunohistochemistry on human samples at 1:100 (fig 4i). Adv Sci (Weinh) (2021) ncbi
R&D Systems
mouse monoclonal (37020)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 2e
R&D Systems CD8A antibody (R&D Systems, MAB3801) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2e). J Pers Med (2021) ncbi
Bio X Cell
mouse monoclonal (OKT-8)
  • blocking or activating experiments; mouse; loading ...; fig 2d
Bio X Cell CD8A antibody (Bio X Cell, OKT-8) was used in blocking or activating experiments on mouse samples (fig 2d). J Infect Dis (2015) ncbi
Dako
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:150; fig 4b
Dako CD8A antibody (DAKO, M7103) was used in immunohistochemistry on human samples at 1:150 (fig 4b). Cancers (Basel) (2022) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 3
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Cancer Sci (2021) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:200. Front Oncol (2021) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:400; loading ...; fig 2
Dako CD8A antibody (DAKO, C8/144B) was used in immunohistochemistry on human samples at 1:400 (fig 2). Ann Hematol (2021) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:800; fig s1e
  • immunohistochemistry; fruit fly ; 1:800; fig s1e
Dako CD8A antibody (Dako, C8/144B, M7103) was used in immunohistochemistry on human samples at 1:800 (fig s1e) and in immunohistochemistry on fruit fly samples at 1:800 (fig s1e). Nature (2021) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:25; loading ...; fig 2i
Dako CD8A antibody (Dako, C8/144b) was used in immunohistochemistry on human samples at 1:25 (fig 2i). elife (2020) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:1; loading ...; fig 1b
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:1 (fig 1b). Breast Cancer Res (2020) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples (fig 5). Front Immunol (2020) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; loading ...
Dako CD8A antibody (DAKO, M7103) was used in immunohistochemistry - paraffin section on human samples . elife (2020) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; fig 3a
Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry - paraffin section on human samples (fig 3a). Acta Neuropathol Commun (2020) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; mouse; loading ...; fig s6
Dako CD8A antibody (DAKO, M7103) was used in immunohistochemistry on mouse samples (fig s6). Oncoimmunology (2020) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:50; loading ...; fig 1, 4, 5
Dako CD8A antibody (Dako Glostrup, Denmark, c8/144B) was used in immunohistochemistry on human samples at 1:50 (fig 1, 4, 5). Microorganisms (2020) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:200; loading ...; fig 2b
Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry on human samples at 1:200 (fig 2b). Cancer Immunol Immunother (2020) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 2a-b
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2a-b). Ann Clin Transl Neurol (2020) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:200; loading ...; fig 2f
Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry on human samples at 1:200 (fig 2f). Nature (2020) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 4
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 4). Exp Eye Res (2020) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 4b
Dako CD8A antibody (DAKO, M7103) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 4b). Nat Commun (2019) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1c
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples (fig 1c). Cell (2019) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:100; loading ...; fig 1c
Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry on human samples at 1:100 (fig 1c). JCO Precis Oncol (2019) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig s2c
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig s2c). Nat Med (2019) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - frozen section; human; 1 ug/ml; loading ...; fig 4c, 4d
Dako CD8A antibody (Dako, M710301-2) was used in immunohistochemistry - frozen section on human samples at 1 ug/ml (fig 4c, 4d). Cell (2018) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; loading ...; fig s3a
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples (fig s3a). J Clin Invest (2018) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; fig s2a
Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry - paraffin section on human samples (fig s2a). Cell (2018) ncbi
mouse monoclonal (C8/144B)
  • immunocytochemistry; human; 1:250; fig s4
In order to elucidate the clinical importance of IDO1 protein in hormone receptor-positive breast cancer, Dako CD8A antibody (Dako, C8/144B) was used in immunocytochemistry on human samples at 1:250 (fig s4). J Immunother Cancer (2017) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2c
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples (fig 2c). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; loading ...; fig 3b
Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry on human samples (fig 3b). Oncotarget (2017) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:200; loading ...
In order to report the function of CD70-CD27 signaling in patients infected with Epstein-Barr virus, Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry on human samples at 1:200. J Exp Med (2017) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; fig 1c
In order to profile the infiltration levels of immune cell populations in 19 cancer types, Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry on human samples (fig 1c). Genome Biol (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1Ac
In order to measure programmed death-ligand 1 expression and immune checkpoints and assess their prognostic value for resected head and neck squamous cell cancer, Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1Ac). Sci Rep (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:25; loading ...; fig 4b
In order to explore the role of hippocampal T cell infiltration in tau-driven pathophysiology and cognitive impairments, Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:25 (fig 4b). Brain (2017) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:250; loading ...; fig 2h
In order to look for C3d+ microglial clusters in patients with multiple sclerosis, Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 2h). Glia (2017) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2c
Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2c). J Immunol Res (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:25; fig 5a
In order to define the contribution of CD103+ tumor-infiltrating lymphocytes to high-grade serous epithelial ovarian cancer, Dako CD8A antibody (DAKO, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:25 (fig 5a). Oncotarget (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...
In order to analyze small-cell lung cancer samples for CD274 mutations, Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:200. Clin Cancer Res (2017) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:25; loading ...; fig 3i
In order to characterize American patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, Dako CD8A antibody (Dako, CD8/144B) was used in immunohistochemistry on human samples at 1:25 (fig 3i). JCI Insight (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 3
In order to characterize cases of recurrent panniculitis in children with lipoatrophy, Dako CD8A antibody (DAKO, C8/144B) was used in immunohistochemistry - paraffin section on human samples (tbl 3). J Eur Acad Dermatol Venereol (2017) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; fig 1
In order to determine the density and distribution of tumor-infiltrating lymphocytes and tertiary lymphoid structures in pulmonary metastases from primary colorectal cancer and correlate them with clinicopathological variables, Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry - paraffin section on human samples (fig 1). Clin Exp Metastasis (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...
Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry - paraffin section on human samples at 1:50. Oncol Lett (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 1
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 1). Acta Neuropathol Commun (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1af
Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1af). Cancer Immunol Immunother (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
In order to analyze differentially expressed granzyme inhibitors in pediatric primitive neuroectodermal tumors of the central nervous system, Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
Dako CD8A antibody (Dako, M710301-2) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). J Neuroimmune Pharmacol (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - frozen section; human; fig 3
In order to characterize dermatomyositis with or without anti-melanoma differentiation-associated gene 5 antibodies that show distinct NOS2 expression but a common interferon signature, Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - frozen section on human samples (fig 3). Am J Pathol (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig s2
In order to identify immunogenic subset of metastatic uveal melanoma, Dako CD8A antibody (DAKO, CD8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig s2). Clin Cancer Res (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:100; fig 6
In order to report angiopoietin-2 as a target in both naive and bevacizumab-treated glioblastoma, Dako CD8A antibody (DAKO, C8/144B) was used in immunohistochemistry on human samples at 1:100 (fig 6). EMBO Mol Med (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:250; fig 3
In order to compare multiple sclerosis to autoimmune encephalitis in humans, Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 3). Acta Neuropathol Commun (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2c
In order to correlate the pathological profile of facet joints and clinical features of patients With thoracolumbar kyphosis secondary to ankylosing spondylitis, Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2c). Spine (Phila Pa 1976) (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
In order to elucidate mechanisms that regulate T cell glycolytic metabolism, Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Nat Immunol (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; fig s5
In order to discover tumour immunity and immunotherapy caused by epigenetic silencing of TH1-type chemokines, Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry - paraffin section on human samples (fig s5). Nature (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; fig 1
In order to describe the immune cell infiltrates found in pituitary adenomas, Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples (fig 1). Endocr Pathol (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; fig s4
Dako CD8A antibody (DAKO, M7103) was used in immunohistochemistry - paraffin section on human samples (fig s4). Mol Cancer (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry on human samples . World J Urol (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:40
Dako CD8A antibody (DAKO Corporation, C8/144B) was used in immunohistochemistry on human samples at 1:40. Virchows Arch (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:100; loading ...; fig 4b
In order to develop a new type of T-cell chimeric antigen receptor (T-CAR) immunotherapy for solid tumors., Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry on human samples at 1:100 (fig 4b). Cancer Immunol Res (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; fig 4
Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry - paraffin section on human samples (fig 4). Scand J Immunol (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; fig 4i
In order to identify a MCF2L variant linked to cardiovascular disease, Dako CD8A antibody (DAKO, 144B) was used in immunohistochemistry on human samples (fig 4i). Eur J Hum Genet (2016) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:50
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry on human samples at 1:50. Scand J Immunol (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; loading ...; fig 2
Dako CD8A antibody (DAKO, M7103) was used in immunohistochemistry on human samples (fig 2). Sci Rep (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry on human samples . Dig Dis Sci (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples . Ann Neurol (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; fig 1g
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples (fig 1g). J Immunol (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:100
Dako CD8A antibody (DAKO, M7103 (C8/144B)) was used in immunohistochemistry on human samples at 1:100. Muscle Nerve (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human
In order to study the role of lymph node in the early rectal cancer, Dako CD8A antibody (DakoCytomation, C8/144B) was used in immunohistochemistry on human samples . Dis Markers (2014) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human
Dako CD8A antibody (DAKO, C8/144B) was used in immunohistochemistry - paraffin section on human samples . Eur J Cancer (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:400
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry on human samples at 1:400. J Cutan Pathol (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; mouse
Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry - paraffin section on mouse samples . Arthritis Rheumatol (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:200
Dako CD8A antibody (DAKO, C8/144B) was used in immunohistochemistry on human samples at 1:200. BMC Clin Pathol (2014) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; mouse; 1:100
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Immunobiology (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; ready-to-use
In order to determine if the presence of the DUSP22-IRF4 translocation is a distinctive histological features in patients with cutaneous anaplastic large cell lymphoma, Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples at ready-to-use. Histopathology (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:100
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:100. Int J Cancer (2015) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:100
Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry - paraffin section on human samples at 1:100. Cancer Immunol Res (2014) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human
In order to characterize stroma cells and ductal epithelium comparing chronic pancreatitis and pancreatic ductal adenocarcinoma, Dako CD8A antibody (Dako Cytomation, C8/144B) was used in immunohistochemistry - paraffin section on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:50
Dako CD8A antibody (Dako, M7103) was used in immunohistochemistry - paraffin section on human samples at 1:50. Br J Dermatol (2014) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human
Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry on human samples . Arthritis Rheumatol (2014) ncbi
mouse monoclonal (C8/144B)
  • immunocytochemistry; human; 1:30
Dako CD8A antibody (Dako, C8/144B) was used in immunocytochemistry on human samples at 1:30. J Crohns Colitis (2014) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:300
Dako CD8A antibody (Dako A/S, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:300. Clin Exp Allergy (2014) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:100
In order to study the role of TORC1 in the fetal brain lesions observed in tuberous sclerosis complex, Dako CD8A antibody (DAKO, C8/144B) was used in immunohistochemistry - paraffin section on human samples at 1:100. Brain Pathol (2013) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human
Dako CD8A antibody (DakoCytomation, C8/144B) was used in immunohistochemistry - paraffin section on human samples . Cancer (2011) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; fig 4
In order to investigate the clinical and pathological features in a girl with common variable immunodeficiency, Dako CD8A antibody (Dako, C8/144B) was used in immunohistochemistry - paraffin section on human samples (fig 4). Int J Surg Pathol (2014) ncbi
Beckman Coulter
mouse monoclonal (B9.11)
  • flow cytometry; human; loading ...; fig s2
Beckman Coulter CD8A antibody (Beckman Coulter, B9.11) was used in flow cytometry on human samples (fig s2). EBioMedicine (2020) ncbi
mouse monoclonal (B9.11)
  • flow cytometry; human; loading ...; fig 1a
Beckman Coulter CD8A antibody (Beckman Coulter, IM2638U) was used in flow cytometry on human samples (fig 1a). elife (2020) ncbi
mouse monoclonal (B9.11)
  • flow cytometry; human; loading ...; fig s4a, s8a
Beckman Coulter CD8A antibody (Beckman Coulter, B9.11) was used in flow cytometry on human samples (fig s4a, s8a). Nat Commun (2020) ncbi
mouse monoclonal (B9.11)
  • flow cytometry; human; 1:100; loading ...; fig 2a
Beckman Coulter CD8A antibody (Beckman Coulter, B9.11) was used in flow cytometry on human samples at 1:100 (fig 2a). Nat Commun (2019) ncbi
mouse monoclonal (SFCI21Thy2D3)
  • flow cytometry; human; loading ...; fig 1
Beckman Coulter CD8A antibody (Beckman Coulter, SFCI21Thy2D3) was used in flow cytometry on human samples (fig 1). BMC Cancer (2019) ncbi
mouse monoclonal (B9.11)
  • flow cytometry; human; loading ...; fig 1
Beckman Coulter CD8A antibody (Beckman Coulter, IM2638U) was used in flow cytometry on human samples (fig 1). Exp Ther Med (2017) ncbi
mouse monoclonal (SFCI21Thy2D3)
  • flow cytometry; human; loading ...; fig 1
Beckman Coulter CD8A antibody (Beckman Coulter, 6604728) was used in flow cytometry on human samples (fig 1). Exp Ther Med (2017) ncbi
mouse monoclonal (SFCI21Thy2D3)
  • flow cytometry; human; loading ...; fig 4a
Beckman Coulter CD8A antibody (Beckman Coulter, SFCI21Thy2D3) was used in flow cytometry on human samples (fig 4a). Sci Rep (2017) ncbi
mouse monoclonal (SFCI21Thy2D3)
  • flow cytometry; human; loading ...; fig 3e
Beckman Coulter CD8A antibody (Beckman Coulter, 6607102) was used in flow cytometry on human samples (fig 3e). Oncoimmunology (2016) ncbi
mouse monoclonal (B9.11)
  • flow cytometry; human; loading ...; fig 3e
Beckman Coulter CD8A antibody (Beckman Coulter, A82791) was used in flow cytometry on human samples (fig 3e). Oncoimmunology (2016) ncbi
mouse monoclonal (SFCI21Thy2D3)
  • flow cytometry; human; 1:400; loading ...; fig s2
Beckman Coulter CD8A antibody (Beckman Coulter, RPA-T8) was used in flow cytometry on human samples at 1:400 (fig s2). JCI Insight (2017) ncbi
mouse monoclonal (B9.11)
  • flow cytometry; human; loading ...; tbl s2
Beckman Coulter CD8A antibody (Beckman Coulter, IM2469U) was used in flow cytometry on human samples (tbl s2). Science (2016) ncbi
mouse monoclonal (SFCI21Thy2D3)
  • flow cytometry; human; fig 7a
Beckman Coulter CD8A antibody (BECKMAN COULTER, 6603861) was used in flow cytometry on human samples (fig 7a). J Exp Clin Cancer Res (2016) ncbi
mouse monoclonal (SFCI21Thy2D3)
  • flow cytometry; human; loading ...; fig 3b
In order to suggest that the BRD4-p300 signaling cascade promotes antitumor T cell grafts that could be used adoptive immunotherapy, Beckman Coulter CD8A antibody (Beckman Coulter, SFCI21Thy2D3) was used in flow cytometry on human samples (fig 3b). J Clin Invest (2016) ncbi
mouse monoclonal (B9.11)
  • flow cytometry; human; loading ...; fig 1c
Beckman Coulter CD8A antibody (Beckman-Coulter, B9.11) was used in flow cytometry on human samples (fig 1c). J Immunol (2016) ncbi
mouse monoclonal (B9.11)
  • flow cytometry; human; 1:100; fig 1
Beckman Coulter CD8A antibody (Beckman Coulter, IM2638U) was used in flow cytometry on human samples at 1:100 (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (B9.11)
Beckman Coulter CD8A antibody (Beckman Coulter, B9??11) was used . Clin Exp Immunol (2015) ncbi
mouse monoclonal (B9.11)
  • flow cytometry; human
Beckman Coulter CD8A antibody (Beckman-Coulter, B9.11) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (SFCI21Thy2D3)
  • flow cytometry; human
Beckman Coulter CD8A antibody (Beckman Coulter, SFCI21Thy2D3) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2014) ncbi
mouse monoclonal (B9.11)
  • flow cytometry; human; fig 1
In order to characterize VLA-4 blockade and promotion of differential routes into human CNS involving MCAM-adhesion of TH17 cells and PSGL-1 rolling of T cells, Beckman Coulter CD8A antibody (Beckman Coulter, B9.11) was used in flow cytometry on human samples (fig 1). J Exp Med (2014) ncbi
mouse monoclonal (B9.11)
  • flow cytometry; human
Beckman Coulter CD8A antibody (Beckman-Coulter, B9.11) was used in flow cytometry on human samples . FASEB J (2014) ncbi
mouse monoclonal (SFCI21Thy2D3)
  • flow cytometry; human
Beckman Coulter CD8A antibody (Beckman-Coulter, SFCI21Thy2D3) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (B9.11)
  • immunocytochemistry; human
In order to analyze HIV-specific naive and memory CD4(+) T cells through two methods, Beckman Coulter CD8A antibody (Beckman Coulter, B9.11) was used in immunocytochemistry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (B9.11)
  • flow cytometry; human
Beckman Coulter CD8A antibody (Beckman Coulter, A66332) was used in flow cytometry on human samples . Ann Neurol (2014) ncbi
mouse monoclonal (B9.11)
  • flow cytometry; human
Beckman Coulter CD8A antibody (Beckman Coulter, B9.11) was used in flow cytometry on human samples . J Immunol Res (2014) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D8A8Y)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 6d
Cell Signaling Technology CD8A antibody (CST, 85336S) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6d). Nat Commun (2021) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 4a
Cell Signaling Technology CD8A antibody (Cell Signaling, 70306) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 4a). J Immunother Cancer (2021) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry; human; 1:50; loading ...
Cell Signaling Technology CD8A antibody (Cell Signaling, 70306) was used in immunohistochemistry on human samples at 1:50. J Immunother Cancer (2021) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig s1e
Cell Signaling Technology CD8A antibody (Cell Signaling, 70306) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig s1e). Sci Transl Med (2021) ncbi
domestic rabbit monoclonal (D8A8Y)
  • immunohistochemistry; human; loading ...; fig 6e
Cell Signaling Technology CD8A antibody (CST, 85336) was used in immunohistochemistry on human samples (fig 6e). Cancer Sci (2020) ncbi
domestic rabbit monoclonal (D8A8Y)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig s7e
Cell Signaling Technology CD8A antibody (Cell Signaling, D8A8Y) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig s7e). Nature (2020) ncbi
mouse monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2e
  • immunohistochemistry - paraffin section; human; loading ...; fig e9b, e9c
Cell Signaling Technology CD8A antibody (Cell Signaling, D4B9C) was used in immunohistochemistry - paraffin section on mouse samples (fig 2e) and in immunohistochemistry - paraffin section on human samples (fig e9b, e9c). Nature (2019) ncbi
mouse monoclonal (RIV11)
  • flow cytometry; human; 1:1000; loading ...; tbl 1
Cell Signaling Technology CD8A antibody (Cell signaling, 3572) was used in flow cytometry on human samples at 1:1000 (tbl 1). Exp Ther Med (2016) ncbi
Agilent Technologies
monoclonal (C8/144B)
  • immunohistochemistry; human; 1:200; loading ...; fig 1j
Agilent Technologies CD8A antibody (Agilent, C8/144B) was used in immunohistochemistry on human samples at 1:200 (fig 1j). Neuropathol Appl Neurobiol (2021) ncbi
monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2
Agilent Technologies CD8A antibody (Agilent, M710301) was used in immunohistochemistry - paraffin section on human samples (fig 2). J Clin Invest (2019) ncbi
Biocare Medical
domestic rabbit monoclonal (SP16)
  • immunohistochemistry; human; loading ...; fig 2a
Biocare Medical CD8A antibody (Biocare, SP16) was used in immunohistochemistry on human samples (fig 2a). PLoS ONE (2020) ncbi
domestic rabbit monoclonal (SP16)
  • immunohistochemistry - paraffin section; human; loading ...; fig s5b
Biocare Medical CD8A antibody (Biocare Medical, CRM311) was used in immunohistochemistry - paraffin section on human samples (fig s5b). Cell (2019) ncbi
Tonbo Biosciences
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 7a
Tonbo Biosciences CD8A antibody (Tonbo Biosciences, RPA-T8) was used in flow cytometry on human samples (fig 7a). PLoS Pathog (2017) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig s2a
Tonbo Biosciences CD8A antibody (Tonbo Biosciences, Hit8a) was used in flow cytometry on human samples (fig s2a). Science (2016) ncbi
Cell Marque
monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; loading ...; fig s6d
Cell Marque CD8A antibody (Cellmarque, 108M-96) was used in immunohistochemistry - paraffin section on human samples (fig s6d). Cell (2019) ncbi
monoclonal (C8/144B)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1e
Cell Marque CD8A antibody (Cell Marque, 108M-98) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1e). Nat Commun (2019) ncbi
Exbio
  • flow cytometry; human; fig 2
Exbio CD8A antibody (Exbio, 1 T-207-T100) was used in flow cytometry on human samples (fig 2). Oncoimmunology (2015) ncbi
Ventana
domestic rabbit monoclonal (SP57)
  • immunohistochemistry - paraffin section; human; 1:800; loading ...; fig 1e
Ventana CD8A antibody (Ventana, 790-4460) was used in immunohistochemistry - paraffin section on human samples at 1:800 (fig 1e). Nat Med (2019) ncbi
National Institutes of Health AIDS Research and Reference Reagent Program
unidentified recombinant (12277)
  • flow cytometry; human; loading ...; fig s1a
National Institutes of Health AIDS Research and Reference Reagent Program CD8A antibody (NHP Reagents, PR-3802) was used in flow cytometry on human samples (fig s1a). Cell (2019) ncbi
BD Biosciences
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:50; loading ...; fig 2i
BD Biosciences CD8A antibody (BD, 561453) was used in flow cytometry on human samples at 1:50 (fig 2i). Nat Commun (2022) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:50; loading ...
BD Biosciences CD8A antibody (BD, 555369) was used in flow cytometry on human samples at 1:50. Life Sci Alliance (2022) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 3i
BD Biosciences CD8A antibody (BD, 562282) was used in flow cytometry on human samples (fig 3i). Nat Commun (2022) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:200; loading ...; fig s5d
BD Biosciences CD8A antibody (BD Biosciences, SK-1) was used in flow cytometry on human samples at 1:200 (fig s5d). Nature (2021) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:400; loading ...; fig s2a
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples at 1:400 (fig s2a). Nature (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig 3g
BD Biosciences CD8A antibody (BD Bioscience, SK1) was used in flow cytometry on human samples (fig 3g). J Immunother Cancer (2021) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 3g
BD Biosciences CD8A antibody (BD Bioscience, RPA-T8) was used in flow cytometry on human samples (fig 3g). J Immunother Cancer (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; 1:1000; loading ...; fig 7l
BD Biosciences CD8A antibody (BD Biosciences, 560179) was used in flow cytometry on mouse samples at 1:1000 (fig 7l). Cell Rep Med (2021) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 6a
BD Biosciences CD8A antibody (BD Biosciences, 562428) was used in flow cytometry on human samples (fig 6a). Proc Natl Acad Sci U S A (2021) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Pharmingen, RPA-T8) was used in flow cytometry on human samples . Arthritis Res Ther (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:200; loading ...; fig 4e
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples at 1:200 (fig 4e). Nat Commun (2021) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD8A antibody (BD Bioscience, RPA-T8) was used in flow cytometry on human samples (fig 3a). J Immunother Cancer (2021) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig 2a). Int J Mol Sci (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; loading ...; fig 2e
BD Biosciences CD8A antibody (BD Biosciences, 557834) was used in flow cytometry on mouse samples (fig 2e). J Autoimmun (2021) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...
BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples . EMBO Mol Med (2021) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; 1:50; loading ...; fig 7e
BD Biosciences CD8A antibody (BD Pharmingen, 555634) was used in flow cytometry on human samples at 1:50 (fig 7e). elife (2021) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD8A antibody (BD, RPA-T8) was used in flow cytometry on human samples (fig 3a). BMC Cancer (2020) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig 5a). J Clin Invest (2021) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD8A antibody (BD Biosciences, 560662) was used in flow cytometry on human samples (fig 3a). elife (2020) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...
BD Biosciences CD8A antibody (BD Biosciences, 557834) was used in flow cytometry on human samples . J Clin Invest (2020) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2s5a
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig 2s5a). elife (2020) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2s1
BD Biosciences CD8A antibody (BD Biosciences, 561453) was used in flow cytometry on human samples (fig 2s1). elife (2020) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 9c
BD Biosciences CD8A antibody (BD, RPA-T8) was used in flow cytometry on human samples (fig 9c). J Exp Med (2020) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s2a
  • flow cytometry; mouse; loading ...; fig s2a
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig s2a) and in flow cytometry on mouse samples (fig s2a). Nature (2020) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig e1a, 3h
BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples (fig e1a, 3h). Nature (2019) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; 1:50; fig 4c
BD Biosciences CD8A antibody (BD, 555635) was used in flow cytometry on human samples at 1:50 (fig 4c). Nature (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 10d
BD Biosciences CD8A antibody (BD Biosciences, 555368) was used in flow cytometry on human samples (fig 10d). Hum Vaccin Immunother (2020) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 12f
BD Biosciences CD8A antibody (BD Biosciences, 347314) was used in flow cytometry on human samples (fig 12f). Hum Vaccin Immunother (2020) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; rhesus macaque; loading ...; fig s5
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on rhesus macaque samples (fig s5). Science (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:167; loading ...; fig s6
BD Biosciences CD8A antibody (BD Biosciences, 555368) was used in flow cytometry on human samples at 1:167 (fig s6). Science (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig s1). J Immunol (2019) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:75; loading ...; fig s10a
BD Biosciences CD8A antibody (BD Pharmigen, 560179) was used in flow cytometry on human samples at 1:75 (fig s10a). Nat Commun (2019) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples (fig 4a). J Exp Med (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s2
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig s2). JCI Insight (2019) ncbi
mouse monoclonal (Hit8a)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig s3b
BD Biosciences CD8A antibody (BD Biosciences, HIT8A) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig s3b). J Invest Dermatol (2019) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 2b
BD Biosciences CD8A antibody (BD Pharmingen, 555634) was used in flow cytometry on human samples (fig 2b). Cancer Immunol Res (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; tbl 1
BD Biosciences CD8A antibody (BD, 555369) was used in flow cytometry on human samples (tbl 1). J Exp Med (2019) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:100; loading ...; fig e3a
BD Biosciences CD8A antibody (BD, 560179) was used in flow cytometry on human samples at 1:100 (fig e3a). Nat Med (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 5
BD Biosciences CD8A antibody (BD, RPAT8) was used in flow cytometry on human samples (fig 5). Front Immunol (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:100; loading ...; fig 1d
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples at 1:100 (fig 1d). Gastroenterology (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2d
BD Biosciences CD8A antibody (BD, 563821) was used in flow cytometry on human samples (fig 2d). Cell (2019) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples (fig 1a). Immunol Cell Biol (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; loading ...; fig s2
BD Biosciences CD8A antibody (BD Biosciences, 558207) was used in flow cytometry on mouse samples (fig s2). J Clin Invest (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 3c
BD Biosciences CD8A antibody (BD Horizons, 562428) was used in flow cytometry on human samples (fig 3c). BMC Immunol (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig s1). Arthritis Res Ther (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2h
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig 2h). Proc Natl Acad Sci U S A (2019) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 2b
BD Biosciences CD8A antibody (BD Biosciences, HIT8a) was used in flow cytometry on human samples (fig 2b). J Immunol (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD8A antibody (BD, RPA-T8) was used in flow cytometry on human samples (fig 1a). J Virol (2019) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig 1c). Nat Med (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; loading ...; fig 1c
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on mouse samples (fig 1c). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 5e
BD Biosciences CD8A antibody (BD, 348803) was used in flow cytometry on human samples (fig 5e). Cell (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig 2a). Cancer (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:100; loading ...
BD Biosciences CD8A antibody (BD Pharmingen, 555367) was used in flow cytometry on human samples at 1:100. Nature (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; rhesus macaque; loading ...; fig 1c
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on rhesus macaque samples (fig 1c). J Virol (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; 1:400; loading ...; fig 2a
BD Biosciences CD8A antibody (BD Biosciences, 561949) was used in flow cytometry on mouse samples at 1:400 (fig 2a). Oncol Rep (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 2b
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig 2b). J Infect Dis (2018) ncbi
mouse monoclonal (RPA-T8)
  • immunohistochemistry - frozen section; human; loading ...; fig 4a
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in immunohistochemistry - frozen section on human samples (fig 4a). J Infect Dis (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s1b
BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples (fig s1b). J Clin Invest (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig 1c). Int J Hematol (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s5c
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig s5c). Leukemia (2019) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s7e
BD Biosciences CD8A antibody (BD Biosciences, 560347) was used in flow cytometry on human samples (fig s7e). Nat Immunol (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig 2a). J Exp Med (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD8A antibody (BD, RPA-T8) was used in flow cytometry on human samples (fig 2a). J Immunol (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; tbl 1
BD Biosciences CD8A antibody (BD Biosciences, 560774) was used in flow cytometry on human samples (tbl 1). J Clin Invest (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig 1c). Clin Exp Immunol (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD8A antibody (BD Biosciences, 563795) was used in flow cytometry on human samples (fig 1a). Oncotarget (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig 2a). J Clin Invest (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1f
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig 1f). Nat Med (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD8A antibody (BD Bioscience, 347314) was used in flow cytometry on human samples (fig 1b). J Clin Invest (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; 1:60; loading ...; fig 7a
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on mouse samples at 1:60 (fig 7a). J Virol (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig 4a
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig 4a). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (RPA-T8)
BD Biosciences CD8A antibody (BD Biosciences, 558207) was used . J Clin Invest (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1
BD Biosciences CD8A antibody (BD Biosciences, 557085) was used in flow cytometry on human samples (fig 1). Oncotarget (2018) ncbi
mouse monoclonal (SK1)
  • immunohistochemistry; human; loading ...; fig 2c
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in immunohistochemistry on human samples (fig 2c). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 2c
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig 2c). Sci Rep (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig 4a). J Clin Invest (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 5b
BD Biosciences CD8A antibody (BD Biosciences, PRA-T8) was used in flow cytometry on human samples (fig 5b). J Exp Med (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; rhesus macaque; fig 1a
BD Biosciences CD8A antibody (BD Biosciences, 557760) was used in flow cytometry on rhesus macaque samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1d
BD Biosciences CD8A antibody (BD Horizon, RPA-T8) was used in flow cytometry on human samples (fig 1d). Nature (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 3e
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig 3e). J Clin Invest (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 5b
BD Biosciences CD8A antibody (BD Pharmingen, RPA-T8) was used in flow cytometry on human samples (fig 5b). Obes Facts (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD8A antibody (BD Bioscience, SK1) was used in flow cytometry on human samples (fig 1a). Biol Blood Marrow Transplant (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples (fig 3a). J Virol (2018) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 4f
BD Biosciences CD8A antibody (BD Pharmingen, HIT8a) was used in flow cytometry on human samples (fig 4f). Nature (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 7
BD Biosciences CD8A antibody (BD Bioscience, SK1) was used in flow cytometry on human samples (fig 7). J Immunol (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s2a
BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples (fig s2a). Nature (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1a
In order to study the expression of CCR10 and CXCR3 in circulating CD8 T cells specific for human herpes simplex virus, BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples (fig 1a). J Virol (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 5a
In order to detail MAIT cell responses to various microorganisms and cytokines, BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig 5a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD8A antibody (BD, RPA-T8) was used in flow cytometry on human samples (fig 1a). J Exp Med (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1j
In order to determine the role of PD-1 in regulating anti-tumor T cell reactivities, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig 1j). Science (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 5d
In order to find a role for IL-4 in promoting breast cancer aggressiveness, BD Biosciences CD8A antibody (BD Bioscience, RPA-T8) was used in flow cytometry on human samples (fig 5d). Cancer Res (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; loading ...; fig 8c
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on mouse samples (fig 8c). Sci Rep (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...
In order to examine AnxA1 in peripheral blood mononuclear cells from patients with coronary artery disease, BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples . PLoS ONE (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples . J Immunol (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; loading ...; fig s3
BD Biosciences CD8A antibody (BD Biosciences, 555366) was used in flow cytometry on mouse samples (fig s3). Nat Commun (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; loading ...
In order to assess the effects of targeting the chimeric antigen receptors to the TRAC locus, BD Biosciences CD8A antibody (BD biosciences, 557834) was used in flow cytometry on mouse samples . Nature (2017) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; fig 1c
In order to investigate lactam-specific T-cell response in the skin and blood of humans, BD Biosciences CD8A antibody (BD Biosciences, HIT8a) was used in flow cytometry on human samples (fig 1c). J Allergy Clin Immunol (2018) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig s4b
BD Biosciences CD8A antibody (BD Biosciences, 555635) was used in flow cytometry on human samples (fig s4b). Oncotarget (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 2d
BD Biosciences CD8A antibody (BD, 641400) was used in flow cytometry on human samples (fig 2d). Sci Rep (2017) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 2b
BD Biosciences CD8A antibody (BD, HIT8a) was used in flow cytometry on human samples (fig 2b). Oncoimmunology (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1
In order to examine the potential of IL-2 to enhance T regulatory cell therapy, BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig 1). Clin Exp Immunol (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; rhesus macaque; loading ...; fig s4b
In order to study CXCR5+ CD8 T cells in SIV-infected animals, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on rhesus macaque samples (fig s4b). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1d
BD Biosciences CD8A antibody (BD Biosciences, 562428) was used in flow cytometry on human samples (fig 1d). Oncoimmunology (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...
BD Biosciences CD8A antibody (Pharmingen, SK1) was used in flow cytometry on human samples . Oncol Lett (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1
BD Biosciences CD8A antibody (BD Biosciences, 560917) was used in flow cytometry on human samples (fig 1). PLoS ONE (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 5b
In order to propose that decidual stromal cells are a cellular source of BAFF for B cells present in decidua during pregnancy, BD Biosciences CD8A antibody (BD Bioscience, 555369) was used in flow cytometry on human samples (fig 5b). Sci Rep (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD8A antibody (BD Bioscience, SK1) was used in flow cytometry on human samples (fig s1). Haematologica (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; rhesus macaque; loading ...; fig s9
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on rhesus macaque samples (fig s9). PLoS Pathog (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s2
In order to search for compounds that suppress pro-inflammatory cytokine production in the context of protein kinase C activation, BD Biosciences CD8A antibody (BD Pharmingen, 557086) was used in flow cytometry on human samples (fig s2). Retrovirology (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 3
In order to develop a functional assay to assess the risk of developing acute graft-versus-host disease, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig 3). J Immunol Res (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s1a
In order to describe complete autosomal recessive IL-17RA deficiency in patients with chronic mucocutaneous candidiasis, BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; rhesus macaque; loading ...; fig 3f
In order to discuss the assessment of species cross-reactive human agents in large animal graft-versus-host disease models, BD Biosciences CD8A antibody (BD Pharmingen, 560774) was used in flow cytometry on rhesus macaque samples (fig 3f). Transplantation (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2a
In order to study the role of PD-1 and Tim-3 crosstalk in the regulation of antitumor T cell responses, BD Biosciences CD8A antibody (BD, 555367) was used in flow cytometry on human samples (fig 2a). Oncoimmunology (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 2a
In order to functionally characterize herpes simplex virus-specific CD8 positive T cells, BD Biosciences CD8A antibody (BD Pharmingen, SK1) was used in flow cytometry on human samples (fig 2a). J Virol (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s12c
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig s12c). J Clin Invest (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 5a
In order to determine which cells express CD83, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig 5a). J Immunol (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:20; loading ...; fig 1c
BD Biosciences CD8A antibody (BD Biosciences, 557834) was used in flow cytometry on human samples at 1:20 (fig 1c). Nat Commun (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; African green monkey; 1:20; fig 4b
BD Biosciences CD8A antibody (BD Biosciences, 558207) was used in flow cytometry on African green monkey samples at 1:20 (fig 4b). Nat Commun (2016) ncbi
mouse monoclonal (SK1)
  • blocking or activating experiments; human; fig 3a
In order to propose that blocking antibodies suppress autoreactive CD8 positive T-cell activation in a relatively selective manner, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in blocking or activating experiments on human samples (fig 3a). Sci Rep (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; rhesus macaque; loading ...; fig s11a
In order to assess the efficacy of targeting alpha4 beta7 integrin to treat SIV, BD Biosciences CD8A antibody (BD, 339188) was used in flow cytometry on rhesus macaque samples (fig s11a). Science (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; rhesus macaque; loading ...; fig 8b
BD Biosciences CD8A antibody (BD, 561421) was used in flow cytometry on rhesus macaque samples (fig 8b). Sci Rep (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1a, s2i
In order to discuss targeting CD123 to treat systemic lupus erythematosus, BD Biosciences CD8A antibody (BD Biosciences, 555369) was used in flow cytometry on human samples (fig 1a, s2i). JCI Insight (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1a, s2i
In order to discuss targeting CD123 to treat systemic lupus erythematosus, BD Biosciences CD8A antibody (BD Biosciences, 561423) was used in flow cytometry on human samples (fig 1a, s2i). JCI Insight (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1d
BD Biosciences CD8A antibody (BD Biosciences, 563823) was used in flow cytometry on human samples (fig 1d). Cell (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 3h
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, BD Biosciences CD8A antibody (BD, RPA-T8) was used in flow cytometry on human samples (fig 3h). J Exp Med (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...
In order to determine the S. Typhi, S. Paratyphi A, and S. Paratyphi B cross-reactive CD4 positive T cell responses elicited by immunization with Ty21a, BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples . Clin Immunol (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; rhesus macaque; loading ...; fig 1a
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on rhesus macaque samples (fig 1a). Front Immunol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 6a
BD Biosciences CD8A antibody (Becton Dickinson, RPA-T8) was used in flow cytometry on human samples (fig 6a). J Virol (2016) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 3c
In order to assess dextran-based nanoparticles as a drug delivery system to target myeloid cells of the liver, BD Biosciences CD8A antibody (BD Biosciences, 560959) was used in flow cytometry on human samples (fig 3c). Nanomedicine (Lond) (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1g
In order to characterize side population T cells, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig 1g). J Clin Invest (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s1a
In order to compare expression and function of the CD300 family of receptors between neonatal and adult immune cells, BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig s1a). Sci Rep (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 1
BD Biosciences CD8A antibody (BD Biosciences, 563823) was used in flow cytometry on human samples (fig 1). Mol Med Rep (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; rhesus macaque; loading ...; fig 1a
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on rhesus macaque samples (fig 1a). J Virol (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s1a
In order to report the composition and temporal dynamics of the Epstein-Barr virus-specific T-cell receptor repertoire in immunocompromised transplant patients, BD Biosciences CD8A antibody (BD Biosciences, 341051) was used in flow cytometry on human samples (fig s1a). Immunol Cell Biol (2017) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; fig s9a, s9d
In order to explore the role of exhausted CD8 positive CXCR5 positive T cells in mice chronically infected with lymphocytic choriomeningitis virus, BD Biosciences CD8A antibody (BD, HIT8a) was used in flow cytometry on human samples (fig s9a, s9d). Nature (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:50; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BD Biosciences CD8A antibody (BD, RPA-T8) was used in flow cytometry on human samples at 1:50 (tbl s2). Nat Immunol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
In order to assess the contribution of cytomorphology and flow cytometry to histopathological studies of brain biopsies, BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig 1e
In order to report that patients with PTEN mutations experience autoimmunity and lymphoid hyperplasia, BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples (fig 1e). J Allergy Clin Immunol (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; fig ev1
BD Biosciences CD8A antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig ev1). Mol Syst Biol (2016) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig 3b
In order to utilize humanized major histocompatibility class I- and class II-deficient NOG mice to assess the antitumor effect of an anti-programmed death-1 antibody, BD Biosciences CD8A antibody (BD Pharmingen, HIT8a) was used in flow cytometry on human samples (fig 3b). Clin Cancer Res (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; 1:100; loading ...
In order to explore the anti-viral effects of iRhom2, BD Biosciences CD8A antibody (BD, 558207) was used in flow cytometry on mouse samples at 1:100. Nat Immunol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 3
In order to test if CD4 positive T cells expressing immune checkpoint molecules are enriched in HIV-infected cells in patients receiving antiretroviral therapy, BD Biosciences CD8A antibody (BD, 558207) was used in flow cytometry on human samples (fig 3). PLoS Pathog (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 6b
BD Biosciences CD8A antibody (BD, RPA-T8) was used in flow cytometry on human samples (fig 6b). J Immunol (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples (fig s1a). J Immunol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 8
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, BD Biosciences CD8A antibody (BD Biosciences, 562311) was used in flow cytometry on human samples (fig 8). Nat Immunol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig s2a
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig s2a). Eur J Immunol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s2
  • flow cytometry; mouse; loading ...; fig s5
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, BD Biosciences CD8A antibody (BD Bioscience, RPA-T8) was used in flow cytometry on human samples (fig s2) and in flow cytometry on mouse samples (fig s5). J Clin Invest (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s2c
BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples (fig s2c). J Clin Invest (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 2
In order to study activation of myeloid dendritic cells, regulatory T cells and effector cells in lichen planus, BD Biosciences CD8A antibody (BD Biosciences, RPA T8) was used in flow cytometry on human samples (fig 2). J Transl Med (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; fig 3
BD Biosciences CD8A antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 3). Oncotarget (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 3b
  • flow cytometry; mouse; loading ...; fig st1
BD Biosciences CD8A antibody (BD Pharmingen, SK1) was used in flow cytometry on human samples (fig 3b) and in flow cytometry on mouse samples (fig st1). J Clin Invest (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 2a
In order to monitor T cells expressing a CD19-specific chimeric antigen receptor in vivo non-invasively, BD Biosciences CD8A antibody (Biosciences, 347313) was used in flow cytometry on human samples (fig 2a). Mol Imaging Biol (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig s3
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig s3). Sci Rep (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; rhesus macaque; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BD Biosciences CD8A antibody (BD Biosciences, 561945) was used in flow cytometry on rhesus macaque samples . Nat Med (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; fig 1
In order to analyze the induction of immune-mediated survival advantage in murine intracranial glioma by agonist anti-GITR monoclonal antibody and stereotactic radation, BD Biosciences CD8A antibody (BD, 564115) was used in flow cytometry on mouse samples (fig 1). J Immunother Cancer (2016) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; 1:50; loading ...; fig s2e
In order to study how retinoic acid-induced HOXA gene expression controls hematopoietic stem/progenitor cells fate, identify, and function, BD Biosciences CD8A antibody (BD, 555635) was used in flow cytometry on human samples at 1:50 (fig s2e). Nat Cell Biol (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...
In order to test if the two hematopoietic systems in patients with mixed chimerism remain functional and study immunological differences, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples . PLoS ONE (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:50; fig 2
BD Biosciences CD8A antibody (BD PharMingen, 555368) was used in flow cytometry on human samples at 1:50 (fig 2). Oncoimmunology (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:40; fig 4
BD Biosciences CD8A antibody (BD PharMingen, 560179) was used in flow cytometry on human samples at 1:40 (fig 4). Oncoimmunology (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s3
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig s3). PLoS ONE (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; 1:200; fig 4
BD Biosciences CD8A antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples at 1:200 (fig 4). Nat Immunol (2016) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; loading ...; fig s1
In order to characterize the immune responses of children immunized with Plasmodium falciparum apical membrane antigen 1, BD Biosciences CD8A antibody (BD Biosciences, Hit8a) was used in flow cytometry on human samples (fig s1). Vaccine (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig s3a
In order to discover that T follicular helper cells preferentially express the transcriptional coactivator Bob1, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig s3a). Eur J Immunol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; fig 6
BD Biosciences CD8A antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 6). Oncoimmunology (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; fig s1
In order to characterize promotion of an effective anti-tumor immune response by enhancing the production of type 1 interferons by 2'-5' oligoadenylate synthetase-like 1 (OASL1) deficiency in mice, BD Biosciences CD8A antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig s1). Cancer Immunol Immunother (2016) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; fig s1
In order to develop an HLA-A2-specific chimeric antigen receptor and use it to generate alloantigen-specific human T regulatory cells, BD Biosciences CD8A antibody (BD Biosciences, 555635) was used in flow cytometry on human samples (fig s1). J Clin Invest (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; fig 3
BD Biosciences CD8A antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 2d
In order to demonstrate that effector T-cell accumulation and TCR repertoire diversity reduction precede the development of foot ulcers in diabetic patients, BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples (fig 2d). Cell Mol Immunol (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 2a
In order to compare the immune compartmentalization between ileum and colon in healthy and inflamed mucosa, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig 2a). J Crohns Colitis (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; 1:600; fig 2
BD Biosciences CD8A antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples at 1:600 (fig 2). PLoS ONE (2016) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD8A antibody (BD, 555635) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig 3
In order to assess the impact of neoantigen intratumor heterogeneity on antitumor immunity, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig 3). Science (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig 1
In order to determine mucosal characteristics of lymphocytic and collagenous colitis, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig 1). J Crohns Colitis (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
In order to assess extinguishing of HIV-1 replication by cooperation of APOBEC3F and APOBEC3G, BD Biosciences CD8A antibody (Becton, 347314) was used in flow cytometry on human samples . J Virol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; tbl 2
In order to determine the contribution of Leukocyte Ig Like Receptors to Mycobacterium tuberculosis infection, BD Biosciences CD8A antibody (BD Pharmingen, 557945) was used in flow cytometry on human samples (tbl 2). Sci Rep (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 1
BD Biosciences CD8A antibody (BD, 557746) was used in flow cytometry on human samples (fig 1). Nat Biotechnol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig st1
BD Biosciences CD8A antibody (BD Horizon, RPA-T8) was used in flow cytometry on human samples (fig st1). J Autoimmun (2016) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; fig 5
BD Biosciences CD8A antibody (BD Bioscience, HIT8a) was used in flow cytometry on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; 1:400; fig 1
BD Biosciences CD8A antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples at 1:400 (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; fig 3
BD Biosciences CD8A antibody (Becton Dickinson Biosciences, 53-6,7) was used in flow cytometry on mouse samples (fig 3). PLoS Pathog (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD8A antibody (BD Pharmingen, RPA-T8) was used in flow cytometry on human samples (fig 2a). PLoS ONE (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; fig s1
In order to investigate the control of LAT recruitment to the immune synapse and T-cell activation in vivo by IFT20, BD Biosciences CD8A antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig s1). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Pharmingen, 557746) was used in flow cytometry on human samples . Mediators Inflamm (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD8A antibody (BD Biosciences, 347314) was used in flow cytometry on human samples (fig 3a). Mol Med Rep (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; fig 2
BD Biosciences CD8A antibody (BD Biosciences, 53.67) was used in flow cytometry on mouse samples (fig 2). J Gastrointest Surg (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 4b
In order to study heat-shock protein 70 in non-small cell lung cancer cells, BD Biosciences CD8A antibody (BD, 555366) was used in flow cytometry on human samples (fig 4b). Front Immunol (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; rhesus macaque; fig s4
In order to describe a selective CD28 antagonist for treatment of rheumatoid arthritis, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on rhesus macaque samples (fig s4). Clin Exp Immunol (2016) ncbi
mouse monoclonal (Hit8a)
  • immunohistochemistry - paraffin section; mouse; fig s1
In order to discover tumour immunity and immunotherapy caused by epigenetic silencing of TH1-type chemokines, BD Biosciences CD8A antibody (BD Biosciences, 550372) was used in immunohistochemistry - paraffin section on mouse samples (fig s1). Nature (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 1
BD Biosciences CD8A antibody (BD Biosciences, # 557760) was used in flow cytometry on human samples (fig 1). Immunol Res (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; fig 3
BD Biosciences CD8A antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 3). J Inflamm (Lond) (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 4a
In order to assess the efficacy of a single vaccination of the Yellow Fever vaccine, BD Biosciences CD8A antibody (BD Biosciences, 347314) was used in flow cytometry on human samples (fig 4a). Hum Vaccin Immunother (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Pharmingen, 557834) was used in flow cytometry on human samples . Am J Reprod Immunol (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 3
BD Biosciences CD8A antibody (BD, RPA-T8) was used in flow cytometry on human samples (fig 3). Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 1a
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig 1a). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BD Biosciences CD8A antibody (BD, RPA-T8) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (RPA-T8)
  • immunohistochemistry - frozen section; mouse; fig 4
In order to study mediation of TLR7-dependent inflammation and autoimmunity by B cell autophagy, BD Biosciences CD8A antibody (BD Biosciences, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig 4). Autophagy (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:20; fig 6
BD Biosciences CD8A antibody (BD Biosciences, 557945) was used in flow cytometry on human samples at 1:20 (fig 6). Nat Commun (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; tbl 1
In order to discuss using the infiltrate to diagnosis B-cell lymphomas, BD Biosciences CD8A antibody (BD, RPA-T8) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig S1
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig S1). J Neuroinflammation (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig 2
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig 2). J Immunol (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:50; fig 1
BD Biosciences CD8A antibody (BD, 341051) was used in flow cytometry on human samples at 1:50 (fig 1). Nat Commun (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; fig 2
BD Biosciences CD8A antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig 3,4,5
BD Biosciences CD8A antibody (BD, 557834) was used in flow cytometry on human samples (fig 3,4,5). Nucleic Acids Res (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BD Biosciences CD8A antibody (Becton-Dickinson, SK1) was used in flow cytometry on human samples . Histochem Cell Biol (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, BD Biosciences CD8A antibody (BD Biosciences, clone RPA-T8) was used in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; fig 2
  • immunocytochemistry; mouse; fig 4
BD Biosciences CD8A antibody (BD Bioscience, 53.6.7) was used in flow cytometry on mouse samples (fig 2) and in immunocytochemistry on mouse samples (fig 4). Nat Immunol (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1
In order to elucidate Th17 cell polarization, depletion, and restoration in response to HIV infection and antiretroviral therapy, BD Biosciences CD8A antibody (BD Pharmingen, SK1) was used in flow cytometry on human samples (fig 1). Retrovirology (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig 6
In order to report the phase I trial results of CDX-301, BD Biosciences CD8A antibody (Becton Dickinson, SK1) was used in flow cytometry on human samples (fig 6). Bone Marrow Transplant (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 2
BD Biosciences CD8A antibody (BD, 557760) was used in flow cytometry on human samples (fig 2). Scand J Immunol (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 2b
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples (fig 2b). J Immunol (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:100; fig 3d
In order to show that hepatitis B virus exposure in utero enhances immunity to bacterial infections, BD Biosciences CD8A antibody (Becton Dickinson, RPA-T8) was used in flow cytometry on human samples at 1:100 (fig 3d). Nat Commun (2015) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; fig 1f
BD Biosciences CD8A antibody (BD Biosciences, HIT8a) was used in flow cytometry on human samples (fig 1f). J Immunol (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
In order to measure the memory CD4(+) T-cell responses to each varicella zoster virus protein at baseline and after zoster vaccination, BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
In order to analyze mucosal pinch biopsies collected predominantly during colonoscopies, BD Biosciences CD8A antibody (BD Horizon, RPA-T8) was used in flow cytometry on human samples . J Immunol Methods (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
In order to show that intermediate DNA methylation is a conserved signature of gene regulation and exon usage, BD Biosciences CD8A antibody (BD Biosciences, 561947) was used in flow cytometry on human samples . Nat Commun (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; fig 7
BD Biosciences CD8A antibody (BD Pharmingen, 641400) was used in flow cytometry on mouse samples (fig 7). J Immunol (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; tbl 2
BD Biosciences CD8A antibody (BD Bioscience, SK1) was used in flow cytometry on human samples (tbl 2). Clin Transplant (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig 2
BD Biosciences CD8A antibody (BD Pharmingen, SK1) was used in flow cytometry on human samples (fig 2). J Immunol (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; African green monkey; loading ...; fig s2a
In order to describe the functional characteristics and dynamics of T cells in individual granulomas, BD Biosciences CD8A antibody (BD biosciences, SK1) was used in flow cytometry on African green monkey samples (fig s2a). PLoS Pathog (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig 1
BD Biosciences CD8A antibody (BD Pharmingen, SK1) was used in flow cytometry on human samples (fig 1). J Virol (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig s1
BD Biosciences CD8A antibody (BD Bioscience, SK1) was used in flow cytometry on human samples (fig s1). Cell Res (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Pharmingen, 555367) was used in flow cytometry on human samples . Alcohol (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
In order to assess the effects of long-term cryopreservation of fixed cells on the measurement of mycobacteria induced CD4 T cell immunity, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples . J Immunol Methods (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; rhesus macaque
In order to examine the mechanism of anti-alpha4 antibody treatment in monkeys, BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on rhesus macaque samples . PLoS Pathog (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples . Eur J Cancer (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples . Eur J Immunol (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 2
BD Biosciences CD8A antibody (BD Pharmingen, 558207) was used in flow cytometry on human samples (fig 2). Clin Cancer Res (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; crab eating macaque; fig s2
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on crab eating macaque samples (fig s2). J Autoimmun (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Biosciences, 560179) was used in flow cytometry on human samples . Cancer Res (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
In order to assess the efficacy of using flow cytometry immunophenotyping with fine-needle aspiration cytology for the diagnosis of thyroid lymphoma, BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD, RPA-T8) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; fig s1
BD Biosciences CD8A antibody (BD Bioscience, 53-6.8) was used in flow cytometry on mouse samples (fig s1). J Immunol (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD, RPA-T8) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
In order to study the incidence of coronary heart disease in cytomegalovirus-seropositive individuals, BD Biosciences CD8A antibody (BD, 641400) was used in flow cytometry on human samples . Circ Res (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; crab eating macaque
In order to describe a prime-boost regimen for the HIV vaccination of Macaca fascicularis, BD Biosciences CD8A antibody (BD, SK-1) was used in flow cytometry on crab eating macaque samples . PLoS ONE (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; rhesus macaque
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples . J Virol (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; fig s3
BD Biosciences CD8A antibody (Pharmingen, 560662) was used in flow cytometry on mouse samples (fig s3). Stem Cell Res (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples . Rheumatology (Oxford) (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (SK1)
  • immunocytochemistry; human
In order to study the role of dendritic cells in relation to T cells, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in immunocytochemistry on human samples . J Immunol (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; rhesus macaque
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; baboons; fig 1
In order to study the effect of age, gender, social status and peer group on T cells in baboons, BD Biosciences CD8A antibody (Becton-Dickinson, clone RPA-T8) was used in flow cytometry on baboons samples (fig 1). PLoS ONE (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
In order to test the safety and immunogenicity of an adenovirus 35-vectored tuberculosis vaccine candidate AERAS-402 in infants, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples . Vaccine (2014) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human
In order to test the safety and immunogenicity of an adenovirus 35-vectored tuberculosis vaccine candidate AERAS-402 in infants, BD Biosciences CD8A antibody (BD Biosciences, Clone HIT8a) was used in flow cytometry on human samples . Vaccine (2014) ncbi
mouse monoclonal (SK1)
  • immunocytochemistry; mouse
BD Biosciences CD8A antibody (PharMingen, SK1) was used in immunocytochemistry on mouse samples . Hum Pathol (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Bioscience, RPA-T8) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; tbl 1
BD Biosciences CD8A antibody (BD Biosciences, 560917) was used in flow cytometry on human samples (tbl 1). Chronobiol Int (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; rhesus macaque
BD Biosciences CD8A antibody (BD Pharmingen, 558207) was used in flow cytometry on rhesus macaque samples . J Virol (2014) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Biosciences, HIT8a) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
  • immunocytochemistry; human
In order to study the effect of atorvastatin on telomerase activity in peripheral blood mononuclear cells and T-lymphocytes, BD Biosciences CD8A antibody (BD, 560273) was used in flow cytometry on human samples and in immunocytochemistry on human samples . Atherosclerosis (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Horizon, RPA-T8) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig 1
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples (fig 1). J Infect Dis (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig s1
In order to investigate the impact of CCR6(+)CXCR3(+)CCR4(-) cells in latent tuberculosis infection, BD Biosciences CD8A antibody (BD Bioscience, RPA-T8) was used in flow cytometry on human samples (fig s1). J Immunol (2014) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Biosciences, HIT8a) was used in flow cytometry on human samples . Am J Transplant (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig 3
In order to characterize two cases of anaplastic large cell lymphoma using flow cytometry, BD Biosciences CD8A antibody (Becton Dickinson, RPA-T8) was used in flow cytometry on human samples (fig 3). Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; African green monkey; fig s1
BD Biosciences CD8A antibody (BD Biosciences, Sk1) was used in flow cytometry on African green monkey samples (fig s1). PLoS Pathog (2014) ncbi
mouse monoclonal (SK1)
  • immunocytochemistry; human
In order to analyze HIV-specific naive and memory CD4(+) T cells through two methods, BD Biosciences CD8A antibody (BD, SK1) was used in immunocytochemistry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Pharmingen, RPA-T8) was used in flow cytometry on human samples . Int J Cancer (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; rhesus macaque; loading ...; fig s1a
In order to explore germinal center-related hyperimmune responses and disease severity during viral infection, BD Biosciences CD8A antibody (BD Pharmingen, RPA-T8) was used in flow cytometry on rhesus macaque samples (fig s1a). J Immunol (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Pharmingen, RPA-T8) was used in flow cytometry on human samples . J Virol (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 50 ug/ml
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples at 50 ug/ml. J Immunol (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Biosciences, HIT8a) was used in flow cytometry on human samples . J Clin Immunol (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Bioscience, RPA-T8) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; chimpanzee
In order to study the in vitro response of gammadelta T-cell subsets from HIV1-infected and control chimpanzees to T-cell activators, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on chimpanzee samples . J Med Primatol (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
In order to study NK function in solid tumors, BD Biosciences CD8A antibody (BD Biosciences, RPA-T8) was used in flow cytometry on human samples . Int J Cancer (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
In order to study NK function in solid tumors, BD Biosciences CD8A antibody (BD Biosciences, SK1) was used in flow cytometry on human samples . Int J Cancer (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; tbl 1
In order to study the effect of innate lymphoid cells on B cells, BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples (tbl 1). Nat Immunol (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Biosciences, clone RPA T8) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD, RPA-T8) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; fig 5
BD Biosciences CD8A antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 5). Mucosal Immunol (2014) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human; fig 1
In order to study mucosal associated invariant T cells and B cell interactions, BD Biosciences CD8A antibody (BD Pharmingen, clone HIT8a) was used in flow cytometry on human samples (fig 1). Front Immunol (2014) ncbi
mouse monoclonal (Hit8a)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD Biosciences, #555635) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s2
In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, BD Biosciences CD8A antibody (BD Bioscience, SK1) was used in flow cytometry on human samples (fig s2). J Infect Dis (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 2a
In order to assess the effect of delayed administration of the BCG vaccine on the induced immune response in Ugandan children, BD Biosciences CD8A antibody (BD Biosciences, SK-1) was used in flow cytometry on human samples (fig 2a). J Infect Dis (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
In order to use zinc-finger nucleases to simultaneous modify ccr5 and cxcr4 in primary human CD4(+) T cells and introduce these cells into a humanized mouse model of HIV-1 infection, BD Biosciences CD8A antibody (BD, RPA-T8) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; tbl 1
In order to compare fine needle aspiration cytology with flow cytometry immunophenotyping for the diagnosis of lymphoproliferative processes in the salivary glands, BD Biosciences CD8A antibody (BD, clone SK1) was used in flow cytometry on human samples (tbl 1). Cytopathology (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig 2
BD Biosciences CD8A antibody (Becton-Dickinson, 340659) was used in flow cytometry on human samples (fig 2). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples . Cell Stress Chaperones (2012) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
In order to study the use of DEC-205 targeting in vaccination against Epstein-Barr virus, BD Biosciences CD8A antibody (BD, SK1) was used in flow cytometry on human samples . Blood (2008) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; mouse; 25 ug/ml
BD Biosciences CD8A antibody (BD PharMingen, 53-6.7) was used in flow cytometry on mouse samples at 25 ug/ml. Infect Immun (2005) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; South American squirrel monkey
In order to discuss available reagents for studying the neotropical primate squirrel monkey, BD Biosciences CD8A antibody (BD, RPA-T8) was used in flow cytometry on South American squirrel monkey samples . J Immunol Methods (2005) ncbi
Leica Biosystems
  • immunohistochemistry; human; 1:1000; loading ...
Leica Biosystems CD8A antibody (Leica Biosystems, NCL-L-CD8-4B11) was used in immunohistochemistry on human samples at 1:1000. Cancer Sci (2022) ncbi
monoclonal (4B11)
  • immunohistochemistry; human; 1:50; loading ...; fig 1
Leica Biosystems CD8A antibody (Leica Biosystems, 4B11) was used in immunohistochemistry on human samples at 1:50 (fig 1). Mol Clin Oncol (2021) ncbi
  • immunohistochemistry - paraffin section; human; 1:600; loading ...; fig 7a
Leica Biosystems CD8A antibody (Leica, CD8-4B11-L-CE) was used in immunohistochemistry - paraffin section on human samples at 1:600 (fig 7a). Immunity (2021) ncbi
monoclonal (4B11)
  • immunohistochemistry; human; fig 1c
Leica Biosystems CD8A antibody (Novocastra (Leica), 4B11) was used in immunohistochemistry on human samples (fig 1c). BMC Cancer (2021) ncbi
monoclonal (4B11)
  • immunohistochemistry - paraffin section; human; 1:40; loading ...; fig 2i
Leica Biosystems CD8A antibody (Novocastra, 4B11) was used in immunohistochemistry - paraffin section on human samples at 1:40 (fig 2i). Arch Dermatol Res (2017) ncbi
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 5b
Leica Biosystems CD8A antibody (Leica Biosystems, NCL-L-CD8-4B11) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 5b). J Cutan Pathol (2017) ncbi
  • immunohistochemistry - paraffin section; human; 1:50; fig s3
Leica Biosystems CD8A antibody (Novocastra, NCL-CD8-4B11) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig s3). Oncoimmunology (2017) ncbi
  • immunohistochemistry - paraffin section; human; 1:20; fig 4a
Leica Biosystems CD8A antibody (Leica Novo Castra, NCL-CD8-4B11) was used in immunohistochemistry - paraffin section on human samples at 1:20 (fig 4a). Respirology (2017) ncbi
monoclonal (4B11)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 2c
In order to investigate the role of PD-L1 and T-cell infiltration in metastatic high-grade osteosarcoma, Leica Biosystems CD8A antibody (Novocastra, 4B11) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2c). Cancer Immunol Immunother (2017) ncbi
monoclonal (4B11)
  • immunohistochemistry; human; fig 4b
Leica Biosystems CD8A antibody (Novocastra, 4B11) was used in immunohistochemistry on human samples (fig 4b). Histopathology (2017) ncbi
mouse monoclonal (1A5)
  • immunohistochemistry - paraffin section; human; 1:20; tbl 1
Leica Biosystems CD8A antibody (Novocastra, 1A5) was used in immunohistochemistry - paraffin section on human samples at 1:20 (tbl 1). Rom J Morphol Embryol (2016) ncbi
monoclonal
  • immunohistochemistry - paraffin section; human; fig 1
In order to assess the correlation with the immune infiltration in breast cancer due to the presence of HMGB1and LC3B puncta expression in malignant cells, Leica Biosystems CD8A antibody (Novocastra reagents, NCL-LCD8- 295) was used in immunohistochemistry - paraffin section on human samples (fig 1). Autophagy (2016) ncbi
mouse monoclonal (1A5)
  • immunohistochemistry; human; 1:50; loading ...; fig 1a
In order to explore the relationship between tumor-infiltrating lymphocytes and the clinical outcomes of triple-negative breast cancers, Leica Biosystems CD8A antibody (Leica biosystems, 1A5) was used in immunohistochemistry on human samples at 1:50 (fig 1a). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (1A5)
  • immunohistochemistry; human; 1:40
In order to discuss diagnostic challenges involved with folliculotropic mycosis fungoides, Leica Biosystems CD8A antibody (Novocastro, 1A5) was used in immunohistochemistry on human samples at 1:40. J Cutan Pathol (2015) ncbi
monoclonal (4B11)
  • immunohistochemistry - paraffin section; human
Leica Biosystems CD8A antibody (Leica, 4B11) was used in immunohistochemistry - paraffin section on human samples . Int J Gynecol Pathol (2014) ncbi
MilliporeSigma
mouse monoclonal (UCHT-4)
  • immunocytochemistry; human; loading ...; fig s1h
In order to find and characterize a polypeptide encoded by the long non-coding RNA, LINC00961, MilliporeSigma CD8A antibody (Sigma-Aldrich, C7423) was used in immunocytochemistry on human samples (fig s1h). Nature (2017) ncbi
mouse monoclonal (UCHT-4)
  • immunocytochemistry; human; fig s5a
  • western blot; human; fig s5b
In order to elucidate how adaptor protein 2 complexes regulate clathrin-coated pit assembly, MilliporeSigma CD8A antibody (Sigma, C7423) was used in immunocytochemistry on human samples (fig s5a) and in western blot on human samples (fig s5b). J Cell Biol (2017) ncbi
mouse monoclonal (UCHT-4)
  • blocking or activating experiments; human; loading ...
In order to propose that ikarugamycin is a useful reagent to study routes of endocytic trafficking, MilliporeSigma CD8A antibody (Sigma, C7423) was used in blocking or activating experiments on human samples . Traffic (2016) ncbi
mouse monoclonal (UCHT-4)
  • ELISA; human; fig s5f
In order to analyze beta-arrestin-mediated removal of the G protein-coupled receptor Gpr161 from the primary cilium determined by Smoothened, MilliporeSigma CD8A antibody (SigmaAldrich, C7423) was used in ELISA on human samples (fig s5f). J Cell Biol (2016) ncbi
mouse monoclonal (UCHT-4)
  • immunocytochemistry; human; fig 2
MilliporeSigma CD8A antibody (Sigma, C7423) was used in immunocytochemistry on human samples (fig 2). Traffic (2015) ncbi
mouse monoclonal (UCHT-4)
  • flow cytometry; African green monkey
  • immunocytochemistry; African green monkey; 1:50
MilliporeSigma CD8A antibody (Sigma, C7423) was used in flow cytometry on African green monkey samples and in immunocytochemistry on African green monkey samples at 1:50. J Cell Sci (2016) ncbi
mouse monoclonal (UCHT-4)
  • immunocytochemistry; human; fig 9a
In order to promote biogenesis of membrane-trafficking intermediates by engagement of OCRL1 with F-BAR protein pacsin 2, MilliporeSigma CD8A antibody (Sigma-Aldrich, C7423) was used in immunocytochemistry on human samples (fig 9a). Mol Biol Cell (2016) ncbi
Articles Reviewed
  1. Ravindranathan S, Passang T, Li J, Wang S, Dhamsania R, Ware M, et al. Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma. Nat Commun. 2022;13:6418 pubmed publisher
  2. Kemper K, Gielen E, Boross P, Houtkamp M, Plantinga T, de Poot S, et al. Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models. Life Sci Alliance. 2022;5: pubmed publisher
  3. Huang J, Huang Q, Xue J, Liu H, Guo Y, Chen H, et al. Fibrinogen like protein-1 knockdown suppresses the proliferation and metastasis of TU-686 cells and sensitizes laryngeal cancer to LAG-3 blockade. J Int Med Res. 2022;50:3000605221126874 pubmed publisher
  4. Ni H, Zhang H, Li L, Huang H, Guo H, Zhang L, et al. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer. J Immunother Cancer. 2022;10: pubmed publisher
  5. Amaral E, Foreman T, Namasivayam S, Hilligan K, Kauffman K, Barbosa Bomfim C, et al. GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection. J Exp Med. 2022;219: pubmed publisher
  6. Zhan Z, Liu L, Cheng M, Gao Y, Zhou W. The Effects of 6 Common Antidiabetic Drugs on Anti-PD1 Immune Checkpoint Inhibitor in Tumor Treatment. J Immunol Res. 2022;2022:2651790 pubmed publisher
  7. Ochiai R, Hayashi K, Yamamoto H, Fujii R, Saichi N, Shinchi H, et al. Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatment. Cancer Sci. 2022;113:3960-3971 pubmed publisher
  8. Zhang T, Xia W, Song X, Mao Q, Huang X, Chen B, et al. Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway. J Hematol Oncol. 2022;15:114 pubmed publisher
  9. Coy S, Wang S, Stopka S, Lin J, Yapp C, Ritch C, et al. Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma. Nat Commun. 2022;13:4814 pubmed publisher
  10. Sullivan P, Kumar R, Li W, Hoglund V, Wang L, Zhang Y, et al. FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma. Mol Cancer Ther. 2022;21:1608-1621 pubmed publisher
  11. Jin Y, Lorvik K, Jin Y, Beck C, Sike A, Persiconi I, et al. Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer. Mol Ther Oncolytics. 2022;26:189-206 pubmed publisher
  12. Lei X, Lin H, Wang J, Ou Z, Ruan Y, Sadagopan A, et al. Mitochondrial fission induces immunoescape in solid tumors through decreasing MHC-I surface expression. Nat Commun. 2022;13:3882 pubmed publisher
  13. Laffey K, Stiles R, Ludescher M, Davis T, Khwaja S, Bram R, et al. Early expression of mature αβ TCR in CD4-CD8- T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations. Proc Natl Acad Sci U S A. 2022;119:e2118529119 pubmed publisher
  14. Zhang L, Zheng D, Yan Y, Yu Y, Chen R, Li Z, et al. Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis. Arthritis Res Ther. 2022;24:148 pubmed publisher
  15. Chen P, Katsuyama E, Satyam A, Li H, Rubio J, Jung S, et al. CD38 reduces mitochondrial fitness and cytotoxic T cell response against viral infection in lupus patients by suppressing mitophagy. Sci Adv. 2022;8:eabo4271 pubmed publisher
  16. Qin L, Wang L, Zhang J, Zhou H, Yang Z, Wang Y, et al. Therapeutic strategies targeting uPAR potentiate anti-PD-1 efficacy in diffuse-type gastric cancer. Sci Adv. 2022;8:eabn3774 pubmed publisher
  17. Pan C, Wu Q, Wang S, Mei Z, Zhang L, Gao X, et al. Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma. Oncoimmunology. 2022;11:2073010 pubmed publisher
  18. Hickman T, Choi E, Whiteman K, Muralidharan S, Pai T, Johnson T, et al. BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity. PLoS ONE. 2022;17:e0266980 pubmed publisher
  19. Jung K, Son M, Lee S, Kim J, Ko D, Yoo S, et al. Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8+ T cells for cancer immunotherapy. Mol Cancer. 2022;21:102 pubmed publisher
  20. Meléndez E, Chondronasiou D, Mosteiro L, Mart xed nez de Villarreal J, Fern xe1 ndez Alfara M, Lynch C, et al. Natural killer cells act as an extrinsic barrier for in vivo reprogramming. Development. 2022;149: pubmed publisher
  21. Jiang Z, Qin L, Tang Y, Liao R, Shi J, He B, et al. Human induced-T-to-natural killer cells have potent anti-tumour activities. Biomark Res. 2022;10:13 pubmed publisher
  22. Wennerberg E, Mukherjee S, Spada S, Hung C, Agrusa C, Chen C, et al. Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer. Sci Transl Med. 2022;14:eabe8195 pubmed publisher
  23. Boby N, Cao X, Williams K, Gadila S, Shroyer M, Didier P, et al. Simian Immunodeficiency Virus Infection Mediated Changes in Jejunum and Peripheral SARS-CoV-2 Receptor ACE2 and Associated Proteins or Genes in Rhesus Macaques. Front Immunol. 2022;13:835686 pubmed publisher
  24. Shen X, Geng R, Li Q, Chen Y, Li S, Wang Q, et al. ACE2-independent infection of T lymphocytes by SARS-CoV-2. Signal Transduct Target Ther. 2022;7:83 pubmed publisher
  25. Ploeger C, Schreck J, Huth T, Fraas A, Albrecht T, Charbel A, et al. STAT1 and STAT3 Exhibit a Crosstalk and Are Associated with Increased Inflammation in Hepatocellular Carcinoma. Cancers (Basel). 2022;14: pubmed publisher
  26. Yokomizo K, Waki K, Ozawa M, Yamamoto K, Ogasawara S, Yano H, et al. Knockout of high-mobility group box 1 in B16F10 melanoma cells induced host immunity-mediated suppression of in vivo tumor growth. Med Oncol. 2022;39:58 pubmed publisher
  27. Kinkhabwala A, Herbel C, Pankratz J, Yushchenko D, R xfc berg S, Praveen P, et al. MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors. Sci Rep. 2022;12:1911 pubmed publisher
  28. Almishri W, Swain L, D Mello C, Le T, Urbanski S, Nguyen H. ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice. Front Immunol. 2021;12:779119 pubmed publisher
  29. Pulkka O, Viisanen L, Tynninen O, Laaksonen M, Reichardt P, Reichardt A, et al. Fibrinogen-like protein 2 in gastrointestinal stromal tumour. J Cell Mol Med. 2022;26:1083-1094 pubmed publisher
  30. Nakamura Y, Kinoshita J, Yamaguchi T, Aoki T, Saito H, Hamabe Horiike T, et al. Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast. Gastric Cancer. 2022;25:515-526 pubmed publisher
  31. Chen Y, Feng R, He B, Wang J, Xian N, Huang G, et al. PD-1H Expression Associated With CD68 Macrophage Marker Confers an Immune-Activated Microenvironment and Favorable Overall Survival in Human Esophageal Squamous Cell Carcinoma. Front Mol Biosci. 2021;8:777370 pubmed publisher
  32. Zhang Q, Hresko M, Picton L, Su L, Hollander M, Nunez Cruz S, et al. A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia. Sci Transl Med. 2021;13:eabg6986 pubmed publisher
  33. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed publisher
  34. Fierle J, Brioschi M, de Tiani M, Wetterwald L, Atsaves V, Abram Saliba J, et al. Soluble trivalent engagers redirect cytolytic T cell activity toward tumor endothelial marker 1. Cell Rep Med. 2021;2:100362 pubmed publisher
  35. Mao C, Jiang S, Wang X, Tao S, Jiang B, Mao C, et al. BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma. Int J Biol Sci. 2021;17:2461-2475 pubmed publisher
  36. Wu S, Xiao Y, Wei J, Xu X, Jin X, Hu X, et al. MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer. J Immunother Cancer. 2021;9: pubmed publisher
  37. Oberhardt V, Luxenburger H, Kemming J, Schulien I, Ciminski K, Giese S, et al. Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature. 2021;597:268-273 pubmed publisher
  38. Spiegel J, Patel S, Muffly L, Hossain N, Oak J, Baird J, et al. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat Med. 2021;27:1419-1431 pubmed publisher
  39. Bruand M, Barras D, Mina M, Ghisoni E, Morotti M, Lanitis E, et al. Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING. Cell Rep. 2021;36:109412 pubmed publisher
  40. Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, et al. Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. J Immunother Cancer. 2021;9: pubmed publisher
  41. Nathan A, Rossin E, Kaseke C, Park R, Khatri A, Koundakjian D, et al. Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses. Cell. 2021;: pubmed publisher
  42. Yue X, Petersen F, Shu Y, Kasper B, Magatsin J, Ahmadi M, et al. Transfer of PBMC From SSc Patients Induces Autoantibodies and Systemic Inflammation in Rag2-/-/IL2rg-/- Mice. Front Immunol. 2021;12:677970 pubmed publisher
  43. Li N, Torres M, Spetz M, Wang R, Peng L, Tian M, et al. CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice. Cell Rep Med. 2021;2:100297 pubmed publisher
  44. Motozono C, Toyoda M, Zahradník J, Saito A, Nasser H, Tan T, et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe. 2021;29:1124-1136.e11 pubmed publisher
  45. Li R, Yang Z, Shao F, Cheng H, Wen Y, Sun S, et al. Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes. Nat Commun. 2021;12:3785 pubmed publisher
  46. Wu Q, Tian A, Li B, Leduc M, Forveille S, Hamley P, et al. IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms. J Immunother Cancer. 2021;9: pubmed publisher
  47. Wang Z, Muecksch F, Schaefer Babajew D, Finkin S, Viant C, Gaebler C, et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature. 2021;595:426-431 pubmed publisher
  48. Zhang J, Qi J, Wei H, Lei Y, Yu H, Liu N, et al. TGFβ1 in Cancer-Associated Fibroblasts Is Associated With Progression and Radiosensitivity in Small-Cell Lung Cancer. Front Cell Dev Biol. 2021;9:667645 pubmed publisher
  49. Muranushi R, Araki K, Yokobori T, Chingunjav B, Hoshino K, Dolgormaa G, et al. High membrane expression of CMTM6 in hepatocellular carcinoma is associated with tumor recurrence. Cancer Sci. 2021;112:3314-3323 pubmed publisher
  50. Zhang H, Xia Y, Wang F, Luo M, Yang K, Liang S, et al. Aldehyde Dehydrogenase 2 Mediates Alcohol-Induced Colorectal Cancer Immune Escape through Stabilizing PD-L1 Expression. Adv Sci (Weinh). 2021;8:2003404 pubmed publisher
  51. Zhang Y, Chen Y, Li Y, Huang F, Luo B, Yuan Y, et al. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  52. Hawerkamp H, Domdey A, Radau L, Sewerin P, Oláh P, Homey B, et al. Tofacitinib downregulates antiviral immune defence in keratinocytes and reduces T cell activation. Arthritis Res Ther. 2021;23:144 pubmed publisher
  53. Wu K, Zheng X, Yao Z, Zheng Z, Huang W, Mu X, et al. Accumulation of CD45RO+CD8+ T cells is a diagnostic and prognostic biomarker for clear cell renal cell carcinoma. Aging (Albany NY). 2021;13:14304-14321 pubmed publisher
  54. Zimmer T, Broekaart D, Luinenburg M, Mijnsbergen C, Anink J, Sim N, et al. Balloon cells promote immune system activation in focal cortical dysplasia type 2b. Neuropathol Appl Neurobiol. 2021;47:826-839 pubmed publisher
  55. Roca C, Burton O, Gergelits V, Prezzemolo T, Whyte C, Halpert R, et al. AutoSpill is a principled framework that simplifies the analysis of multichromatic flow cytometry data. Nat Commun. 2021;12:2890 pubmed publisher
  56. Zhou S, Meng F, Du S, Qian H, Ding N, Sha H, et al. Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation. J Immunother Cancer. 2021;9: pubmed publisher
  57. Egedal J, Xie G, Packard T, Laustsen A, Neidleman J, Georgiou K, et al. Hyaluronic acid is a negative regulator of mucosal fibroblast-mediated enhancement of HIV infection. Mucosal Immunol. 2021;: pubmed publisher
  58. Martínez Zamudio R, Dewald H, Vasilopoulos T, Gittens Williams L, Fitzgerald Bocarsly P, Herbig U. Senescence-associated β-galactosidase reveals the abundance of senescent CD8+ T cells in aging humans. Aging Cell. 2021;20:e13344 pubmed publisher
  59. Zhou J, Pei X, Yang Y, Wang Z, Gao W, Ye R, et al. Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma. J Immunother Cancer. 2021;9: pubmed publisher
  60. Mandolesi M, Sheward D, Hanke L, Ma J, Pushparaj P, Perez Vidakovics L, et al. SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses. Cell Rep Med. 2021;2:100252 pubmed publisher
  61. Pezzuto F, Lunardi F, Vedovelli L, Fortarezza F, Urso L, Grosso F, et al. P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment. Front Oncol. 2021;11:653497 pubmed publisher
  62. Gómez Ferrer M, Villanueva Badenas E, Sánchez Sánchez R, Sánchez López C, Baquero M, Sepulveda P, et al. HIF-1α and Pro-Inflammatory Signaling Improves the Immunomodulatory Activity of MSC-Derived Extracellular Vesicles. Int J Mol Sci. 2021;22: pubmed publisher
  63. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
  64. Azzimonti B, Raimondo L, Squarzanti D, Rosso T, Zanetta P, Aluffi Valletti P, et al. Macrophages expressing TREM-1 are involved in the progression of HPV16-related oropharyngeal squamous cell carcinoma. Ann Med. 2021;53:541-550 pubmed publisher
  65. Harada Y, Kazama S, Morikawa T, Sonoda H, Ishi H, Emoto S, et al. Clinical significance of CD8+ and FoxP3+ tumor-infiltrating lymphocytes and MFG-E8 expression in lower rectal cancer with preoperative chemoradiotherapy. Mol Clin Oncol. 2021;14:87 pubmed publisher
  66. Szabo P, Dogra P, Gray J, Wells S, Connors T, Weisberg S, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797-814.e6 pubmed publisher
  67. Kuroda H, Jamiyan T, Yamaguchi R, Kakumoto A, Abe A, Harada O, et al. Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast. BMC Cancer. 2021;21:286 pubmed publisher
  68. Shen T, Liu J, Wang C, Rixiati Y, Li S, Cai L, et al. Targeting Erbin in B cells for therapy of lung metastasis of colorectal cancer. Signal Transduct Target Ther. 2021;6:115 pubmed publisher
  69. Brune M, Stussi G, Lundberg P, Vela V, Heim D, Manz M, et al. Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort. Ann Hematol. 2021;100:1169-1179 pubmed publisher
  70. Chiou S, Tseng D, Reuben A, Mallajosyula V, Molina I, Conley S, et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 2021;54:586-602.e8 pubmed publisher
  71. Paul S, Pearlman A, Douglass J, Mog B, Hsiue E, Hwang M, et al. TCR β chain-directed bispecific antibodies for the treatment of T cell cancers. Sci Transl Med. 2021;13: pubmed publisher
  72. Hsiue E, Wright K, Douglass J, Hwang M, Mog B, Pearlman A, et al. Targeting a neoantigen derived from a common TP53 mutation. Science. 2021;371: pubmed publisher
  73. Choi Y, Kim Y, Oh S, Suh K, Kim Y, Lee G, et al. Senescent Tumor Cells Build a Cytokine Shield in Colorectal Cancer. Adv Sci (Weinh). 2021;8:2002497 pubmed publisher
  74. Khosravi Maharlooei M, Li H, Hoelzl M, Zhao G, Ruiz A, Misra A, et al. Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system mice. J Autoimmun. 2021;119:102612 pubmed publisher
  75. Liu M, Li N, Qu C, Gao Y, Wu L, Hu L. Amylin deposition activates HIF1α and 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3 (PFKFB3) signaling in failing hearts of non-human primates. Commun Biol. 2021;4:188 pubmed publisher
  76. Jaworek C, Verel Yilmaz Y, Driesch S, Ostgathe S, Cook L, Wagner S, et al. Cohort Analysis of ADAM8 Expression in the PDAC Tumor Stroma. J Pers Med. 2021;11: pubmed publisher
  77. Li Y, Sun Y, Kulke M, Hechler T, Van der Jeught K, Dong T, et al. Targeted immunotherapy for HER2-low breast cancer with 17p loss. Sci Transl Med. 2021;13: pubmed publisher
  78. Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes C, Finkin S, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021;592:616-622 pubmed publisher
  79. Wang Q, Gao H, Clark K, Mugisha C, Davis K, Tang J, et al. CARD8 is an inflammasome sensor for HIV-1 protease activity. Science. 2021;371: pubmed publisher
  80. Biswas S, Mandal G, Payne K, Anadon C, Gatenbee C, Chaurio R, et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature. 2021;591:464-470 pubmed publisher
  81. Wang F, Ye W, Wang S, He Y, Zhong H, Wang Y, et al. Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapy. Neoplasia. 2021;23:281-293 pubmed publisher
  82. You G, Lee Y, Kang Y, Park H, Park K, Kim H, et al. B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8+ tumor-infiltrating lymphocytes. Sci Adv. 2021;7: pubmed publisher
  83. Nagle V, Henry K, Hertz C, Graham M, Campos C, Parada L, et al. Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8 PET. Clin Cancer Res. 2021;27:1958-1966 pubmed publisher
  84. Vavassori V, Mercuri E, Marcovecchio G, Castiello M, Schiroli G, Albano L, et al. Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome. EMBO Mol Med. 2021;13:e13545 pubmed publisher
  85. Gaebler C, Wang Z, Lorenzi J, Muecksch F, Finkin S, Tokuyama M, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639-644 pubmed publisher
  86. Wang Y, Mohseni M, Grauel A, Diez J, Guan W, Liang S, et al. SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms. Sci Rep. 2021;11:1399 pubmed publisher
  87. Break T, Oikonomou V, Dutzan N, Desai J, Swidergall M, Freiwald T, et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science. 2021;371: pubmed publisher
  88. Costa B, Fletcher M, Boskovic P, Ivanova E, Eisemann T, Lohr S, et al. A Set of Cell Lines Derived from a Genetic Murine Glioblastoma Model Recapitulates Molecular and Morphological Characteristics of Human Tumors. Cancers (Basel). 2021;13: pubmed publisher
  89. Lafouresse F, Jugele R, Müller S, Doineau M, Duplan Eche V, Espinosa E, et al. Stochastic asymmetric repartition of lytic machinery in dividing CD8+ T cells generates heterogeneous killing behavior. elife. 2021;10: pubmed publisher
  90. Hu Z, Luo C, Hurtado P, Li H, Wang S, Hu B, et al. Brain-derived neurotrophic factor precursor in the immune system is a novel target for treating multiple sclerosis. Theranostics. 2021;11:715-730 pubmed publisher
  91. Gregorova M, Morse D, Brignoli T, Steventon J, Hamilton F, Albur M, et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. elife. 2020;9: pubmed publisher
  92. Campolo M, Filippone A, Biondo C, Mancuso G, Casili G, Lanza M, et al. TLR7/8 in the Pathogenesis of Parkinson's Disease. Int J Mol Sci. 2020;21: pubmed publisher
  93. Snyder M, Sembrat J, Noda K, MYERBURG M, Craig A, Mitash N, et al. Human Lung-Resident Macrophages Colocalize with and Provide Costimulation to PD1hi Tissue-Resident Memory T Cells. Am J Respir Crit Care Med. 2021;203:1230-1244 pubmed publisher
  94. Lund M, Howard C, Thurecht K, Campbell D, Mahler S, Walsh B. A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells. BMC Cancer. 2020;20:1214 pubmed publisher
  95. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed publisher
  96. Harro C, Perez Sanz J, Costich T, Payne K, Anadon C, Chaurio R, et al. Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice. J Clin Invest. 2021;131: pubmed publisher
  97. Luo B, Zhan Y, Luo M, Dong H, Liu J, Lin Y, et al. Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration. Cell Death Dis. 2020;11:973 pubmed publisher
  98. Biasci D, Smoragiewicz M, Connell C, Wang Z, Gao Y, Thaventhiran J, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci U S A. 2020;117:28960-28970 pubmed publisher
  99. Fujimori D, Kinoshita J, Yamaguchi T, Nakamura Y, Gunjigake K, Ohama T, et al. Established fibrous peritoneal metastasis in an immunocompetent mouse model similar to clinical immune microenvironment of gastric cancer. BMC Cancer. 2020;20:1014 pubmed publisher
  100. Wang C, Weng M, Xia S, Zhang M, Chen C, Tang J, et al. Distinct roles of programmed death ligand 1 alternative splicing isoforms in colorectal cancer. Cancer Sci. 2021;112:178-193 pubmed publisher
  101. Zahedi K, Brooks M, Barone S, Rahmati N, Murray Stewart T, Dunworth M, et al. Ablation of polyamine catabolic enzymes provokes Purkinje cell damage, neuroinflammation, and severe ataxia. J Neuroinflammation. 2020;17:301 pubmed publisher
  102. Moreno Valladares M, Silva T, Garcés J, Sáenz Antoñanzas A, Moreno Cugnon L, Álvarez Satta M, et al. CD8+ T cells are present at low levels in the white matter with physiological and pathological aging. Aging (Albany NY). 2020;12:18928-18941 pubmed publisher
  103. Neidleman J, Luo X, Frouard J, Xie G, Hsiao F, Ma T, et al. Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir. elife. 2020;9: pubmed publisher
  104. Cui X, Ma C, Vasudevaraja V, Serrano J, Tong J, Peng Y, et al. Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy. elife. 2020;9: pubmed publisher
  105. Bhattacharya P, Ellegård R, Khalid M, Svanberg C, Govender M, Keita A, et al. Complement opsonization of HIV affects primary infection of human colorectal mucosa and subsequent activation of T cells. elife. 2020;9: pubmed publisher
  106. Zhang K, Zhang L, Mi Y, Tang Y, Ren F, Liu B, et al. A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration. Cancer Sci. 2020;111:4041-4050 pubmed publisher
  107. Dhanasekaran R, Park J, Yevtodiyenko A, Bellovin D, Adam S, Kd A, et al. MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCC. Mol Ther Nucleic Acids. 2020;21:850-859 pubmed publisher
  108. Tan E, Hopkins R, Lim C, Jamuar S, Ong C, Thoon K, et al. Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. J Clin Invest. 2020;130:5817-5832 pubmed publisher
  109. Moreno Valladares M, Moreno Cugnon L, Silva T, Garcés J, Sáenz Antoñanzas A, Álvarez Satta M, et al. CD8+ T cells are increased in the subventricular zone with physiological and pathological aging. Aging Cell. 2020;:e13198 pubmed publisher
  110. Li Z, Zhang H, Huang Y, Huang J, Sun P, Zhou N, et al. Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation. Nat Commun. 2020;11:3806 pubmed publisher
  111. Hood S, Cosma G, Foulds G, Johnson C, Reeder S, McArdle S, et al. Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data. elife. 2020;9: pubmed publisher
  112. Camu W, Mickunas M, Veyrune J, Payan C, Garlanda C, Locati M, et al. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial. EBioMedicine. 2020;59:102844 pubmed publisher
  113. Danzer H, Glaesner J, Baerenwaldt A, Reitinger C, Lux A, Heger L, et al. Human Fcγ-receptor IIb modulates pathogen-specific versus self-reactive antibody responses in lyme arthritis. elife. 2020;9: pubmed publisher
  114. Fischer M, Ruhnau J, Schulze J, Obst D, Floel A, Vogelgesang A. Spermine and spermidine modulate T-cell function in older adults with and without cognitive decline ex vivo. Aging (Albany NY). 2020;12:13716-13739 pubmed publisher
  115. Ning Y, Ding J, Sun X, Xie Y, Su M, Ma C, et al. HDAC9 deficiency promotes tumor progression by decreasing the CD8+ dendritic cell infiltration of the tumor microenvironment. J Immunother Cancer. 2020;8: pubmed publisher
  116. Benezeder T, Painsi C, Patra V, Dey S, Holcmann M, Lange Asschenfeldt B, et al. Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis. elife. 2020;9: pubmed publisher
  117. Grifoni A, Weiskopf D, Ramirez S, Mateus J, Dan J, Moderbacher C, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181:1489-1501.e15 pubmed publisher
  118. Cao W, Fang F, Gould T, Li X, Kim C, Gustafson C, et al. Ecto-NTPDase CD39 is a negative checkpoint that inhibits follicular helper cell generation. J Clin Invest. 2020;130:3422-3436 pubmed publisher
  119. Ma T, Luo X, George A, Mukherjee G, Sen N, Spitzer T, et al. HIV efficiently infects T cells from the endometrium and remodels them to promote systemic viral spread. elife. 2020;9: pubmed publisher
  120. Zurli V, Montecchi T, Heilig R, Poschke I, Volkmar M, Wimmer G, et al. Phosphoproteomics of CD2 signaling reveals AMPK-dependent regulation of lytic granule polarization in cytotoxic T cells. Sci Signal. 2020;13: pubmed publisher
  121. Liu X, Kong W, Peterson C, McGrail D, Hoang A, Zhang X, et al. PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma. Nat Commun. 2020;11:2135 pubmed publisher
  122. Liu G, Yu Y, Feng F, Zhu P, Zhang H, Zhang D, et al. Human CD8+CD28- T suppressor cells expanded by common gamma chain (γc) cytokines retain steady allospecific suppressive capacity in vivo. BMC Immunol. 2020;21:23 pubmed publisher
  123. Pallikkuth S, Chaudhury S, Lu P, Pan L, Jongert E, Wille Reece U, et al. A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses. elife. 2020;9: pubmed publisher
  124. Murata K, Nakatsugawa M, Rahman M, Nguyen L, Millar D, Mulder D, et al. Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma. elife. 2020;9: pubmed publisher
  125. Wong S, Lenzini S, Cooper M, Mooney D, Shin J. Soft extracellular matrix enhances inflammatory activation of mesenchymal stromal cells to induce monocyte production and trafficking. Sci Adv. 2020;6:eaaw0158 pubmed publisher
  126. Kim M, Chung Y, Kim H, Woo J, Ahn S, Park S. Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast. Breast Cancer Res. 2020;22:32 pubmed publisher
  127. Beziat V, Tavernier S, Chen Y, Ma C, Materna M, Laurence A, et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med. 2020;217: pubmed publisher
  128. Oh W, Jung J, Choi Y, Mun J, Ku S, Song C. Protective effects of fermented rice extract on ulcerative colitis induced by dextran sodium sulfate in mice. Food Sci Nutr. 2020;8:1718-1728 pubmed publisher
  129. Chaurasiya S, Yang A, Kang S, Lu J, Kim S, Park A, et al. Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model. Oncoimmunology. 2020;9:1729300 pubmed publisher
  130. He T, Yost S, Frankel P, Dagis A, Cao Y, Wang R, et al. Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis. PLoS ONE. 2020;15:e0229955 pubmed publisher
  131. Hunka J, Riley J, Debes G. Approaches to overcome flow cytometry limitations in the analysis of cells from veterinary relevant species. BMC Vet Res. 2020;16:83 pubmed publisher
  132. Raehtz K, Barrenas F, Xu C, Busman Sahay K, Valentine A, Law L, et al. African green monkeys avoid SIV disease progression by preventing intestinal dysfunction and maintaining mucosal barrier integrity. PLoS Pathog. 2020;16:e1008333 pubmed publisher
  133. Herrera Rios D, Mughal S, Teuber Hanselmann S, Pierscianek D, Sucker A, Jansen P, et al. Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain. Front Immunol. 2020;11:120 pubmed publisher
  134. Tezera L, Bielecka M, Ogongo P, Walker N, Ellis M, Garay Baquero D, et al. Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α. elife. 2020;9: pubmed publisher
  135. Park J, Botting R, Domínguez Conde C, Popescu D, Lavaert M, Kunz D, et al. A cell atlas of human thymic development defines T cell repertoire formation. Science. 2020;367: pubmed publisher
  136. Chen H, Cong X, Wu C, Wu X, Wang J, Mao K, et al. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells. Sci Adv. 2020;6:eaax4690 pubmed publisher
  137. Rodríguez Lorenzo S, Konings J, van der Pol S, Kamermans A, Amor S, van Horssen J, et al. Inflammation of the choroid plexus in progressive multiple sclerosis: accumulation of granulocytes and T cells. Acta Neuropathol Commun. 2020;8:9 pubmed publisher
  138. Seitz C, Schroeder S, Knopf P, Krahl A, Hau J, Schleicher S, et al. GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells. Oncoimmunology. 2020;9:1683345 pubmed publisher
  139. Noh B, Kwak J, Eom D. Immune classification for the PD-L1 expression and tumour-infiltrating lymphocytes in colorectal adenocarcinoma. BMC Cancer. 2020;20:58 pubmed publisher
  140. Sellier Y, Marliot F, Bessières B, Stirnemann J, Encha Razavi F, Guilleminot T, et al. Adaptive and Innate Immune Cells in Fetal Human Cytomegalovirus-Infected Brains. Microorganisms. 2020;8: pubmed publisher
  141. Boudewijns S, Bloemendal M, de Haas N, Westdorp H, Bol K, Schreibelt G, et al. Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial. Cancer Immunol Immunother. 2020;69:477-488 pubmed publisher
  142. Nixon C, Mavigner M, Sampey G, Brooks A, Spagnuolo R, Irlbeck D, et al. Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo. Nature. 2020;578:160-165 pubmed publisher
  143. Bracher A, Alcalá C, Ferrer J, Melzer N, Hohlfeld R, Casanova B, et al. An expanded parenchymal CD8+ T cell clone in GABAA receptor encephalitis. Ann Clin Transl Neurol. 2020;7:239-244 pubmed publisher
  144. Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed publisher
  145. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed publisher
  146. Gate D, Saligrama N, Leventhal O, Yang A, Unger M, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020;577:399-404 pubmed publisher
  147. Epps S, Coplin N, Luthert P, Dick A, Coupland S, Nicholson L. Features of ectopic lymphoid-like structures in human uveitis. Exp Eye Res. 2020;191:107901 pubmed publisher
  148. Le Nours J, Gherardin N, Ramarathinam S, Awad W, Wiede F, Gully B, et al. A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1. Science. 2019;366:1522-1527 pubmed publisher
  149. Uhlen M, Karlsson M, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366: pubmed publisher
  150. Williford J, Ishihara J, Ishihara A, Mansurov A, Hosseinchi P, Marchell T, et al. Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Sci Adv. 2019;5:eaay1357 pubmed publisher
  151. Jimeno R, Lebrusant Fernandez M, Margreitter C, LUCAS B, Veerapen N, Kelly G, et al. Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells. elife. 2019;8: pubmed publisher
  152. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  153. Lynn R, Weber E, Sotillo E, Gennert D, Xu P, Good Z, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576:293-300 pubmed publisher
  154. Park C, Kehrl J. An integrin/MFG-E8 shuttle loads HIV-1 viral-like particles onto follicular dendritic cells in mouse lymph node. elife. 2019;8: pubmed publisher
  155. Callender L, Carroll E, Bober E, Akbar A, Solito E, Henson S. Mitochondrial mass governs the extent of human T cell senescence. Aging Cell. 2020;19:e13067 pubmed publisher
  156. Calvanese V, Nguyen A, Bolan T, Vavilina A, Su T, Lee L, et al. MLLT3 governs human haematopoietic stem-cell self-renewal and engraftment. Nature. 2019;576:281-286 pubmed publisher
  157. Martínez Fábregas J, Wilmes S, Wang L, Hafer M, Pohler E, Lokau J, et al. Kinetics of cytokine receptor trafficking determine signaling and functional selectivity. elife. 2019;8: pubmed publisher
  158. Ma A, Motyka B, Gutfreund K, Shi Y, George R. A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B. Hum Vaccin Immunother. 2020;16:756-778 pubmed publisher
  159. Clark D, Dhanasekaran S, Petralia F, Pan J, Song X, Hu Y, et al. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. Cell. 2019;179:964-983.e31 pubmed publisher
  160. Zhang Q, He Y, Luo N, Patel S, Han Y, Gao R, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179:829-845.e20 pubmed publisher
  161. Strickley J, Messerschmidt J, Awad M, Li T, Hasegawa T, Ha D, et al. Immunity to commensal papillomaviruses protects against skin cancer. Nature. 2019;: pubmed publisher
  162. Ladinsky M, Khamaikawin W, Jung Y, Lin S, Lam J, An D, et al. Mechanisms of virus dissemination in bone marrow of HIV-1-infected humanized BLT mice. elife. 2019;8: pubmed publisher
  163. Pecher A, Kettemann F, Asteriti E, Schmid H, Duerr Stoerzer S, Keppeler H, et al. Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis. Arthritis Res Ther. 2019;21:212 pubmed publisher
  164. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed publisher
  165. Zou F, Lu L, Liu J, Xia B, Zhang W, Hu Q, et al. Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56. Nat Commun. 2019;10:4109 pubmed publisher
  166. Harel M, Ortenberg R, Varanasi S, Mangalhara K, Mardamshina M, Markovits E, et al. Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence. Cell. 2019;179:236-250.e18 pubmed publisher
  167. Di Mascio M, Lifson J, Srinivasula S, Kim I, Degrange P, Keele B, et al. Evaluation of an antibody to α4β7 in the control of SIVmac239-nef-stop infection. Science. 2019;365:1025-1029 pubmed publisher
  168. Zhang Y, Xu J, Hua J, Liu J, Liang C, Meng Q, et al. A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma. J Immunother Cancer. 2019;7:233 pubmed publisher
  169. Jordan S, Tung N, Casanova Acebes M, Chang C, Cantoni C, Zhang D, et al. Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell. 2019;178:1102-1114.e17 pubmed publisher
  170. Choi J, Lee E, Kim S, Park S, Oh S, Kang J, et al. Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer. BMC Cancer. 2019;19:817 pubmed publisher
  171. Findlay E, Currie A, Zhang A, Ovciarikova J, Young L, Stevens H, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019;8:1608106 pubmed publisher
  172. Crank M, Ruckwardt T, Chen M, Morabito K, Phung E, Costner P, et al. A proof of concept for structure-based vaccine design targeting RSV in humans. Science. 2019;365:505-509 pubmed publisher
  173. Verma V, Shrimali R, Ahmad S, Dai W, Wang H, Lu S, et al. PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance. Nat Immunol. 2019;20:1231-1243 pubmed publisher
  174. Leclerc M, Voilin E, Gros G, Corgnac S, de Montpreville V, Validire P, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10:3345 pubmed publisher
  175. Smillie C, Biton M, Ordovas Montanes J, Sullivan K, Burgin G, Graham D, et al. Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis. Cell. 2019;178:714-730.e22 pubmed publisher
  176. Banga R, Rebecchini C, Procopio F, Noto A, Munoz O, Ioannidou K, et al. Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement. PLoS Pathog. 2019;15:e1007918 pubmed publisher
  177. Meckiff B, Ladell K, McLaren J, Ryan G, Leese A, James E, et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. J Immunol. 2019;203:1276-1287 pubmed publisher
  178. Burel J, Pomaznoy M, Lindestam Arlehamn C, Weiskopf D, da Silva Antunes R, Jung Y, et al. Circulating T cell-monocyte complexes are markers of immune perturbations. elife. 2019;8: pubmed publisher
  179. Fransen N, Crusius J, Smolders J, Mizee M, Van Eden C, Luchetti S, et al. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. Brain Pathol. 2020;30:106-119 pubmed publisher
  180. Xia Y, Gao Y, Wang B, Zhang H, Zhang Q. Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry. Gastroenterol Res Pract. 2019;2019:5436961 pubmed publisher
  181. Pascual García M, Bonfill Teixidor E, Planas Rigol E, Rubio Perez C, Iurlaro R, Arias A, et al. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy. Nat Commun. 2019;10:2416 pubmed publisher
  182. Dangaj D, Bruand M, Grimm A, Ronet C, Barras D, Duttagupta P, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 2019;35:885-900.e10 pubmed publisher
  183. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  184. Han L, Hu J, Ma B, Wen D, Zhang T, Lu Z, et al. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis. Diagn Pathol. 2019;14:52 pubmed publisher
  185. Lee J, Park S, Park H, Kim S, Lee J, Lee J, et al. Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma. Cell. 2019;177:1842-1857.e21 pubmed publisher
  186. Gauthier L, Morel A, Anceriz N, Rossi B, Blanchard Alvarez A, Grondin G, et al. Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity. Cell. 2019;177:1701-1713.e16 pubmed publisher
  187. Ahmed R, Omidian Z, Giwa A, Cornwell B, Majety N, Bell D, et al. A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen. Cell. 2019;177:1583-1599.e16 pubmed publisher
  188. Escolano A, Gristick H, Abernathy M, Merkenschlager J, Gautam R, Oliveira T, et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature. 2019;: pubmed publisher
  189. Merve A, Zhang X, Pomella N, Acquati S, Hoeck J, Dumas A, et al. c-MYC overexpression induces choroid plexus papillomas through a T-cell mediated inflammatory mechanism. Acta Neuropathol Commun. 2019;7:2 pubmed publisher
  190. Fenwick C, Loredo Varela J, Joo V, Pellaton C, Farina A, Rajah N, et al. Tumor suppression of novel anti-PD-1 antibodies mediated through CD28 costimulatory pathway. J Exp Med. 2019;: pubmed publisher
  191. Swaims Kohlmeier A, Haddad L, Li Z, Brookmeyer K, Baker J, Widom C, et al. Chronic immune barrier dysregulation among women with a history of violence victimization. JCI Insight. 2019;4: pubmed publisher
  192. Cirelli K, Carnathan D, Nogal B, Martin J, Rodriguez O, Upadhyay A, et al. Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance. Cell. 2019;177:1153-1171.e28 pubmed publisher
  193. Del Duca E, Pavel A, Dubin C, Song T, Wallace E, Peng X, et al. Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy Individuals. J Invest Dermatol. 2019;139:2228-2232.e10 pubmed publisher
  194. Veatch J, Jesernig B, Kargl J, Fitzgibbon M, Lee S, Baik C, et al. Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations. Cancer Immunol Res. 2019;7:910-922 pubmed publisher
  195. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed publisher
  196. Terahara K, Iwabuchi R, Hosokawa M, Nishikawa Y, Takeyama H, Takahashi Y, et al. A CCR5+ memory subset within HIV-1-infected primary resting CD4+ T cells is permissive for replication-competent, latently infected viruses in vitro. BMC Res Notes. 2019;12:242 pubmed publisher
  197. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed publisher
  198. Ferdosi S, Ewaisha R, Moghadam F, Krishna S, Park J, Ebrahimkhani M, et al. Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes. Nat Commun. 2019;10:1842 pubmed publisher
  199. Yang W, Lee K, Srivastava R, Kuo F, Krishna C, Chowell D, et al. Immunogenic neoantigens derived from gene fusions stimulate T cell responses. Nat Med. 2019;25:767-775 pubmed publisher
  200. Middha S, Yaeger R, Shia J, Stadler Z, King S, Guercio S, et al. Majority of B2M-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-High. JCO Precis Oncol. 2019;3: pubmed publisher
  201. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  202. Pavel Dinu M, Wiebking V, Dejene B, Srifa W, Mantri S, Nicolas C, et al. Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nat Commun. 2019;10:1634 pubmed publisher
  203. Hammerich L, Marron T, Upadhyay R, Svensson Arvelund J, Dhainaut M, Hussein S, et al. Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination. Nat Med. 2019;25:814-824 pubmed publisher
  204. Dang A, Teles R, Weiss D, Parvatiyar K, Sarno E, Ochoa M, et al. IL-26 contributes to host defense against intracellular bacteria. J Clin Invest. 2019;129:1926-1939 pubmed publisher
  205. Oda H, Beck D, Kuehn H, Sampaio Moura N, Hoffmann P, Ibarra M, et al. Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC. Front Immunol. 2019;10:479 pubmed publisher
  206. Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed publisher
  207. Cao Y, Trillo Tinoco J, Sierra R, Anadon C, Dai W, Mohamed E, et al. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nat Commun. 2019;10:1280 pubmed publisher
  208. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed publisher
  209. Gong B, Kiyotani K, Sakata S, Nagano S, Kumehara S, Baba S, et al. Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer. J Exp Med. 2019;: pubmed publisher
  210. Lee J, Stone M, Porrett P, Thomas S, Komar C, Li J, et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019;567:249-252 pubmed publisher
  211. Karimzadeh H, Kiraithe M, Oberhardt V, Salimi Alizei E, Bockmann J, Schulze zur Wiesch J, et al. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level. Gastroenterology. 2019;156:1820-1833 pubmed publisher
  212. Mayassi T, Ladell K, Gudjonson H, McLaren J, Shaw D, Tran M, et al. Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease. Cell. 2019;176:967-981.e19 pubmed publisher
  213. Wen Z, Jin K, Shen Y, Yang Z, Li Y, Wu B, et al. N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation. Nat Immunol. 2019;20:313-325 pubmed publisher
  214. Banki Z, Krabbendam L, Klaver D, Leng T, Kruis S, Mehta H, et al. Antibody opsonization enhances MAIT cell responsiveness to bacteria via a TNF-dependent mechanism. Immunol Cell Biol. 2019;97:538-551 pubmed publisher
  215. Cao Z, Ji J, Zhang C, Wang F, Xu H, Yu Y, et al. The preoperative neutrophil-to-lymphocyte ratio is not a marker of prostate cancer characteristics but is an independent predictor of biochemical recurrence in patients receiving radical prostatectomy. Cancer Med. 2019;8:1004-1012 pubmed publisher
  216. Muller Durovic B, Grählert J, Devine O, Akbar A, Hess C. CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age. Aging (Albany NY). 2019;11:724-740 pubmed publisher
  217. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed publisher
  218. Chi V, Garaud S, De Silva P, Thibaud V, Stamatopoulos B, Berehad M, et al. Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients. BMC Cancer. 2019;19:81 pubmed publisher
  219. van der Lee D, Reijmers R, Honders M, Hagedoorn R, de Jong R, Kester M, et al. Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia. J Clin Invest. 2019;129:774-785 pubmed publisher
  220. Dagur R, Branch Woods A, Mathews S, Joshi P, Quadros R, Harms D, et al. Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infection. BMC Immunol. 2019;20:2 pubmed publisher
  221. Koppejan H, Jansen D, Hameetman M, Thomas R, Toes R, van Gaalen F. Altered composition and phenotype of mucosal-associated invariant T cells in early untreated rheumatoid arthritis. Arthritis Res Ther. 2019;21:3 pubmed publisher
  222. Ha D, Tanaka A, Kibayashi T, Tanemura A, Sugiyama D, Wing J, et al. Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody. Proc Natl Acad Sci U S A. 2019;116:609-618 pubmed publisher
  223. Kumar A, Lee J, Suknuntha K, D Souza S, Thakur A, Slukvin I. NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells. J Immunol. 2019;202:770-776 pubmed publisher
  224. Amelio P, Portevin D, Hella J, Reither K, Kamwela L, Lweno O, et al. HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses. J Virol. 2019;93: pubmed publisher
  225. Bouafia A, Lofek S, Bruneau J, Chentout L, Lamrini H, Trinquand A, et al. Loss of ARHGEF1 causes a human primary antibody deficiency. J Clin Invest. 2019;129:1047-1060 pubmed publisher
  226. Scheper W, Kelderman S, Fanchi L, Linnemann C, Bendle G, de Rooij M, et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat Med. 2019;25:89-94 pubmed publisher
  227. Du X, de Almeida P, Manieri N, de Almeida Nagata D, Wu T, Harden Bowles K, et al. CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1. Proc Natl Acad Sci U S A. 2018;115:E11731-E11740 pubmed publisher
  228. Andre P, Denis C, Soulas C, Bourbon Caillet C, Lopez J, Arnoux T, et al. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Cell. 2018;175:1731-1743.e13 pubmed publisher
  229. Wiedemann G, Aithal C, Kraechan A, Heise C, Cadilha B, Zhang J, et al. Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma. Transl Oncol. 2019;12:350-360 pubmed publisher
  230. Williams P, Basu S, Garcia Manero G, Hourigan C, Oetjen K, Cortes J, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019;125:1470-1481 pubmed publisher
  231. Deng M, Gui X, Kim J, Xie L, Chen W, Li Z, et al. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. Nature. 2018;562:605-609 pubmed publisher
  232. Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed publisher
  233. Hoang T, Harper J, Pino M, Wang H, Micci L, King C, et al. Bone Marrow-Derived CD4+ T Cells Are Depleted in Simian Immunodeficiency Virus-Infected Macaques and Contribute to the Size of the Replication-Competent Reservoir. J Virol. 2019;93: pubmed publisher
  234. Chen Y, Huang Y, Lu X, Wang G, Chi P. Antitumor effects of the silencing of programmed cell death ligand 1 in colorectal cancer via immunoregulation. Oncol Rep. 2018;40:3370-3380 pubmed publisher
  235. Patel N, Vukmanovic Stejic M, Suárez Fariñas M, Chambers E, Sandhu D, Fuentes Duculan J, et al. Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen-Specific Challenge. J Infect Dis. 2018;218:S88-S98 pubmed publisher
  236. Petrelli A, Mijnheer G, Hoytema van Konijnenburg D, van der Wal M, Giovannone B, Mocholí E, et al. PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation. J Clin Invest. 2018;128:4669-4681 pubmed publisher
  237. Watanabe N, Takaku T, Takeda K, Shirane S, Toyota T, Koike M, et al. Dasatinib-induced anti-leukemia cellular immunity through a novel subset of CD57 positive helper/cytotoxic CD4 T cells in chronic myelogenous leukemia patients. Int J Hematol. 2018;108:588-597 pubmed publisher
  238. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
  239. Tai Y, Lin L, Xing L, Cho S, Yu T, Acharya C, et al. APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia. 2019;33:426-438 pubmed publisher
  240. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
  241. Marijt K, Blijleven L, Verdegaal E, Kester M, Kowalewski D, Rammensee H, et al. Identification of non-mutated neoantigens presented by TAP-deficient tumors. J Exp Med. 2018;215:2325-2337 pubmed publisher
  242. Zhu L, Xie X, Zhang L, Wang H, Jie Z, Zhou X, et al. TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival. Nat Commun. 2018;9:2812 pubmed publisher
  243. Yang T, St John L, Garber H, Kerros C, Ruisaard K, Clise Dwyer K, et al. Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation. J Immunol. 2018;201:1389-1399 pubmed publisher
  244. Pratt D, Dominah G, Lobel G, Obungu A, Lynes J, Sanchez V, et al. Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype Glioblastoma. Neurosurgery. 2018;: pubmed publisher
  245. D Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, et al. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018;128:3490-3503 pubmed publisher
  246. Hartana C, Ahlén Bergman E, Broome A, Berglund S, Johansson M, Alamdari F, et al. Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer. Clin Exp Immunol. 2018;194:39-53 pubmed publisher
  247. Chute C, Yang X, Meyer K, Yang N, O Neil K, Kasza I, et al. Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases. Breast Cancer Res. 2018;20:66 pubmed publisher
  248. Moysi E, Pallikkuth S, de Armas L, Gonzalez L, Ambrozak D, George V, et al. Altered immune cell follicular dynamics in HIV infection following influenza vaccination. J Clin Invest. 2018;128:3171-3185 pubmed publisher
  249. Bu D, Singh R, Choi E, Ruella M, Nunez Cruz S, Mansfield K, et al. Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma. Oncotarget. 2018;9:25764-25780 pubmed publisher
  250. Khan A, Srivastava R, Vahed H, Roy S, Walia S, Kim G, et al. Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107+ CD8+ T Cells That Infiltrate the Corneas and Trigeminal Ganglia of Humanized HLA Transgenic Rabbits and Protect . J Virol. 2018;92: pubmed publisher
  251. Boutboul D, Kuehn H, Van de Wyngaert Z, Niemela J, Callebaut I, Stoddard J, et al. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. J Clin Invest. 2018;128:3071-3087 pubmed publisher
  252. Frascaroli G, Lecher C, Varani S, Setz C, van der Merwe J, Brune W, et al. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4+ and CD8+ T Cells. Front Immunol. 2018;9:1129 pubmed publisher
  253. Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, et al. CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers. Sci Immunol. 2018;3: pubmed publisher
  254. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu Y, Zheng Z, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24:724-730 pubmed publisher
  255. Honeycutt J, Liao B, Nixon C, Cleary R, Thayer W, Birath S, et al. T cells establish and maintain CNS viral infection in HIV-infected humanized mice. J Clin Invest. 2018;128:2862-2876 pubmed publisher
  256. Ng S, Yoshida N, Christie A, Ghandi M, Dharia N, Dempster J, et al. Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models. Nat Commun. 2018;9:2024 pubmed publisher
  257. Kityo C, Makamdop K, Rothenberger M, Chipman J, Hoskuldsson T, Beilman G, et al. Lymphoid tissue fibrosis is associated with impaired vaccine responses. J Clin Invest. 2018;128:2763-2773 pubmed publisher
  258. Kiener R, Fleischmann M, Wiegand M, Lemmermann N, Schwegler C, Kaufmann C, et al. Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors. J Virol. 2018;92: pubmed publisher
  259. Wang E, Pjechova M, Nightingale K, Vlahava V, Patel M, Růcková E, et al. Suppression of costimulation by human cytomegalovirus promotes evasion of cellular immune defenses. Proc Natl Acad Sci U S A. 2018;115:4998-5003 pubmed publisher
  260. Ferrando Martinez S, Moysi E, Pegu A, Andrews S, Nganou Makamdop K, Ambrozak D, et al. Accumulation of follicular CD8+ T cells in pathogenic SIV infection. J Clin Invest. 2018;128:2089-2103 pubmed publisher
  261. Shi Y, Zhang P, Wang G, Liu X, Sun X, Zhang X, et al. Description of organ-specific phenotype, and functional characteristics of tissue resident lymphocytes from liver transplantation donor and research on immune tolerance mechanism of liver. Oncotarget. 2018;9:15552-15565 pubmed publisher
  262. Peranzoni E, Lemoine J, Vimeux L, Feuillet V, Barrin S, Kantari Mimoun C, et al. Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment. Proc Natl Acad Sci U S A. 2018;115:E4041-E4050 pubmed publisher
  263. Zhang C, Peng Y, Hublitz P, Zhang H, Dong T. Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy. Sci Rep. 2018;8:5549 pubmed publisher
  264. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed publisher
  265. Miles J, Tan M, Dolton G, Edwards E, Galloway S, Laugel B, et al. Peptide mimic for influenza vaccination using nonnatural combinatorial chemistry. J Clin Invest. 2018;128:1569-1580 pubmed publisher
  266. Li N, van Unen V, Höllt T, Thompson A, van Bergen J, Pezzotti N, et al. Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine. J Exp Med. 2018;215:1383-1396 pubmed publisher
  267. Trapecar M, Khan S, Cohn B, Wu F, Sanjabi S. B cells are the predominant mediators of early systemic viral dissemination during rectal LCMV infection. Mucosal Immunol. 2018;11:1158-1167 pubmed publisher
  268. Qu S, Xue H, Dong X, Lin D, Wu R, Nabavi N, et al. Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model. Int J Cancer. 2018;143:419-429 pubmed publisher
  269. Seki A, Rutz S. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells. J Exp Med. 2018;215:985-997 pubmed publisher
  270. Carisey A, Mace E, Saeed M, Davis D, Orange J. Nanoscale Dynamism of Actin Enables Secretory Function in Cytolytic Cells. Curr Biol. 2018;28:489-502.e9 pubmed publisher
  271. Linehan J, Harrison O, Han S, Byrd A, Vujkovic Cvijin I, Villarino A, et al. Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair. Cell. 2018;172:784-796.e18 pubmed publisher
  272. Huang S, Ren Y, Thomas A, Chan D, Mueller S, Ward A, et al. Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells. J Clin Invest. 2018;128:876-889 pubmed publisher
  273. Vo L, Kinney M, Liu X, Zhang Y, Barragan J, Sousa P, et al. Regulation of embryonic haematopoietic multipotency by EZH1. Nature. 2018;553:506-510 pubmed publisher
  274. Warthan M, Washington S, Franzese S, Ramus R, Kim K, York T, et al. The role of endoplasmic reticulum aminopeptidase 2 in modulating immune detection of choriocarcinoma. Biol Reprod. 2018;98:309-322 pubmed publisher
  275. Rivino L, Le Bert N, Gill U, Kunasegaran K, Cheng Y, Tan D, et al. Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation. J Clin Invest. 2018;128:668-681 pubmed publisher
  276. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed publisher
  277. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed publisher
  278. Wang C, Edilova M, Wagar L, Mujib S, Singer M, Bernard N, et al. Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy. J Immunol. 2018;200:558-564 pubmed publisher
  279. Jasinski Bergner S, Büttner M, Quandt D, Seliger B, Kielstein H. Adiponectin and Its Receptors Are Differentially Expressed in Human Tissues and Cell Lines of Distinct Origin. Obes Facts. 2017;10:569-583 pubmed publisher
  280. Hutten T, Norde W, Woestenenk R, Wang R, Maas F, Kester M, et al. Increased Coexpression of PD-1, TIGIT, and KLRG-1 on Tumor-Reactive CD8+ T Cells During Relapse after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018;24:666-677 pubmed publisher
  281. Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira N, et al. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature. 2018;553:91-95 pubmed publisher
  282. Moreno Cubero E, Subira D, Sanz de Villalobos E, Parra Cid T, Madejon A, Miquel J, et al. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity. J Virol. 2018;92: pubmed publisher
  283. Herndler Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017;114:E9626-E9634 pubmed publisher
  284. Meng W, Tang A, Ye X, Gui X, Li L, Fan X, et al. Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody. Antimicrob Agents Chemother. 2018;62: pubmed publisher
  285. Carvajal Hausdorf D, Mani N, Velcheti V, Schalper K, Rimm D. Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer. J Immunother Cancer. 2017;5:81 pubmed publisher
  286. Matos T, O Malley J, Lowry E, Hamm D, Kirsch I, Robins H, et al. Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing ?? T cell clones. J Clin Invest. 2017;127:4031-4041 pubmed publisher
  287. Matsuyama K, Mizutani Y, Takahashi T, Shu E, Kanoh H, Miyazaki T, et al. Enhanced dendritic cells and regulatory T cells in the dermis of porokeratosis. Arch Dermatol Res. 2017;309:749-756 pubmed publisher
  288. Pinaud L, Samassa F, Porat Z, Ferrari M, Belotserkovsky I, Parsot C, et al. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes. Proc Natl Acad Sci U S A. 2017;114:9954-9959 pubmed publisher
  289. Burr M, Sparbier C, Chan Y, Williamson J, Woods K, Beavis P, et al. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature. 2017;549:101-105 pubmed publisher
  290. Zhang X, Lian X, Dai Z, Zheng H, Chen X, Zheng Y. ?3-Deletion Isoform of HLA-A11 Modulates Cytotoxicity of NK Cells: Correlations with HIV-1 Infection of Cells. J Immunol. 2017;199:2030-2042 pubmed publisher
  291. Patel S, Sanjana N, Kishton R, Eidizadeh A, Vodnala S, Cam M, et al. Identification of essential genes for cancer immunotherapy. Nature. 2017;548:537-542 pubmed publisher
  292. Jiang X, Björkström N, Melum E. Intact CD100-CD72 Interaction Necessary for TCR-Induced T Cell Proliferation. Front Immunol. 2017;8:765 pubmed publisher
  293. Hensel M, Peng T, Cheng A, De Rosa S, Wald A, Laing K, et al. Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells. J Virol. 2017;91: pubmed publisher
  294. Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed publisher
  295. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  296. Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443 pubmed publisher
  297. Zheng C, Zheng L, Yoo J, Guo H, Zhang Y, Guo X, et al. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell. 2017;169:1342-1356.e16 pubmed publisher
  298. Garcia Hernandez M, Uribe Uribe N, Espinosa González R, Kast W, Khader S, Rangel Moreno J. A Unique Cellular and Molecular Microenvironment Is Present in Tertiary Lymphoid Organs of Patients with Spontaneous Prostate Cancer Regression. Front Immunol. 2017;8:563 pubmed publisher
  299. Cerboni S, Jeremiah N, Gentili M, Gehrmann U, Conrad C, Stolzenberg M, et al. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes. J Exp Med. 2017;214:1769-1785 pubmed publisher
  300. Chevrier S, Levine J, Zanotelli V, Silina K, Schulz D, Bacac M, et al. An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell. 2017;169:736-749.e18 pubmed publisher
  301. Roy A, Attarha S, Weishaupt H, Edqvist P, Swartling F, Bergqvist M, et al. Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression. Oncotarget. 2017;8:24815-24827 pubmed publisher
  302. Ma S, Imadojemu S, Beer K, Seykora J. Inflammatory features of frontal fibrosing alopecia. J Cutan Pathol. 2017;44:672-676 pubmed publisher
  303. Chen C, Sun W, Chen J, Huang J. Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: A retrospective small-scale study. Exp Ther Med. 2017;13:1490-1494 pubmed publisher
  304. Stevanović S, Pasetto A, Helman S, Gartner J, Prickett T, Howie B, et al. Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer. Science. 2017;356:200-205 pubmed publisher
  305. Berthel A, Zoernig I, Valous N, Kahlert C, Klupp F, Ulrich A, et al. Detailed resolution analysis reveals spatial T cell heterogeneity in the invasive margin of colorectal cancer liver metastases associated with improved survival. Oncoimmunology. 2017;6:e1286436 pubmed publisher
  306. Dong P, Wen X, Liu J, Yan C, Yuan J, Luo L, et al. Simultaneous detection of decidual Th1/Th2 and NK1/NK2 immunophenotyping in unknown recurrent miscarriage using 8-color flow cytometry with FSC/Vt extended strategy. Biosci Rep. 2017;37: pubmed publisher
  307. Gaggianesi M, Turdo A, Chinnici A, Lipari E, Apuzzo T, Benfante A, et al. IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition. Cancer Res. 2017;77:3268-3279 pubmed publisher
  308. Huang A, Postow M, Orlowski R, Mick R, Bengsch B, Manne S, et al. T-cell invigoration to tumour burden ratio associated with anti-PD-1 response. Nature. 2017;545:60-65 pubmed publisher
  309. Kim W, Kim M, Kim D, Byun J, Huy H, Song H, et al. Suppressor of Cytokine Signaling 2 Negatively Regulates NK Cell Differentiation by Inhibiting JAK2 Activity. Sci Rep. 2017;7:46153 pubmed publisher
  310. Mucksová J, Plachý J, Staněk O, Hejnar J, Kalina J, Benešová B, et al. Cytokine response to the RSV antigen delivered by dendritic cell-directed vaccination in congenic chicken lines. Vet Res. 2017;48:18 pubmed publisher
  311. Zhang J, Xu X, Shi M, Chen Y, Yu D, Zhao C, et al. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. Oncoimmunology. 2017;6:e1258504 pubmed publisher
  312. Bittner S, Knoll G, Ehrenschwender M. Death receptor 3 signaling enhances proliferation of human regulatory T cells. FEBS Lett. 2017;591:1187-1195 pubmed publisher
  313. Bergström I, Lundberg A, Jonsson S, Särndahl E, Ernerudh J, Jonasson L. Annexin A1 in blood mononuclear cells from patients with coronary artery disease: Its association with inflammatory status and glucocorticoid sensitivity. PLoS ONE. 2017;12:e0174177 pubmed publisher
  314. Eapen M, McAlinden K, Tan D, Weston S, Ward C, Muller H, et al. Profiling cellular and inflammatory changes in the airway wall of mild to moderate COPD. Respirology. 2017;22:1125-1132 pubmed publisher
  315. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed publisher
  316. Nishimura Y, Gautam R, Chun T, Sadjadpour R, Foulds K, Shingai M, et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature. 2017;543:559-563 pubmed publisher
  317. Klinker M, Marklein R, Lo Surdo J, Wei C, Bauer S. Morphological features of IFN-γ-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity. Proc Natl Acad Sci U S A. 2017;114:E2598-E2607 pubmed publisher
  318. Li R, Rezk A, Li H, Gommerman J, Prat A, Bar Or A. Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses. J Immunol. 2017;198:3245-3254 pubmed publisher
  319. Cardinaud S, Urrutia A, Rouers A, Coulon P, Kervevan J, Richetta C, et al. Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells. Eur J Immunol. 2017;47:818-829 pubmed publisher
  320. Pardi N, Secreto A, Shan X, Debonera F, Glover J, Yi Y, et al. Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nat Commun. 2017;8:14630 pubmed publisher
  321. Yoder A, Guo K, Dillon S, Phang T, Lee E, Harper M, et al. The transcriptome of HIV-1 infected intestinal CD4+ T cells exposed to enteric bacteria. PLoS Pathog. 2017;13:e1006226 pubmed publisher
  322. Eyquem J, Mansilla Soto J, Giavridis T, van der Stegen S, Hamieh M, Cunanan K, et al. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. Nature. 2017;543:113-117 pubmed publisher
  323. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed publisher
  324. Sullivan A, Wang E, Farrell J, Whitaker P, Faulkner L, Peckham D, et al. ?-Lactam hypersensitivity involves expansion of circulating and skin-resident TH22 cells. J Allergy Clin Immunol. 2018;141:235-249.e8 pubmed publisher
  325. Yang Y, Hu S, Liu J, Cui Y, Fan Y, Lv T, et al. CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway. Sci Rep. 2017;7:42893 pubmed publisher
  326. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang S, Marquardt N, et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017;46:287-300 pubmed publisher
  327. Malnati M, Ugolotti E, Monti M, Battista D, Vanni I, Bordo D, et al. Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control. Sci Rep. 2017;7:42470 pubmed publisher
  328. Ren J, Zhang X, Liu X, Fang C, Jiang S, June C, et al. A versatile system for rapid multiplex genome-edited CAR T cell generation. Oncotarget. 2017;8:17002-17011 pubmed publisher
  329. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  330. Wouters K, Gaens K, Bijnen M, Verboven K, Jocken J, Wetzels S, et al. Circulating classical monocytes are associated with CD11c+ macrophages in human visceral adipose tissue. Sci Rep. 2017;7:42665 pubmed publisher
  331. Su S, Zou Z, Chen F, Ding N, Du J, Shao J, et al. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. Oncoimmunology. 2017;6:e1249558 pubmed publisher
  332. Watanabe N, Bajgain P, Sukumaran S, Ansari S, Heslop H, Rooney C, et al. Fine-tuning the CAR spacer improves T-cell potency. Oncoimmunology. 2016;5:e1253656 pubmed publisher
  333. Jeffery H, Jeffery L, Lutz P, Corrigan M, Webb G, Hirschfield G, et al. Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 2017;188:394-411 pubmed publisher
  334. Canté Barrett K, Mendes R, Li Y, Vroegindeweij E, Pike Overzet K, Wabeke T, et al. Loss of CD44dim Expression from Early Progenitor Cells Marks T-Cell Lineage Commitment in the Human Thymus. Front Immunol. 2017;8:32 pubmed publisher
  335. Mylvaganam G, Rios D, Abdelaal H, Iyer S, Tharp G, Mavigner M, et al. Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection. Proc Natl Acad Sci U S A. 2017;114:1976-1981 pubmed publisher
  336. Parrot T, Oger R, Benlalam H, Raingeard de la Blétière D, Jouand N, Coutolleau A, et al. CD40L confers helper functions to human intra-melanoma class-I-restricted CD4+CD8+ double positive T cells. Oncoimmunology. 2016;5:e1250991 pubmed publisher
  337. Salvatori G, Foligno S, Sirleto P, Genovese S, Russo S, Coletti V, et al. Sometimes it is better to wait: First Italian case of a newborn with transient abnormal myelopoiesis and a favorable prognosis. Oncol Lett. 2017;13:191-195 pubmed publisher
  338. An Q, Wang Y, Hu S, Fang D, Xuan C, Xu S, et al. Clinical significance of lymphocyte subset changes in hemophagocytic lymphohistiocytosis of children. Exp Ther Med. 2016;12:3549-3552 pubmed publisher
  339. Hurtado Guerrero I, Pinto Medel M, Urbaneja P, Rodriguez Bada J, Leon A, Guerrero M, et al. Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß. PLoS ONE. 2017;12:e0170031 pubmed publisher
  340. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed publisher
  341. Kim J, Kwon C, Joh J, Sinn D, Choi G, Park J, et al. Differences in Peripheral Blood Lymphocytes between Brand-Name and Generic Tacrolimus Used in Stable Liver Transplant Recipients. Med Princ Pract. 2017;26:221-228 pubmed publisher
  342. Lim Y, Koh J, Kim K, Chie E, Kim S, Lee K, et al. Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy. Target Oncol. 2017;12:211-218 pubmed publisher
  343. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  344. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed publisher
  345. Bolzoni M, Ronchetti D, Storti P, Donofrio G, Marchica V, Costa F, et al. IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts. Haematologica. 2017;102:773-784 pubmed publisher
  346. Roberts E, Carnathan D, Li H, Shaw G, Silvestri G, Betts M. Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog. 2016;12:e1006135 pubmed publisher
  347. Matsumoto A, Pasut A, Matsumoto M, Yamashita R, Fung J, Monteleone E, et al. mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide. Nature. 2017;541:228-232 pubmed publisher
  348. Izawa K, Martin E, Soudais C, Bruneau J, Boutboul D, Rodriguez R, et al. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection. J Exp Med. 2017;214:73-89 pubmed publisher
  349. Kadlecova Z, Spielman S, Loerke D, Mohanakrishnan A, Reed D, Schmid S. Regulation of clathrin-mediated endocytosis by hierarchical allosteric activation of AP2. J Cell Biol. 2017;216:167-179 pubmed publisher
  350. Berry N, Manoussaka M, Ham C, Ferguson D, Tudor H, Mattiuzzo G, et al. Role of Occult and Post-acute Phase Replication in Protective Immunity Induced with a Novel Live Attenuated SIV Vaccine. PLoS Pathog. 2016;12:e1006083 pubmed publisher
  351. Wahl S, Drong A, Lehne B, Loh M, Scott W, Kunze S, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017;541:81-86 pubmed publisher
  352. Spivak A, Larragoite E, Coletti M, Macedo A, Martins L, Bosque A, et al. Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo. Retrovirology. 2016;13:88 pubmed publisher
  353. Tripathi D, Venkatasubramanian S, Cheekatla S, Paidipally P, Welch E, Tvinnereim A, et al. A TLR9 agonist promotes IL-22-dependent pancreatic islet allograft survival in type 1 diabetic mice. Nat Commun. 2016;7:13896 pubmed publisher
  354. Sairafi D, Stikvoort A, Gertow J, Mattsson J, Uhlin M. Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. J Immunol Res. 2016;2016:5601204 pubmed
  355. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed publisher
  356. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260-268 pubmed publisher
  357. Matsuoka Y, Takahashi M, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, et al. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells. Cell Transplant. 2017;26:1043-1058 pubmed publisher
  358. Lévy R, Okada S, Béziat V, Moriya K, Liu C, Chai L, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113:E8277-E8285 pubmed publisher
  359. Kasturi S, Kozlowski P, Nakaya H, Burger M, Russo P, Pham M, et al. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques. J Virol. 2017;91: pubmed publisher
  360. Yanagisawa H, Hashimoto M, Minagawa S, Takasaka N, Ma R, Moermans C, et al. Role of IL-17A in murine models of COPD airway disease. Am J Physiol Lung Cell Mol Physiol. 2017;312:L122-L130 pubmed publisher
  361. Briceno O, Pinto Cardoso S, Rodríguez Bernabe N, Murakami Ogasawara A, Reyes Teran G. Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment. PLoS ONE. 2016;11:e0166496 pubmed publisher
  362. Rathod K, Kapil V, Velmurugan S, Khambata R, Siddique U, Khan S, et al. Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans. J Clin Invest. 2017;127:169-182 pubmed publisher
  363. Snyder Mackler N, Sanz J, Kohn J, Brinkworth J, Morrow S, Shaver A, et al. Social status alters immune regulation and response to infection in macaques. Science. 2016;354:1041-1045 pubmed
  364. Siegers G, Barreira C, Postovit L, Dekaban G. CD11d ?2 integrin expression on human NK, B, and ?? T cells. J Leukoc Biol. 2017;101:1029-1035 pubmed publisher
  365. Riou C, Bunjun R, Müller T, Kiravu A, Ginbot Z, Oni T, et al. Selective reduction of IFN-γ single positive mycobacteria-specific CD4+ T cells in HIV-1 infected individuals with latent tuberculosis infection. Tuberculosis (Edinb). 2016;101:25-30 pubmed publisher
  366. Hippen K, Watkins B, Tkachev V, Lemire A, Lehnen C, Riddle M, et al. Preclinical Testing of Antihuman CD28 Fab' Antibody in a Novel Nonhuman Primate Small Animal Rodent Model of Xenogenic Graft-Versus-Host Disease. Transplantation. 2016;100:2630-2639 pubmed publisher
  367. Senbabaoglu Y, Gejman R, Winer A, Liu M, Van Allen E, de Velasco G, et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 2016;17:231 pubmed
  368. Sundara Y, Kostine M, Cleven A, Bovee J, Schilham M, Cleton Jansen A. Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy. Cancer Immunol Immunother. 2017;66:119-128 pubmed publisher
  369. Li J, Shayan G, Avery L, Jie H, Gildener Leapman N, Schmitt N, et al. Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk. Oncoimmunology. 2016;5:e1200778 pubmed
  370. Khan S, Woodruff E, Trapecar M, Fontaine K, Ezaki A, Borbet T, et al. Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication. J Exp Med. 2016;213:2913-2929 pubmed
  371. Galindo Albarrán A, López Portales O, Gutiérrez Reyna D, Rodríguez Jorge O, Sánchez Villanueva J, Ramirez Pliego O, et al. CD8+ T Cells from Human Neonates Are Biased toward an Innate Immune Response. Cell Rep. 2016;17:2151-2160 pubmed publisher
  372. Kadivar M, Petersson J, Svensson L, Marsal J. CD8??+ ?? T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease. J Immunol. 2016;197:4584-4592 pubmed
  373. Srivastava R, Khan A, Garg S, Syed S, Furness J, Vahed H, et al. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocula. J Virol. 2017;91: pubmed publisher
  374. Sherbenou D, Aftab B, Su Y, Behrens C, Wiita A, Logan A, et al. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016;126:4640-4653 pubmed publisher
  375. Kim H, Ha S, Hong M, Heo S, Koh Y, Choi E, et al. PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients. Sci Rep. 2016;6:36956 pubmed publisher
  376. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  377. Laurent C, Dorothee G, Hunot S, Martin E, Monnet Y, Duchamp M, et al. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain. 2017;140:184-200 pubmed publisher
  378. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  379. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  380. Sen D, Kaminski J, Barnitz R, Kurachi M, Gerdemann U, Yates K, et al. The epigenetic landscape of T cell exhaustion. Science. 2016;354:1165-1169 pubmed
  381. Michailidou I, Naessens D, Hametner S, Guldenaar W, Kooi E, Geurts J, et al. Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis. Glia. 2017;65:264-277 pubmed publisher
  382. Kaewkangsadan V, Verma C, Eremin J, Cowley G, Ilyas M, Eremin O. Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer. J Immunol Res. 2016;2016:4757405 pubmed
  383. Carreras J, Kikuti Y, Bea S, Miyaoka M, Hiraiwa S, Ikoma H, et al. Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in. Histopathology. 2017;70:595-621 pubmed publisher
  384. Adair J, Waters T, Haworth K, Kubek S, Trobridge G, Hocum J, et al. Semi-automated closed system manufacturing of lentivirus gene-modified haematopoietic stem cells for gene therapy. Nat Commun. 2016;7:13173 pubmed publisher
  385. Clement M, Pearson J, Gras S, van den Berg H, Lissina A, Llewellyn Lacey S, et al. Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies. Sci Rep. 2016;6:35332 pubmed publisher
  386. Byrareddy S, Arthos J, Cicala C, Villinger F, Ortiz K, Little D, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science. 2016;354:197-202 pubmed
  387. Hu X, Valentin A, Dayton F, Kulkarni V, Alicea C, Rosati M, et al. DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV. J Immunol. 2016;197:3999-4013 pubmed
  388. Gabanti E, Bruno F, Scaramuzzi L, Mangione F, Zelini P, Gerna G, et al. Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli. New Microbiol. 2016;39:247-258 pubmed
  389. Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy R, et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol. 2016;90:11259-11278 pubmed
  390. Swaminathan G, Thoryk E, Cox K, Smith J, Wolf J, Gindy M, et al. A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates. Sci Rep. 2016;6:34215 pubmed publisher
  391. Oon S, Huynh H, Tai T, Ng M, Monaghan K, Biondo M, et al. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 2016;1:e86131 pubmed publisher
  392. Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, et al. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Proc Natl Acad Sci U S A. 2016;113:E6467-E6475 pubmed
  393. Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J, et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16 pubmed publisher
  394. Willemen Y, Van den Bergh J, Bonte S, Anguille S, Heirman C, Stein B, et al. The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells. Oncotarget. 2016;7:73960-73970 pubmed publisher
  395. Komdeur F, Wouters M, Workel H, Tijans A, Terwindt A, Brunekreeft K, et al. CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy. Oncotarget. 2016;7:75130-75144 pubmed publisher
  396. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  397. Sugita S, Iwasaki Y, Makabe K, Kimura T, Futagami T, Suegami S, et al. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors. Stem Cell Reports. 2016;7:619-634 pubmed publisher
  398. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed publisher
  399. Vargas Inchaustegui D, Ying O, Demberg T, Robert Guroff M. Evaluation of Functional NK Cell Responses in Vaccinated and SIV-Infected Rhesus Macaques. Front Immunol. 2016;7:340 pubmed publisher
  400. Gaido C, Stone S, Chopra A, Thomas W, LE SOUEF P, Hales B. Immunodominant T-Cell Epitopes in the VP1 Capsid Protein of Rhinovirus Species A and C. J Virol. 2016;90:10459-10471 pubmed publisher
  401. Foerster F, Bamberger D, Schupp J, Weilbächer M, Kaps L, Strobl S, et al. Dextran-based therapeutic nanoparticles for hepatic drug delivery. Nanomedicine (Lond). 2016;11:2663-2677 pubmed
  402. George J, Saito M, Tsuta K, Iwakawa R, Shiraishi K, Scheel A, et al. Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer. Clin Cancer Res. 2017;23:1220-1226 pubmed publisher
  403. Takeda Y, Azuma M, Matsumoto M, Seya T. Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8(+) T cells during vaccine immunotherapy. J Exp Clin Cancer Res. 2016;35:143 pubmed publisher
  404. Boddupalli C, Nair S, Gray S, Nowyhed H, Verma R, Gibson J, et al. ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells. J Clin Invest. 2016;126:3905-3916 pubmed publisher
  405. Goh S, Ngugi D, Lizundia R, Hostettler I, Woods K, Ballingall K, et al. Identification of Theileria lestoquardi Antigens Recognized by CD8+ T Cells. PLoS ONE. 2016;11:e0162571 pubmed publisher
  406. Kim W, Jung H, Nam S, Kim T, Heo D, Kim C, et al. Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis. Virchows Arch. 2016;469:581-590 pubmed
  407. Zenarruzabeitia O, Vitallé J, Garcia Obregon S, Astigarraga I, Eguizabal C, Santos S, et al. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults. Sci Rep. 2016;6:32693 pubmed publisher
  408. Ferre E, Rose S, Rosenzweig S, Burbelo P, Romito K, Niemela J, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1: pubmed
  409. Jiang J, Chen X, An H, Yang B, Zhang F, Cheng X. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep. 2016;6:32320 pubmed publisher
  410. Ilkovitch D, Ferris L. Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules. Mol Med Rep. 2016;14:3935-40 pubmed publisher
  411. Landtwing V, Raykova A, Pezzino G, Beziat V, Marcenaro E, Graf C, et al. Cognate HLA absence in trans diminishes human NK cell education. J Clin Invest. 2016;126:3772-3782 pubmed publisher
  412. Bentzen A, Marquard A, Lyngaa R, Saini S, Ramskov S, Donia M, et al. Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes. Nat Biotechnol. 2016;34:1037-1045 pubmed publisher
  413. Ayala V, Trivett M, Barsov E, Jain S, Piatak M, Trubey C, et al. Adoptive Transfer of Engineered Rhesus Simian Immunodeficiency Virus-Specific CD8+ T Cells Reduces the Number of Transmitted/Founder Viruses Established in Rhesus Macaques. J Virol. 2016;90:9942-9952 pubmed publisher
  414. Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, et al. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Invest. 2016;126:3479-94 pubmed publisher
  415. Daud A, Loo K, Pauli M, Sanchez Rodriguez R, Sandoval P, Taravati K, et al. Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma. J Clin Invest. 2016;126:3447-52 pubmed publisher
  416. Watson D, Bayık D, Srivatsan A, Bergamaschi C, Valentin A, Niu G, et al. Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials. 2016;105:195-205 pubmed publisher
  417. Schade H, Sen S, Neff C, Freed B, Gao D, Gutman J, et al. Programmed Death 1 Expression on CD4+ T Cells Predicts Mortality after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016;22:2172-2179 pubmed publisher
  418. Torrelo A, Noguera Morel L, Hernandez Martin A, Clemente D, Barja J, Buzon L, et al. Recurrent lipoatrophic panniculitis of children. J Eur Acad Dermatol Venereol. 2017;31:536-543 pubmed publisher
  419. Hervier B, Perez M, Allenbach Y, Devilliers H, Cohen F, Uzunhan Y, et al. Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome. J Immunol. 2016;197:1621-30 pubmed publisher
  420. Nguyen T, Bird N, Grant E, Miles J, Thomas P, Kotsimbos T, et al. Maintenance of the EBV-specific CD8+ TCR?? repertoire in immunosuppressed lung transplant recipients. Immunol Cell Biol. 2017;95:77-86 pubmed publisher
  421. He R, Hou S, Liu C, Zhang A, Bai Q, Han M, et al. Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. Nature. 2016;537:412-428 pubmed publisher
  422. Xing Y, Cao R, Hu H. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles). Cell Death Dis. 2016;7:e2322 pubmed publisher
  423. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  424. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  425. Cheng H, Gaddis D, Wu R, McSkimming C, Haynes L, Taylor A, et al. Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest. 2016;126:3236-46 pubmed publisher
  426. Paquin Proulx D, Gibbs A, Bachle S, Checa A, Introini A, Leeansyah E, et al. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. J Immunol. 2016;197:1843-51 pubmed publisher
  427. Debliquis A, Voirin J, Harzallah I, Maurer M, Lerintiu F, Drenou B, et al. Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. Cytometry B Clin Cytom. 2018;94:182-188 pubmed publisher
  428. Chen H, Händel N, Ngeow J, Muller J, Huhn M, Yang H, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol. 2017;139:607-620.e15 pubmed publisher
  429. Voisinne G, García Blesa A, Chaoui K, Fiore F, Bergot E, Girard L, et al. Co-recruitment analysis of the CBL and CBLB signalosomes in primary T cells identifies CD5 as a key regulator of TCR-induced ubiquitylation. Mol Syst Biol. 2016;12:876 pubmed publisher
  430. Seifert A, Zeng S, Zhang J, Kim T, Cohen N, Beckman M, et al. PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors. Clin Cancer Res. 2017;23:454-465 pubmed publisher
  431. Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, et al. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clin Cancer Res. 2017;23:149-158 pubmed publisher
  432. Schweiger T, Berghoff A, Glogner C, Glueck O, Rajky O, Traxler D, et al. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer. Clin Exp Metastasis. 2016;33:727-39 pubmed publisher
  433. Luo W, Li S, Li C, Lian H, Yang Q, Zhong B, et al. iRhom2 is essential for innate immunity to DNA viruses by mediating trafficking and stability of the adaptor STING. Nat Immunol. 2016;17:1057-66 pubmed publisher
  434. Fromentin R, Bakeman W, Lawani M, Khoury G, Hartogensis W, DaFonseca S, et al. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. PLoS Pathog. 2016;12:e1005761 pubmed publisher
  435. Suliman S, Geldenhuys H, Johnson J, Hughes J, Smit E, Murphy M, et al. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses. J Immunol. 2016;197:1100-1110 pubmed publisher
  436. Elkin S, Oswald N, Reed D, Mettlen M, Macmillan J, Schmid S. Ikarugamycin: A Natural Product Inhibitor of Clathrin-Mediated Endocytosis. Traffic. 2016;17:1139-49 pubmed publisher
  437. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed publisher
  438. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed publisher
  439. Heath J, Newhook N, Comeau E, Gallant M, Fudge N, Grant M. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence. J Immunol Res. 2016;2016:7470124 pubmed publisher
  440. Fu T, Yang W, Zhang X, Xu X. Peripheral T-cell lymphoma unspecified type presenting with a pneumothorax as the initial manifestation: A case report and literature review. Oncol Lett. 2016;11:4069-4076 pubmed
  441. Chen P, Roh W, Reuben A, Cooper Z, Spencer C, Prieto P, et al. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade. Cancer Discov. 2016;6:827-37 pubmed publisher
  442. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  443. Xu Y, Chaudhury A, Zhang M, Savoldo B, Metelitsa L, Rodgers J, et al. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest. 2016;126:2678-88 pubmed publisher
  444. Domingues R, de Carvalho G, Aoki V, da Silva Duarte A, Sato M. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus. J Transl Med. 2016;14:171 pubmed publisher
  445. Goetz B, An W, Mohapatra B, Zutshi N, Iseka F, Storck M, et al. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells. Oncotarget. 2016;7:51107-51123 pubmed publisher
  446. Ramos C, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, et al. Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016;126:2588-96 pubmed publisher
  447. Najjar A, Manuri P, Olivares S, Flores L, Mi T, Huls H, et al. Imaging of Sleeping Beauty-Modified CD19-Specific T Cells Expressing HSV1-Thymidine Kinase by Positron Emission Tomography. Mol Imaging Biol. 2016;18:838-848 pubmed
  448. van der Heiden M, van Zelm M, Bartol S, de Rond L, Berbers G, Boots A, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892 pubmed publisher
  449. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  450. Golombeck K, Bönte K, Mönig C, van Loo K, Hartwig M, Schwindt W, et al. Evidence of a pathogenic role for CD8(+) T cells in anti-GABAB receptor limbic encephalitis. Neurol Neuroimmunol Neuroinflamm. 2016;3:e232 pubmed publisher
  451. Wang H, Schuetz C, Arima A, Chihaya Y, Weinbauer G, Habermann G, et al. Assessment of placental transfer and the effect on embryo-fetal development of a humanized monoclonal antibody targeting lymphotoxin-alpha in non-human primates. Reprod Toxicol. 2016;63:82-95 pubmed publisher
  452. Akyol Erikci A, Karagoz B, Bilgi O. Regulatory T Cells in Patients with Idiopathic Thrombocytopenic Purpura. Turk J Haematol. 2016;33:153-5 pubmed publisher
  453. Strønen E, Toebes M, Kelderman S, van Buuren M, Yang W, van Rooij N, et al. Targeting of cancer neoantigens with donor-derived T cell receptor repertoires. Science. 2016;352:1337-41 pubmed publisher
  454. Patel M, Kim J, Theodros D, Tam A, Velarde E, Kochel C, et al. Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma. J Immunother Cancer. 2016;4:28 pubmed publisher
  455. Dou D, Calvanese V, Sierra M, Nguyen A, Minasian A, Saarikoski P, et al. Medial HOXA genes demarcate haematopoietic stem cell fate during human development. Nat Cell Biol. 2016;18:595-606 pubmed publisher
  456. Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al. Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?. PLoS ONE. 2016;11:e0154737 pubmed publisher
  457. Tuşaliu M, Zainea V, Mogoantă C, Dragu A, GoanŢă C, Niţescu M, et al. Diagnostic and therapeutic aspects in malignant sinonasal lymphoma. Rom J Morphol Embryol. 2016;57:233-6 pubmed
  458. Ruibal P, Oestereich L, Lüdtke A, Becker Ziaja B, Wozniak D, Kerber R, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016;533:100-4 pubmed publisher
  459. Reynaldi A, Smith N, Schlub T, Venturi V, Rudd B, Davenport M. Modeling the dynamics of neonatal CD8+ T-cell responses. Immunol Cell Biol. 2016;94:838-848 pubmed publisher
  460. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  461. Harper I, Ali J, Harper S, Wlodek E, Alsughayyir J, Negus M, et al. Augmentation of Recipient Adaptive Alloimmunity by Donor Passenger Lymphocytes within the Transplant. Cell Rep. 2016;15:1214-27 pubmed publisher
  462. Liao R, Jiang N, Tang Z, Li D, Huang P, Luo S, et al. Systemic and intratumoral balances between monocytes/macrophages and lymphocytes predict prognosis in hepatocellular carcinoma patients after surgery. Oncotarget. 2016;7:30951-61 pubmed publisher
  463. Preuße C, Allenbach Y, Hoffmann O, Goebel H, Pehl D, Radke J, et al. Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis. Acta Neuropathol Commun. 2016;4:45 pubmed publisher
  464. Qualai J, Li L, Cantero J, Tarrats A, Fernández M, Sumoy L, et al. Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential. PLoS ONE. 2016;11:e0154253 pubmed publisher
  465. Swamy M, Pathak S, Grzes K, Damerow S, Sinclair L, van Aalten D, et al. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy. Nat Immunol. 2016;17:712-20 pubmed publisher
  466. Graves S, Kouriba B, Diarra I, Daou M, Niangaly A, Coulibaly D, et al. Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate. Vaccine. 2016;34:2546-55 pubmed publisher
  467. Yamashita K, Kawata K, Matsumiya H, Kamekura R, Jitsukawa S, Nagaya T, et al. Bob1 limits cellular frequency of T-follicular helper cells. Eur J Immunol. 2016;46:1361-70 pubmed publisher
  468. Zurawski G, Zurawski S, Flamar A, Richert L, Wagner R, Tomaras G, et al. Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques. PLoS ONE. 2016;11:e0153484 pubmed publisher
  469. Goldstein J, Burlion A, Zaragoza B, Sendeyo K, Polansky J, Huehn J, et al. Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression. PLoS ONE. 2016;11:e0153682 pubmed publisher
  470. Wang S, Gao X, Shen G, Wang W, Li J, Zhao J, et al. Interleukin-10 deficiency impairs regulatory T cell-derived neuropilin-1 functions and promotes Th1 and Th17 immunity. Sci Rep. 2016;6:24249 pubmed publisher
  471. Fend L, Remy Ziller C, Foloppe J, Kempf J, Cochin S, Barraud L, et al. Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironment. Oncoimmunology. 2016;5:e1080414 pubmed
  472. Rueda C, Presicce P, Jackson C, Miller L, Kallapur S, Jobe A, et al. Lipopolysaccharide-Induced Chorioamnionitis Promotes IL-1-Dependent Inflammatory FOXP3+ CD4+ T Cells in the Fetal Rhesus Macaque. J Immunol. 2016;196:3706-15 pubmed publisher
  473. Sim C, Cho Y, Kim B, Baek I, Kim Y, Lee M. 2'-5' Oligoadenylate synthetase-like 1 (OASL1) deficiency in mice promotes an effective anti-tumor immune response by enhancing the production of type I interferons. Cancer Immunol Immunother. 2016;65:663-75 pubmed publisher
  474. Nakatsugawa M, Rahman M, Yamashita Y, Ochi T, Wnuk P, Tanaka S, et al. CD4(+) and CD8(+) TCR? repertoires possess different potentials to generate extraordinarily high-avidity T cells. Sci Rep. 2016;6:23821 pubmed publisher
  475. Yadav A, Betts M, Collman R. Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders. J Neurovirol. 2016;22:584-596 pubmed
  476. Ganesh A, Lemongello D, Lee E, Peterson J, McLaughlin B, Ferre A, et al. Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers. AIDS Res Hum Retroviruses. 2016;32:791-800 pubmed publisher
  477. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  478. Pal K, Hwang S, Somatilaka B, Badgandi H, Jackson P, DeFea K, et al. Smoothened determines ?-arrestin-mediated removal of the G protein-coupled receptor Gpr161 from the primary cilium. J Cell Biol. 2016;212:861-75 pubmed publisher
  479. Slebioda T, Bojarska Junak A, Cyman M, Landowski P, Kaminska B, Celinski K, et al. Expression of death receptor 3 on peripheral blood mononuclear cells differes in adult IBD patients and children with newly diagnosed IBD. Cytometry B Clin Cytom. 2017;92:165-169 pubmed publisher
  480. Macdonald K, Hoeppli R, Huang Q, Gillies J, Luciani D, Orban P, et al. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. J Clin Invest. 2016;126:1413-24 pubmed publisher
  481. Leone D, Kozakowski N, Kornauth C, Waidacher T, Neudert B, Loeffler A, et al. The Phenotypic Characterization of the Human Renal Mononuclear Phagocytes Reveal a Co-Ordinated Response to Injury. PLoS ONE. 2016;11:e0151674 pubmed publisher
  482. Arsenijević A, Milovanovic M, Milovanovic J, Stojanovic B, Zdravkovic N, Leung P, et al. Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens. Sci Rep. 2016;6:23348 pubmed publisher
  483. Moura J, Rodrigues J, Goncalves M, Amaral C, Lima M, Carvalho E. Impaired T-cell differentiation in diabetic foot ulceration. Cell Mol Immunol. 2017;14:758-769 pubmed publisher
  484. Carrasco A, Fernández Bañares F, Pedrosa E, Salas A, Loras C, Rosinach M, et al. Regional Specialisation of T Cell Subsets and Apoptosis in the Human Gut Mucosa: Differences Between Ileum and Colon in Healthy Intestine and Inflammatory Bowel Diseases. J Crohns Colitis. 2016;10:1042-54 pubmed publisher
  485. van Kempen P, Noorlag R, Swartz J, Bovenschen N, Braunius W, Vermeulen J, et al. Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors. Cancer Immunol Immunother. 2016;65:575-85 pubmed publisher
  486. Miller M, Rosten P, Lemieux M, Lai C, Humphries R. Meis1 Is Required for Adult Mouse Erythropoiesis, Megakaryopoiesis and Hematopoietic Stem Cell Expansion. PLoS ONE. 2016;11:e0151584 pubmed publisher
  487. Ladoire S, Enot D, Senovilla L, Ghiringhelli F, Poirier Colame V, Chaba K, et al. The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer. Autophagy. 2016;12:864-75 pubmed publisher
  488. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  489. Vermeulen J, Van Hecke W, Spliet W, Villacorta Hidalgo J, Fisch P, Broekhuizen R, et al. Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme Inhibitors. PLoS ONE. 2016;11:e0151465 pubmed publisher
  490. Matsumoto H, Thike A, Li H, Yeong J, Koo S, Dent R, et al. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer. Breast Cancer Res Treat. 2016;156:237-47 pubmed publisher
  491. McGranahan N, Furness A, Rosenthal R, Ramskov S, Lyngaa R, Saini S, et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science. 2016;351:1463-9 pubmed publisher
  492. Khazen R, Müller S, Gaudenzio N, Espinosa E, Puissegur M, Valitutti S. Melanoma cell lysosome secretory burst neutralizes the CTL-mediated cytotoxicity at the lytic synapse. Nat Commun. 2016;7:10823 pubmed publisher
  493. Carrasco A, Esteve M, Salas A, Pedrosa E, Rosinach M, Aceituno M, et al. Immunological Differences between Lymphocytic and Collagenous Colitis. J Crohns Colitis. 2016;10:1055-66 pubmed publisher
  494. Krisko J, Begum N, Baker C, Foster J, Garcia J. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication. J Virol. 2016;90:4681-4695 pubmed publisher
  495. Hogan L, Jones D, Allen R. Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure. Sci Rep. 2016;6:21780 pubmed publisher
  496. Liu L, Sommermeyer D, Cabanov A, Kosasih P, Hill T, Riddell S. Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy. Nat Biotechnol. 2016;34:430-4 pubmed publisher
  497. Trivedi P, Bruns T, Ward S, Mai M, Schmidt C, Hirschfield G, et al. Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity. J Autoimmun. 2016;68:98-104 pubmed publisher
  498. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed publisher
  499. Haque M, Song J, Fino K, Sandhu P, Song X, Lei F, et al. Stem cell-derived tissue-associated regulatory T cells ameliorate the development of autoimmunity. Sci Rep. 2016;6:20588 pubmed publisher
  500. Buzhdygan T, Lisinicchia J, Patel V, Johnson K, Neugebauer V, Paessler S, et al. Neuropsychological, Neurovirological and Neuroimmune Aspects of Abnormal GABAergic Transmission in HIV Infection. J Neuroimmune Pharmacol. 2016;11:279-93 pubmed publisher
  501. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  502. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed publisher
  503. Aloulou M, Carr E, Gador M, Bignon A, Liblau R, Fazilleau N, et al. Follicular regulatory T cells can be specific for the immunizing antigen and derive from naive T cells. Nat Commun. 2016;7:10579 pubmed publisher
  504. Maelfait J, Roose K, Vereecke L, Mc Guire C, Sze M, Schuijs M, et al. A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection. PLoS Pathog. 2016;12:e1005410 pubmed publisher
  505. Allenbach Y, Leroux G, Suárez Calvet X, Preusse C, Gallardo E, Hervier B, et al. Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression. Am J Pathol. 2016;186:691-700 pubmed publisher
  506. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed publisher
  507. Di Meglio P, Villanova F, Navarini A, Mylonas A, Tosi I, Nestle F, et al. Targeting CD8(+) T cells prevents psoriasis development. J Allergy Clin Immunol. 2016;138:274-276.e6 pubmed publisher
  508. Dieckmann N, Hackmann Y, Aricò M, Griffiths G. Munc18-2 is required for Syntaxin 11 Localization on the Plasma Membrane in Cytotoxic T-Lymphocytes. Traffic. 2015;16:1330-41 pubmed publisher
  509. Kilisch M, Lytovchenko O, Arakel E, Bertinetti D, Schwappach B. A dual phosphorylation switch controls 14-3-3-dependent cell surface expression of TASK-1. J Cell Sci. 2016;129:831-42 pubmed publisher
  510. Younis R, Han K, Webb T. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells. J Immunol. 2016;196:1419-29 pubmed publisher
  511. Vivar O, Masi G, Carpier J, Magalhaes J, Galgano D, Pazour G, et al. IFT20 controls LAT recruitment to the immune synapse and T-cell activation in vivo. Proc Natl Acad Sci U S A. 2016;113:386-91 pubmed publisher
  512. Kim K, Wen X, Yang H, Kim W, Kang G. Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma. PLoS ONE. 2015;10:e0144192 pubmed publisher
  513. Rothermel L, Sabesan A, Stephens D, Chandran S, Paria B, Srivastava A, et al. Identification of an Immunogenic Subset of Metastatic Uveal Melanoma. Clin Cancer Res. 2016;22:2237-49 pubmed publisher
  514. Bjerg Christensen A, Dige A, Vad Nielsen J, Brinkmann C, Bendix M, Østergaard L, et al. Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients. Mediators Inflamm. 2015;2015:120605 pubmed publisher
  515. Arriaga Pizano L, Ferat Osorio E, Rodríguez Abrego G, Mancilla Herrera I, Domínguez Cerezo E, Valero Pacheco N, et al. Differential Immune Profiles in Two Pandemic Influenza A(H1N1)pdm09 Virus Waves at Pandemic Epicenter. Arch Med Res. 2015;46:651-8 pubmed publisher
  516. Paris R, Petrovas C, Ferrando Martinez S, Moysi E, Boswell K, Archer E, et al. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE. 2015;10:e0144767 pubmed publisher
  517. Scholz A, Harter P, Cremer S, Yalcin B, Gurnik S, Yamaji M, et al. Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol Med. 2016;8:39-57 pubmed publisher
  518. Liu T, Weng S, Wang M, Huang W. Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy. APMIS. 2016;124:216-20 pubmed publisher
  519. Zhang N, Deng J, Wu F, Lu X, Huang L, Zhao M. Expression of arginase I and inducible nitric oxide synthase in the peripheral blood and lymph nodes of HIV‑positive patients. Mol Med Rep. 2016;13:731-43 pubmed publisher
  520. Woodfolk J, Glesner J, Wright P, Kepley C, Li M, Himly M, et al. Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2. J Biol Chem. 2016;291:2288-301 pubmed publisher
  521. Höftberger R, Leisser M, Bauer J, Lassmann H. Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?. Acta Neuropathol Commun. 2015;3:80 pubmed publisher
  522. Qian B, Ji M, Qiu Y, Pan T, Wang B, Mao S, et al. Is There any Correlation Between Pathological Profile of Facet Joints and Clinical Feature in Patients With Thoracolumbar Kyphosis Secondary to Ankylosing Spondylitis?: An Immunohistochemical Investigation. Spine (Phila Pa 1976). 2016;41:E512-8 pubmed publisher
  523. Majumder K, Arora N, Modi S, Chugh R, Nomura A, Giri B, et al. A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation of New Therapies. J Gastrointest Surg. 2016;20:53-65; discussion 65 pubmed publisher
  524. Bolton D, Pegu A, Wang K, McGinnis K, Nason M, Foulds K, et al. Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs. J Virol. 2016;90:1321-32 pubmed publisher
  525. Günther S, Ostheimer C, Stangl S, Specht H, Mózes P, Jesinghaus M, et al. Correlation of Hsp70 Serum Levels with Gross Tumor Volume and Composition of Lymphocyte Subpopulations in Patients with Squamous Cell and Adeno Non-Small Cell Lung Cancer. Front Immunol. 2015;6:556 pubmed publisher
  526. Javed A, Leuchte N, Neumann B, Sopper S, Sauermann U. Noncytolytic CD8+ Cell Mediated Antiviral Response Represents a Strong Element in the Immune Response of Simian Immunodeficiency Virus-Infected Long-Term Non-Progressing Rhesus Macaques. PLoS ONE. 2015;10:e0142086 pubmed publisher
  527. Vierboom M, Breedveld E, Kap Y, Mary C, Poirier N, t Hart B, et al. Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis. Clin Exp Immunol. 2016;183:405-18 pubmed publisher
  528. Zhao E, Maj T, Kryczek I, Li W, Wu K, Zhao L, et al. Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nat Immunol. 2016;17:95-103 pubmed publisher
  529. Billcliff P, Noakes C, Mehta Z, Yan G, Mak L, Woscholski R, et al. OCRL1 engages with the F-BAR protein pacsin 2 to promote biogenesis of membrane-trafficking intermediates. Mol Biol Cell. 2016;27:90-107 pubmed publisher
  530. van Nierop G, Janssen M, Mitterreiter J, van de Vijver D, De Swart R, Haagmans B, et al. Intrathecal CD4(+) and CD8(+) T-cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients. Eur J Immunol. 2016;46:347-53 pubmed publisher
  531. Peng D, Kryczek I, Nagarsheth N, Zhao L, Wei S, Wang W, et al. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature. 2015;527:249-53 pubmed publisher
  532. Akhmetzyanova I, Drabczyk M, Neff C, Gibbert K, Dietze K, Werner T, et al. PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing. PLoS Pathog. 2015;11:e1005224 pubmed publisher
  533. Spiesberger K, Paulfranz F, Egger A, Reiser J, Vogl C, Rudolf Scholik J, et al. Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle. PLoS ONE. 2015;10:e0140471 pubmed publisher
  534. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  535. Monahan R, Stein A, Gibbs K, Bank M, Bloom O. Circulating T cell subsets are altered in individuals with chronic spinal cord injury. Immunol Res. 2015;63:3-10 pubmed publisher
  536. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed publisher
  537. Zhao L, Li C, Jin P, Ng C, Lin Z, Li Y, et al. Histopathological features of sinonasal inverted papillomas in chinese patients. Laryngoscope. 2016;126:E141-7 pubmed publisher
  538. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed publisher
  539. Liu K, Yang K, Wu B, Chen H, Chen X, Chen X, et al. Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer. Medicine (Baltimore). 2015;94:e1631 pubmed publisher
  540. Frederiksen J, Buggert M, Noyan K, Nowak P, Sönnerborg A, Lund O, et al. Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection. PLoS ONE. 2015;10:e0137635 pubmed publisher
  541. Held K, Beltrán E, Moser M, Hohlfeld R, Dornmair K. T-cell receptor repertoire of human peripheral CD161hiTRAV1-2+ MAIT cells revealed by next generation sequencing and single cell analysis. Hum Immunol. 2015;76:607-14 pubmed publisher
  542. Min S, Yan M, Kim S, Ravikumar S, Kwon S, Vanarsa K, et al. Green Tea Epigallocatechin-3-Gallate Suppresses Autoimmune Arthritis Through Indoleamine-2,3-Dioxygenase Expressing Dendritic Cells and the Nuclear Factor, Erythroid 2-Like 2 Antioxidant Pathway. J Inflamm (Lond). 2015;12:53 pubmed publisher
  543. Campi Azevedo A, Costa Pereira C, Antonelli L, Fonseca C, Teixeira Carvalho A, Villela Rezende G, et al. Booster dose after 10 years is recommended following 17DD-YF primary vaccination. Hum Vaccin Immunother. 2016;12:491-502 pubmed publisher
  544. Gao T, Ng C, Li C, Li Y, Duan C, Shen L, et al. Smoking is an independent association of squamous metaplasia in Chinese nasal polyps. Int Forum Allergy Rhinol. 2016;6:66-74 pubmed publisher
  545. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed publisher
  546. Djurisic S, Skibsted L, Hviid T. A Phenotypic Analysis of Regulatory T Cells and Uterine NK Cells from First Trimester Pregnancies and Associations with HLA-G. Am J Reprod Immunol. 2015;74:427-44 pubmed publisher
  547. Japp A, Kursunel M, Meier S, Mälzer J, Li X, Rahman N, et al. Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression. Cancer Immunol Immunother. 2015;64:1487-94 pubmed publisher
  548. Zhu F, Qiao J, Cao J, Sun H, Wu Q, Sun Z, et al. Decreased level of cytotoxic T lymphocyte antigen-4 (CTLA-4) in patients with acute immune thrombocytopenia (ITP). Thromb Res. 2015;136:797-802 pubmed publisher
  549. Dunham J, Lee L, van Driel N, Laman J, Ni I, Zhai W, et al. Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis. J Neuroimmune Pharmacol. 2016;11:73-83 pubmed publisher
  550. Yoon K, Byun S, Kwon E, Hwang S, Chu K, Hiraki M, et al. Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53. Science. 2015;349:1261669 pubmed publisher
  551. Klippert A, Stolte Leeb N, Neumann B, Sauermann U, Daskalaki M, Gawanbacht A, et al. Frequencies of lymphoid T-follicular helper cells obtained longitudinally by lymph node fine-needle aspiration correlate significantly with viral load in SIV-infected rhesus monkeys. J Med Primatol. 2015;44:253-62 pubmed publisher
  552. Weist B, Wehler P, El Ahmad L, Schmueck Henneresse M, Millward J, Nienen M, et al. A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients. Kidney Int. 2015;88:1293-1303 pubmed publisher
  553. Riou C, Tanko R, Soares A, Masson L, Werner L, Garrett N, et al. Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype. J Immunol. 2015;195:2273-2281 pubmed publisher
  554. Lu J, Adam B, Jack A, Lam A, Broad R, Chik C. Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas. Endocr Pathol. 2015;26:263-72 pubmed publisher
  555. Owens G, Erickson K, Malone C, Pan C, Huynh M, Chang J, et al. Evidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis. J Neuroinflammation. 2015;12:134 pubmed publisher
  556. He T, Brocca Cofano E, Gillespie D, Xu C, Stock J, Ma D, et al. Critical Role for the Adenosine Pathway in Controlling Simian Immunodeficiency Virus-Related Immune Activation and Inflammation in Gut Mucosal Tissues. J Virol. 2015;89:9616-30 pubmed publisher
  557. Amos J, Himes J, Armand L, Gurley T, Martinez D, Colvin L, et al. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys. J Virol. 2015;89:9485-98 pubmed publisher
  558. Biylgi O, Karagöz B, Türken O, Gültepe M, Özgün A, Tunçel T, et al. CD4+CD25(high), CD8+CD28- cells and thyroid autoantibodies in breast cancer patients. Cent Eur J Immunol. 2014;39:338-44 pubmed publisher
  559. Wang Y, Zhong H, Xie X, Chen C, Huang D, Shen L, et al. Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection. Proc Natl Acad Sci U S A. 2015;112:E3883-92 pubmed publisher
  560. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed publisher
  561. Marshall M, Pattu V, Halimani M, Maier Peuschel M, Müller M, Becherer U, et al. VAMP8-dependent fusion of recycling endosomes with the plasma membrane facilitates T lymphocyte cytotoxicity. J Cell Biol. 2015;210:135-51 pubmed publisher
  562. Weindel C, Richey L, Bolland S, Mehta A, Kearney J, Huber B. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation. Autophagy. 2015;11:1010-24 pubmed publisher
  563. Mikucki M, Fisher D, Matsuzaki J, Skitzki J, Gaulin N, Muhitch J, et al. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nat Commun. 2015;6:7458 pubmed publisher
  564. Adoro S, Cubillos Ruiz J, Chen X, Deruaz M, Vrbanac V, Song M, et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015;6:7562 pubmed publisher
  565. Wu D, Thomas A, Fromm J. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma. Cytometry B Clin Cytom. 2016;90:424-32 pubmed publisher
  566. Perriard G, Mathias A, Enz L, Canales M, Schluep M, Gentner M, et al. Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes. J Neuroinflammation. 2015;12:119 pubmed publisher
  567. Chowdhury A, Hayes T, Bosinger S, Lawson B, Vanderford T, Schmitz J, et al. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques. J Virol. 2015;89:8677-86 pubmed publisher
  568. Chang D, Moniz R, Xu Z, Sun J, Signoretti S, Zhu Q, et al. Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo. Mol Cancer. 2015;14:119 pubmed publisher
  569. Horn T, Laus J, Seitz A, Maurer T, Schmid S, Wolf P, et al. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer. World J Urol. 2016;34:181-7 pubmed publisher
  570. Grieco A, Billett H, Green N, Driscoll M, Bouhassira E. Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1. PLoS ONE. 2015;10:e0129431 pubmed publisher
  571. McCully M, Collins P, Hughes T, Thomas C, Billen J, O Donnell V, et al. Skin Metabolites Define a New Paradigm in the Localization of Skin Tropic Memory T Cells. J Immunol. 2015;195:96-104 pubmed publisher
  572. Vanoli A, Argenti F, Vinci A, La Rosa S, Viglio A, Riboni R, et al. Hepatoid carcinoma of the pancreas with lymphoid stroma: first description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinoma. Virchows Arch. 2015;467:237-45 pubmed publisher
  573. Wang Z, Wan Y, Qiu C, Quiñones Parra S, Zhu Z, Loh L, et al. Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8⁺ T cells. Nat Commun. 2015;6:6833 pubmed publisher
  574. Yu J, Hoffman S, Beal A, Dykon A, Ringenberg M, Hughes A, et al. MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses. PLoS ONE. 2015;10:e0127083 pubmed publisher
  575. Mock U, Machowicz R, Hauber I, Horn S, Abramowski P, Berdien B, et al. mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5. Nucleic Acids Res. 2015;43:5560-71 pubmed publisher
  576. de Winde C, Zuidscherwoude M, Vasaturo A, van der Schaaf A, Figdor C, van Spriel A. Multispectral imaging reveals the tissue distribution of tetraspanins in human lymphoid organs. Histochem Cell Biol. 2015;144:133-46 pubmed publisher
  577. Partlová S, Bouček J, Kloudová K, Lukešová E, Zábrodský M, Grega M, et al. Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma. Oncoimmunology. 2015;4:e965570 pubmed
  578. Byrareddy S, Sidell N, Arthos J, Cicala C, Zhao C, Little D, et al. Species-specific differences in the expression and regulation of α4β7 integrin in various nonhuman primates. J Immunol. 2015;194:5968-79 pubmed publisher
  579. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  580. Wang E, Wang L, Tsai C, Bhoj V, Gershenson Z, Moon E, et al. Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors. Cancer Immunol Res. 2015;3:815-26 pubmed publisher
  581. Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Pérals C, et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 2015;16:628-34 pubmed publisher
  582. Hanley P, Melenhorst J, Nikiforow S, Scheinberg P, Blaney J, Demmler Harrison G, et al. CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo. Sci Transl Med. 2015;7:285ra63 pubmed publisher
  583. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed publisher
  584. Deng N, Mosmann T. Optimization of the cytokine secretion assay for human IL-2 in single and combination assays. Cytometry A. 2015;87:777-83 pubmed publisher
  585. Anandasabapathy N, Breton G, Hurley A, Caskey M, Trumpfheller C, Sarma P, et al. Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplant. 2015;50:924-30 pubmed publisher
  586. Jeon Y, Kim J, Sung J, Han J, Ko Y. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features. Hum Pathol. 2015;46:981-90 pubmed publisher
  587. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed publisher
  588. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  589. Maiwald S, Motazacker M, van Capelleveen J, Sivapalaratnam S, van der Wal A, van der Loos C, et al. A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosis. Eur J Hum Genet. 2016;24:86-91 pubmed publisher
  590. Pombo C, Wherry E, Gostick E, Price D, Betts M. Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+ T-Cell Population in Elite Controllers. J Infect Dis. 2015;212:1376-86 pubmed publisher
  591. Førsvoll J, Janssen E, Møller I, Wathne N, Skaland I, Klos J, et al. Reduced Number of CD8+ Cells in Tonsillar Germinal Centres in Children with the Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis Syndrome. Scand J Immunol. 2015;82:76-83 pubmed publisher
  592. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed publisher
  593. Martner A, Wiktorin H, Lenox B, Ewald Sander F, Aydin E, Aurelius J, et al. Histamine promotes the development of monocyte-derived dendritic cells and reduces tumor growth by targeting the myeloid NADPH oxidase. J Immunol. 2015;194:5014-21 pubmed publisher
  594. Katz S, Burga R, McCormack E, Wang L, Mooring W, Point G, et al. Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases. Clin Cancer Res. 2015;21:3149-59 pubmed publisher
  595. Li G, Nguyen C, Ryckman B, Britt W, Kamil J. A viral regulator of glycoprotein complexes contributes to human cytomegalovirus cell tropism. Proc Natl Acad Sci U S A. 2015;112:4471-6 pubmed publisher
  596. Yarilin D, Xu K, Turkekul M, Fan N, Romin Y, Fijisawa S, et al. Machine-based method for multiplex in situ molecular characterization of tissues by immunofluorescence detection. Sci Rep. 2015;5:9534 pubmed publisher
  597. Lougaris V, Ravelli A, Villanacci V, Salemme M, Soresina A, Fuoti M, et al. Gastrointestinal Pathologic Abnormalities in Pediatric- and Adult-Onset Common Variable Immunodeficiency. Dig Dis Sci. 2015;60:2384-9 pubmed publisher
  598. Trabanelli S, Lecciso M, Salvestrini V, Cavo M, Očadlíková D, Lemoli R, et al. PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response. J Immunol Res. 2015;2015:253191 pubmed publisher
  599. Komori M, Blake A, Greenwood M, Lin Y, Kosa P, Ghazali D, et al. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis. Ann Neurol. 2015;78:3-20 pubmed publisher
  600. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed publisher
  601. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed publisher
  602. Bradley S, Chen Z, Melendez B, Talukder A, Khalili J, Rodríguez Cruz T, et al. BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma. Cancer Immunol Res. 2015;3:602-9 pubmed publisher
  603. Ohnuma K, Hatano R, Aune T, Otsuka H, Iwata S, Dang N, et al. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes. J Immunol. 2015;194:3697-712 pubmed publisher
  604. Laing K, Russell R, Dong L, Schmid D, Stern M, Magaret A, et al. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus. J Infect Dis. 2015;212:1022-31 pubmed publisher
  605. Strick Marchand H, Dusséaux M, Darche S, Huntington N, Legrand N, Masse Ranson G, et al. A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS ONE. 2015;10:e0119820 pubmed publisher
  606. Tian X, Zhang A, Qiu C, Wang W, Yang Y, Qiu C, et al. The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects. J Immunol. 2015;194:3873-82 pubmed publisher
  607. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed publisher
  608. Chung T, Christopher Stine L, Paik J, Corse A, MAMMEN A. The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy. Muscle Nerve. 2015;52:189-95 pubmed publisher
  609. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed publisher
  610. van der Waart A, Fredrix H, van der Voort R, Schaap N, Hobo W, Dolstra H. siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice. Cancer Immunol Immunother. 2015;64:645-54 pubmed publisher
  611. Chijioke O, Marcenaro E, Moretta A, Capaul R, Münz C. Role of the 2B4 Receptor in CD8+ T-Cell-Dependent Immune Control of Epstein-Barr Virus Infection in Mice With Reconstituted Human Immune System Components. J Infect Dis. 2015;212:803-7 pubmed publisher
  612. Boutard B, Vankerckhove S, Markine Goriaynoff N, Sarlet M, Desmecht D, McFadden G, et al. The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression. PLoS ONE. 2015;10:e0118806 pubmed publisher
  613. Elliott G, Hong C, Xing X, Zhou X, Li D, Coarfa C, et al. Intermediate DNA methylation is a conserved signature of genome regulation. Nat Commun. 2015;6:6363 pubmed publisher
  614. Torres Cabala C, Curry J, Li Ning Tapia E, Ramos C, Tetzlaff M, Prieto V, et al. HTLV-1-associated infective dermatitis demonstrates low frequency of FOXP3-positive T-regulatory lymphocytes. J Dermatol Sci. 2015;77:150-5 pubmed publisher
  615. Kim M, Koh J, Kim S, Go H, Jeon Y, Chung D. Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers. Lung Cancer. 2015;88:24-33 pubmed publisher
  616. Valle A, Barbagiovanni G, Jofra T, Stabilini A, Pérol L, Baeyens A, et al. Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulation. J Immunol. 2015;194:2117-27 pubmed publisher
  617. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  618. Lehnhardt A, Strecker M, Eiermann T, Marget M, Thaiss F, Nashan B, et al. High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction. Clin Transplant. 2015;29:359-64 pubmed publisher
  619. Srivastava R, Khan A, Spencer D, Vahed H, Lopes P, Thai N, et al. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic. J Immunol. 2015;194:2232-48 pubmed publisher
  620. Gideon H, Phuah J, Myers A, Bryson B, Rodgers M, Coleman M, et al. Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization. PLoS Pathog. 2015;11:e1004603 pubmed publisher
  621. Däster S, Eppenberger Castori S, Hirt C, Zlobec I, Delko T, Nebiker C, et al. High frequency of CD8 positive lymphocyte infiltration correlates with lack of lymph node involvement in early rectal cancer. Dis Markers. 2014;2014:792183 pubmed publisher
  622. Khan A, Srivastava R, Spencer D, Garg S, Fremgen D, Vahed H, et al. Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes. J Virol. 2015;89:3776-92 pubmed publisher
  623. Du Z, Abedalthagafi M, Aizer A, McHenry A, Sun H, Bray M, et al. Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma. Oncotarget. 2015;6:4704-16 pubmed
  624. Harrer A, Pilz G, Wipfler P, Oppermann K, Sellner J, Hitzl W, et al. High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol. 2015;180:383-92 pubmed publisher
  625. Abdel Mohsen M, Wang C, Strain M, Lada S, Deng X, Cockerham L, et al. Select host restriction factors are associated with HIV persistence during antiretroviral therapy. AIDS. 2015;29:411-20 pubmed publisher
  626. Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, et al. Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Res. 2015;25:208-24 pubmed publisher
  627. Afshar M, Richards S, Mann D, Cross A, Smith G, Netzer G, et al. Acute immunomodulatory effects of binge alcohol ingestion. Alcohol. 2015;49:57-64 pubmed publisher
  628. Karlsson F, Hassan Zahraee M. Quantification of Th1 and Th17 Cells with Intracellular Staining Following PMA/Ionomycin Stimulation. Curr Protoc Cytom. 2015;71:6.35.1-7 pubmed publisher
  629. Kagina B, Mansoor N, Kpamegan E, Penn Nicholson A, Nemes E, Smit E, et al. Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry. J Immunol Methods. 2015;417:22-33 pubmed publisher
  630. Campbell J, Ratai E, Autissier P, Nolan D, Tse S, Miller A, et al. Anti-?4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection. PLoS Pathog. 2014;10:e1004533 pubmed publisher
  631. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed publisher
  632. Setoguchi R, Matsui Y, Mouri K. mTOR signaling promotes a robust and continuous production of IFN-γ by human memory CD8+ T cells and their proliferation. Eur J Immunol. 2015;45:893-902 pubmed publisher
  633. Chacon J, Sarnaik A, Chen J, Creasy C, Kale C, Robinson J, et al. Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy. Clin Cancer Res. 2015;21:611-21 pubmed publisher
  634. Hokuto D, Sho M, Yamato I, Yasuda S, Obara S, Nomi T, et al. Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma. Eur J Cancer. 2015;51:157-65 pubmed publisher
  635. Bell C, Sun Y, Nowak U, Clark J, Howlett S, Pekalski M, et al. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells. J Autoimmun. 2015;56:66-80 pubmed publisher
  636. Renauer P, Coit P, Sawalha A. The DNA methylation signature of human TCRαβ+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response. Clin Immunol. 2015;156:19-27 pubmed publisher
  637. Crompton J, Sukumar M, Roychoudhuri R, Clever D, Gros A, Eil R, et al. Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. Cancer Res. 2015;75:296-305 pubmed publisher
  638. Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, et al. Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom. 2015;88:320-9 pubmed publisher
  639. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
  640. Huss D, Mehta D, Sharma A, You X, Riester K, Sheridan J, et al. In vivo maintenance of human regulatory T cells during CD25 blockade. J Immunol. 2015;194:84-92 pubmed
  641. van Blijswijk J, Schraml B, Rogers N, Whitney P, Zelenay S, Acton S, et al. Altered lymph node composition in diphtheria toxin receptor-based mouse models to ablate dendritic cells. J Immunol. 2015;194:307-15 pubmed publisher
  642. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed publisher
  643. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed publisher
  644. Hoffmann J, Shmeleva E, Boag S, Fiser K, Bagnall A, Murali S, et al. Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated immunosenescence in CMV-seropositive patients. Circ Res. 2015;116:87-98 pubmed publisher
  645. Lester L, Ewalt M, Warnke R, Kim J. Systemic panniculitis-like T-cell lymphoma with involvement of mesenteric fat and subcutis. J Cutan Pathol. 2015;42:46-9 pubmed publisher
  646. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed publisher
  647. Demirkesen C, Esirgen G, Engin B, Songur A, OÄŸuz O. The clinical features and histopathologic patterns of folliculotropic mycosis fungoides in a series of 38 cases. J Cutan Pathol. 2015;42:22-31 pubmed publisher
  648. Venalis P, Kumánovics G, Schulze Koops H, Distler A, Dees C, Zerr P, et al. Cardiomyopathy in murine models of systemic sclerosis. Arthritis Rheumatol. 2015;67:508-16 pubmed publisher
  649. Hermans C, Anz D, Engel J, Kirchner T, Endres S, Mayr D. Analysis of FoxP3+ T-regulatory cells and CD8+ T-cells in ovarian carcinoma: location and tumor infiltration patterns are key prognostic markers. PLoS ONE. 2014;9:e111757 pubmed publisher
  650. Titti F, Maggiorella M, Ferrantelli F, Sernicola L, Bellino S, Collacchi B, et al. Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccines. PLoS ONE. 2014;9:e111360 pubmed publisher
  651. Fujita T, Burwitz B, Chew G, Reed J, Pathak R, Seger E, et al. Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T cells during simian immunodeficiency virus infection in rhesus macaques. J Immunol. 2014;193:5576-83 pubmed publisher
  652. van der Waart A, van de Weem N, Maas F, Kramer C, Kester M, Falkenburg J, et al. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. Blood. 2014;124:3490-500 pubmed publisher
  653. Weiskopf D, Angelo M, Bangs D, Sidney J, Paul S, Peters B, et al. The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes. J Virol. 2015;89:120-8 pubmed publisher
  654. Wilson E, Bial J, Tarlow B, Bial G, Jensen B, Greiner D, et al. Extensive double humanization of both liver and hematopoiesis in FRGN mice. Stem Cell Res. 2014;13:404-12 pubmed publisher
  655. Jansen D, Hameetman M, van Bergen J, Huizinga T, van der Heijde D, Toes R, et al. IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities. Rheumatology (Oxford). 2015;54:728-35 pubmed publisher
  656. Lundholm M, Schröder M, Nagaeva O, Baranov V, Widmark A, Mincheva Nilsson L, et al. Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion. PLoS ONE. 2014;9:e108925 pubmed publisher
  657. Novinger L, Ashikaga T, Krag D. Identification of tumor-binding scFv derived from clonally related B cells in tumor and lymph node of a patient with breast cancer. Cancer Immunol Immunother. 2015;64:29-39 pubmed publisher
  658. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed publisher
  659. Mylvaganam G, Velu V, Hong J, Sadagopal S, Kwa S, Basu R, et al. Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa. J Immunol. 2014;193:4527-36 pubmed publisher
  660. Willis E, Eberle R, Wolf R, White G, McFarlane D. The effects of age and cytomegalovirus on markers of inflammation and lymphocyte populations in captive baboons. PLoS ONE. 2014;9:e107167 pubmed publisher
  661. Perino G, Ricciardi B, Jerabek S, Martignoni G, Wilner G, Maass D, et al. Implant based differences in adverse local tissue reaction in failed total hip arthroplasties: a morphological and immunohistochemical study. BMC Clin Pathol. 2014;14:39 pubmed publisher
  662. Gibbons D, Fleming P, Virasami A, Michel M, Sebire N, Costeloe K, et al. Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nat Med. 2014;20:1206-10 pubmed publisher
  663. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed publisher
  664. Hassan U, Bashir R. Coincidence detection of heterogeneous cell populations from whole blood with coplanar electrodes in a microfluidic impedance cytometer. Lab Chip. 2014;14:4370-81 pubmed publisher
  665. Valentin A, McKinnon K, Li J, Rosati M, Kulkarni V, Pilkington G, et al. Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques. Clin Immunol. 2014;155:91-107 pubmed publisher
  666. Perreau M, Vigano S, Bellanger F, Pellaton C, Buss G, Comte D, et al. Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders. J Exp Med. 2014;211:2033-45 pubmed publisher
  667. Kurktschiev P, Raziorrouh B, Schraut W, Backmund M, Wächtler M, Wendtner C, et al. Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction. J Exp Med. 2014;211:2047-59 pubmed publisher
  668. Kagina B, Tameris M, Geldenhuys H, Hatherill M, Abel B, Hussey G, et al. The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses. Vaccine. 2014;32:5908-17 pubmed publisher
  669. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed publisher
  670. Hu H, Eller M, Zafar S, Zhou Y, Gu M, Wei Z, et al. Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals. Proc Natl Acad Sci U S A. 2014;111:13439-44 pubmed publisher
  671. Bhatti P, Zhang Y, Song X, Makar K, Sather C, Kelsey K, et al. Nightshift work and genome-wide DNA methylation. Chronobiol Int. 2015;32:103-12 pubmed publisher
  672. Yuan Z, Luo R, Peng R, Wang S, Xue C. High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis. Onco Targets Ther. 2014;7:1475-80 pubmed publisher
  673. Matsuda K, Dang Q, Brown C, Keele B, Wu F, Ourmanov I, et al. Characterization of simian immunodeficiency virus (SIV) that induces SIV encephalitis in rhesus macaques with high frequency: role of TRIM5 and major histocompatibility complex genotypes and early entry to the brain. J Virol. 2014;88:13201-11 pubmed publisher
  674. Fabro A, da Silva P, Zocolaro W, de Almeida M, Rangel M, de Oliveira C, et al. The Th17 pathway in the peripheral lung microenvironment interacts with expression of collagen V in the late state of experimental pulmonary fibrosis. Immunobiology. 2015;220:124-35 pubmed publisher
  675. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  676. Schneider Hohendorf T, Rossaint J, Mohan H, Böning D, Breuer J, Kuhlmann T, et al. VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells. J Exp Med. 2014;211:1833-46 pubmed publisher
  677. Onaindia A, Montes Moreno S, Rodriguez Pinilla S, Batlle A, Gonzalez de Villambrosia S, Rodriguez A, et al. Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features. Histopathology. 2015;66:846-55 pubmed publisher
  678. Bennaceur K, Atwill M, Al Zhrany N, Hoffmann J, Keavney B, BREAULT D, et al. Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated mechanism. Atherosclerosis. 2014;236:312-20 pubmed publisher
  679. Ohue Y, Kurose K, Mizote Y, Matsumoto H, Nishio Y, Isobe M, et al. Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody. Clin Cancer Res. 2014;20:5052-63 pubmed publisher
  680. Jin J, Zhang W, Wong K, Kwak M, van Driel I, Yu Q. Inhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulation. PLoS ONE. 2014;9:e104753 pubmed publisher
  681. Tchakoute C, Hesseling A, Kidzeru E, Gamieldien H, Passmore J, Jones C, et al. Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T-cell responses in HIV-exposed infants. J Infect Dis. 2015;211:338-46 pubmed publisher
  682. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed publisher
  683. Saresella M, Piancone F, Marventano I, La Rosa F, Tortorella P, Caputo D, et al. A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis. FASEB J. 2014;28:5000-9 pubmed publisher
  684. Meier D, Docena G, Ramisch D, Toscanini U, Berardi G, Gondolesi G, et al. Immunological status of isolated lymphoid follicles after intestinal transplantation. Am J Transplant. 2014;14:2148-58 pubmed publisher
  685. Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10:e1004291 pubmed publisher
  686. Kusner L, Ciesielski M, Marx A, Kaminski H, Fenstermaker R. Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study. PLoS ONE. 2014;9:e102231 pubmed publisher
  687. Wu D, Allen C, Fromm J. Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue. Cytometry B Clin Cytom. 2015;88:58-63 pubmed publisher
  688. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  689. Chandran P, Keller A, Weinmann L, Seida A, Braun M, Andreev K, et al. The TGF-?-inducible miR-23a cluster attenuates IFN-? levels and antigen-specific cytotoxicity in human CD8? T cells. J Leukoc Biol. 2014;96:633-45 pubmed publisher
  690. Herrera A, Kim H, Bindra B, Jones K, Alyea E, Armand P, et al. A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20:1737-43 pubmed publisher
  691. Butcher L, Garcia M, Arnold M, Ueno H, Goel A, Boland C. Immune response to JC virus T antigen in patients with and without colorectal neoplasia. Gut Microbes. 2014;5:468-75 pubmed publisher
  692. Pegram H, Purdon T, van Leeuwen D, Curran K, Giralt S, Barker J, et al. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. Leukemia. 2015;29:415-22 pubmed publisher
  693. Jacquelin B, Petitjean G, Kunkel D, Liovat A, Jochems S, Rogers K, et al. Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection. PLoS Pathog. 2014;10:e1004241 pubmed publisher
  694. Ye S, Li Z, Luo D, Huang B, Chen Y, Zhang X, et al. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget. 2014;5:5439-52 pubmed
  695. Campion S, Brodie T, Fischer W, Korber B, Rossetti A, Goonetilleke N, et al. Proteome-wide analysis of HIV-specific naive and memory CD4(+) T cells in unexposed blood donors. J Exp Med. 2014;211:1273-80 pubmed publisher
  696. Kubach J, Hubo M, Amendt C, Stroh C, Jonuleit H. IgG1 anti-epidermal growth factor receptor antibodies induce CD8-dependent antitumor activity. Int J Cancer. 2015;136:821-30 pubmed publisher
  697. Kenway Lynch C, Das A, Lackner A, Pahar B. Cytokine/Chemokine responses in activated CD4+ and CD8+ T cells isolated from peripheral blood, bone marrow, and axillary lymph nodes during acute simian immunodeficiency virus infection. J Virol. 2014;88:9442-57 pubmed publisher
  698. Azzimonti B, Zavattaro E, Provasi M, Vidali M, Conca A, Catalano E, et al. Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio. Br J Dermatol. 2015;172:64-73 pubmed publisher
  699. Hong J, Amancha P, Rogers K, Courtney C, Havenar Daughton C, Crotty S, et al. Early lymphoid responses and germinal center formation correlate with lower viral load set points and better prognosis of simian immunodeficiency virus infection. J Immunol. 2014;193:797-806 pubmed publisher
  700. Payne T, Blackinton J, Frisbee A, Pickeral J, Sawant S, Vandergrift N, et al. Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition. J Virol. 2014;88:9514-28 pubmed publisher
  701. Kleppa E, Ramsuran V, Zulu S, Karlsen G, Bere A, Passmore J, et al. Effect of female genital schistosomiasis and anti-schistosomal treatment on monocytes, CD4+ T-cells and CCR5 expression in the female genital tract. PLoS ONE. 2014;9:e98593 pubmed publisher
  702. Jiang B, Wu X, Li X, Yang X, Zhou Y, Yan H, et al. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21. Cell Immunol. 2014;290:10-20 pubmed publisher
  703. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  704. Cichocki F, Schlums H, Li H, Stache V, Holmes T, Lenvik T, et al. Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency. J Exp Med. 2014;211:1079-91 pubmed publisher
  705. Hodi F, Lawrence D, Lezcano C, Wu X, Zhou J, Sasada T, et al. Bevacizumab plus ipilimumab in patients with metastatic melanoma. Cancer Immunol Res. 2014;2:632-42 pubmed publisher
  706. Foster A, Baliwag J, Chen C, Guzman A, Stoll S, Gudjonsson J, et al. IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin. J Immunol. 2014;192:6053-61 pubmed publisher
  707. Bukh I, Calcedo R, Roy S, Carnathan D, Grant R, Qin Q, et al. Increased mucosal CD4+ T cell activation in rhesus macaques following vaccination with an adenoviral vector. J Virol. 2014;88:8468-78 pubmed publisher
  708. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed publisher
  709. Vargas A, Zhou S, Ethier Chiasson M, Flipo D, Lafond J, Gilbert C, et al. Syncytin proteins incorporated in placenta exosomes are important for cell uptake and show variation in abundance in serum exosomes from patients with preeclampsia. FASEB J. 2014;28:3703-19 pubmed publisher
  710. Helm O, Mennrich R, Petrick D, Goebel L, Freitag Wolf S, Roder C, et al. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma. PLoS ONE. 2014;9:e94357 pubmed publisher
  711. Deng N, Weaver J, Mosmann T. Cytokine diversity in the Th1-dominated human anti-influenza response caused by variable cytokine expression by Th1 cells, and a minor population of uncommitted IL-2+IFN?- Thpp cells. PLoS ONE. 2014;9:e95986 pubmed publisher
  712. Breuer J, Schwab N, Schneider Hohendorf T, Marziniak M, Mohan H, Bhatia U, et al. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann Neurol. 2014;75:739-58 pubmed publisher
  713. Tarbox J, Keppel M, Topcagic N, Mackin C, Ben Abdallah M, Baszis K, et al. Elevated double negative T cells in pediatric autoimmunity. J Clin Immunol. 2014;34:594-9 pubmed publisher
  714. Mao C, Mou X, Zhou Y, Yuan G, Xu C, Liu H, et al. Tumor-activated TCR??? T cells from gastric cancer patients induce the antitumor immune response of TCR??? T cells via their antigen-presenting cell-like effects. J Immunol Res. 2014;2014:593562 pubmed publisher
  715. Buggert M, Norstr m M, Salemi M, Hecht F, Karlsson A. Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progression. J Immunol. 2014;192:4685-96 pubmed publisher
  716. Ye W, Xing Y, Paustian C, van de Ven R, Moudgil T, Hilton T, et al. Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cells. J Transl Med. 2014;12:100 pubmed publisher
  717. Marie J, Kovacs D, Pain C, Jouary T, Cota C, Vergier B, et al. Inflammasome activation and vitiligo/nonsegmental vitiligo progression. Br J Dermatol. 2014;170:816-23 pubmed publisher
  718. Cartwright E, McGary C, Cervasi B, Micci L, Lawson B, Elliott S, et al. Divergent CD4+ T memory stem cell dynamics in pathogenic and nonpathogenic simian immunodeficiency virus infections. J Immunol. 2014;192:4666-73 pubmed publisher
  719. Cartellieri M, Koristka S, Arndt C, Feldmann A, Stamova S, von Bonin M, et al. A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. PLoS ONE. 2014;9:e93745 pubmed publisher
  720. Ito S, Bollard C, Carlsten M, Melenhorst J, Biancotto A, Wang E, et al. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers. Mol Ther. 2014;22:1388-1395 pubmed publisher
  721. Hodara V, Parodi L, Chavez D, Smith L, Lanford R, Giavedoni L. Characterization of ??T cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro. J Med Primatol. 2014;43:258-71 pubmed publisher
  722. Loh L, Ivarsson M, Michaelsson J, Sandberg J, Nixon D. Invariant natural killer T cells developing in the human fetus accumulate and mature in the small intestine. Mucosal Immunol. 2014;7:1233-43 pubmed publisher
  723. Prinz P, Mendler A, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int J Cancer. 2014;135:1832-41 pubmed publisher
  724. de Hair M, van de Sande M, Ramwadhdoebe T, Hansson M, Landewe R, van der Leij C, et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol. 2014;66:513-22 pubmed publisher
  725. Rodriguez A, Hodara V, Murthy K, Morrow L, Sanchez M, Bienvenu A, et al. T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus. Cell Immunol. 2014;288:24-30 pubmed publisher
  726. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed publisher
  727. Kaur S, Fielding A, Gassner G, Carter N, Royle S. An unmet actin requirement explains the mitotic inhibition of clathrin-mediated endocytosis. elife. 2014;3:e00829 pubmed publisher
  728. Rizzo S, Basso C, Troost D, Aronica E, Frigo A, Driessen A, et al. T-cell-mediated inflammatory activity in the stellate ganglia of patients with ion-channel disease and severe ventricular arrhythmias. Circ Arrhythm Electrophysiol. 2014;7:224-9 pubmed publisher
  729. Stanisic D, Cutts J, Eriksson E, Fowkes F, Rosanas Urgell A, Siba P, et al. ?? T cells and CD14+ monocytes are predominant cellular sources of cytokines and chemokines associated with severe malaria. J Infect Dis. 2014;210:295-305 pubmed publisher
  730. Poonia B, Pauza C. Levels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy. PLoS ONE. 2014;9:e88884 pubmed publisher
  731. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  732. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  733. Naviglio S, Arrigo S, Martelossi S, Villanacci V, Tommasini A, Loganes C, et al. Severe inflammatory bowel disease associated with congenital alteration of transforming growth factor beta signaling. J Crohns Colitis. 2014;8:770-4 pubmed publisher
  734. Jayaraman A, Jackson D, Message S, Pearson R, Aniscenko J, Caramori G, et al. IL-15 complexes induce NK- and T-cell responses independent of type I IFN signaling during rhinovirus infection. Mucosal Immunol. 2014;7:1151-64 pubmed publisher
  735. Kulkarni V, Valentin A, Rosati M, Alicea C, Singh A, Jalah R, et al. Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques. PLoS ONE. 2014;9:e86254 pubmed publisher
  736. Shikhagaie M, Andersson C, Mori M, Kortekaas Krohn I, Bergqvist A, Dahl R, et al. Mapping of TLR5 and TLR7 in central and distal human airways and identification of reduced TLR expression in severe asthma. Clin Exp Allergy. 2014;44:184-96 pubmed publisher
  737. Salerno Goncalves R, Rezwan T, Sztein M. B cells modulate mucosal associated invariant T cell immune responses. Front Immunol. 2014;4:511 pubmed publisher
  738. Samaranch L, Sebastián W, Kells A, Salegio E, Heller G, Bringas J, et al. AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigen-presenting cell transduction. Mol Ther. 2014;22:329-337 pubmed publisher
  739. Cepeda M, Salas M, Folwarczny J, Leandro A, Hodara V, De La Garza M, et al. Establishment of a neonatal rhesus macaque model to study Mycobacterium tuberculosis infection. Tuberculosis (Edinb). 2013;93 Suppl:S51-9 pubmed publisher
  740. Barsoum I, Smallwood C, Siemens D, Graham C. A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. Cancer Res. 2014;74:665-74 pubmed publisher
  741. Galindo Albarrán A, Ramirez Pliego O, Labastida Conde R, Melchy Pérez E, Liquitaya Montiel A, Esquivel Guadarrama F, et al. CD43 signals prepare human T cells to receive cytokine differentiation signals. J Cell Physiol. 2014;229:172-80 pubmed
  742. Watkins N, Hassan U, Damhorst G, Ni H, Vaid A, Rodriguez W, et al. Microfluidic CD4+ and CD8+ T lymphocyte counters for point-of-care HIV diagnostics using whole blood. Sci Transl Med. 2013;5:214ra170 pubmed publisher
  743. Jones H, Gold M, Giannico G, Troutman A, Vnencak Jones C, Schultenover S, et al. Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing. Int J Gynecol Pathol. 2014;33:64-73 pubmed publisher
  744. Park S, Veerapu N, Shin E, Biancotto A, McCoy J, Capone S, et al. Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med. 2013;19:1638-42 pubmed publisher
  745. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed publisher
  746. Lutwama F, Kagina B, Wajja A, Waiswa F, Mansoor N, Kirimunda S, et al. Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants. J Infect Dis. 2014;209:887-97 pubmed publisher
  747. Didigu C, Wilen C, Wang J, Duong J, Secreto A, Danet Desnoyers G, et al. Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection. Blood. 2014;123:61-9 pubmed publisher
  748. Chicoine L, Rodino Klapac L, Shao G, Xu R, Bremer W, Camboni M, et al. Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin ?2 surrogates. Mol Ther. 2014;22:713-24 pubmed publisher
  749. Abdel Mohsen M, Raposo R, Deng X, Li M, Liegler T, Sinclair E, et al. Expression profile of host restriction factors in HIV-1 elite controllers. Retrovirology. 2013;10:106 pubmed publisher
  750. Bridgeman J, Ladell K, Sheard V, Miners K, Hawkins R, Price D, et al. CD3ζ-based chimeric antigen receptors mediate T cell activation via cis- and trans-signalling mechanisms: implications for optimization of receptor structure for adoptive cell therapy. Clin Exp Immunol. 2014;175:258-67 pubmed publisher
  751. Zufferey C, Germano S, Dutta B, Ritz N, Curtis N. The contribution of non-conventional T cells and NK cells in the mycobacterial-specific IFNγ response in Bacille Calmette-Guérin (BCG)-immunized infants. PLoS ONE. 2013;8:e77334 pubmed publisher
  752. Cornwell W, Lewis M, Fan X, Rappaport J, Rogers T. Effect of chronic morphine administration on circulating T cell population dynamics in rhesus macaques. J Neuroimmunol. 2013;265:43-50 pubmed publisher
  753. Kenway Lynch C, Das A, Pan D, Lackner A, Pahar B. Dynamics of cytokine/chemokine responses in intestinal CD4+ and CD8+ T Cells during Acute Simian Immunodeficiency Virus Infection. J Virol. 2013;87:11916-23 pubmed publisher
  754. Hagberg N, Theorell J, Schlums H, Eloranta M, Bryceson Y, Rönnblom L. Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic cells and CD319 on CD56(dim) NK cells. J Immunol. 2013;191:2989-98 pubmed publisher
  755. Raposo R, Abdel Mohsen M, Holditch S, Kuebler P, Cheng R, Eriksson E, et al. Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals. J Leukoc Biol. 2013;94:1051-9 pubmed publisher
  756. Svajger U, Obermajer N, Jeras M. IFN-?-rich environment programs dendritic cells toward silencing of cytotoxic immune responses. J Leukoc Biol. 2014;95:33-46 pubmed publisher
  757. Turcotte S, Gros A, Hogan K, Tran E, Hinrichs C, Wunderlich J, et al. Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapy. J Immunol. 2013;191:2217-25 pubmed publisher
  758. Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014;25:231-40 pubmed publisher
  759. Cervasi B, Carnathan D, Sheehan K, Micci L, Paiardini M, Kurupati R, et al. Immunological and virological analyses of rhesus macaques immunized with chimpanzee adenoviruses expressing the simian immunodeficiency virus Gag/Tat fusion protein and challenged intrarectally with repeated low doses of SIVmac. J Virol. 2013;87:9420-30 pubmed publisher
  760. Pahar B, Amedee A, Thomas J, Dufour J, Zhang P, Nelson S, et al. Effects of alcohol consumption on antigen-specific cellular and humoral immune responses to SIV in rhesus macaques. J Acquir Immune Defic Syndr. 2013;64:332-41 pubmed publisher
  761. Melis L, Van Praet L, Pircher H, Venken K, Elewaut D. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-? production by interaction with its soluble E-cadherin ligand in chronically inflamed joints. Ann Rheum Dis. 2014;73:1223-31 pubmed publisher
  762. Greig B, Stetler Stevenson M, Lea J. Stabilization media increases recovery in paucicellular cerebrospinal fluid specimens submitted for flow cytometry testing. Cytometry B Clin Cytom. 2014;86:135-8 pubmed publisher
  763. Demberg T, Brocca Cofano E, Kuate S, Aladi S, Vargas Inchaustegui D, Venzon D, et al. Impact of antibody quality and anamnestic response on viremia control post-challenge in a combined Tat/Env vaccine regimen in rhesus macaques. Virology. 2013;440:210-21 pubmed publisher
  764. Paich H, Sheridan P, Handy J, Karlsson E, Schultz Cherry S, Hudgens M, et al. Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity (Silver Spring). 2013;21:2377-86 pubmed publisher
  765. Nikiforow S, Kim H, Bindra B, McDonough S, Glotzbecker B, Armand P, et al. Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2013;19:804-11 pubmed publisher
  766. Palin A, Ramachandran V, Acharya S, Lewis D. Human neonatal naive CD4+ T cells have enhanced activation-dependent signaling regulated by the microRNA miR-181a. J Immunol. 2013;190:2682-91 pubmed publisher
  767. Canary L, Vinton C, Morcock D, Pierce J, Estes J, Brenchley J, et al. Rate of AIDS progression is associated with gastrointestinal dysfunction in simian immunodeficiency virus-infected pigtail macaques. J Immunol. 2013;190:2959-65 pubmed publisher
  768. Yan R, Zhong W, Zhu Y, Zhang X. Trichosanthin-stimulated dendritic cells induce a type 2 helper T lymphocyte response through the OX40 ligand. J Investig Allergol Clin Immunol. 2012;22:491-500 pubmed
  769. Morgan R, Chinnasamy N, Abate Daga D, Gros A, Robbins P, Zheng Z, et al. Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. J Immunother. 2013;36:133-51 pubmed publisher
  770. Mujagic E, Gianni Barrera R, Trani M, Patel A, Gurke L, Heberer M, et al. Induction of aberrant vascular growth, but not of normal angiogenesis, by cell-based expression of different doses of human and mouse VEGF is species-dependent. Hum Gene Ther Methods. 2013;24:28-37 pubmed publisher
  771. Naranbhai V, Altfeld M, Karim S, Ndung u T, Karim Q, Carr W. Changes in Natural Killer cell activation and function during primary HIV-1 Infection. PLoS ONE. 2013;8:e53251 pubmed publisher
  772. Eriksson E, Keh C, Deeks S, Martin J, Hecht F, Nixon D. Differential expression of CD96 surface molecule represents CD8? T cells with dissimilar effector function during HIV-1 infection. PLoS ONE. 2012;7:e51696 pubmed publisher
  773. Lelic A, Verschoor C, Ventresca M, Parsons R, Evelegh C, Bowdish D, et al. The polyfunctionality of human memory CD8+ T cells elicited by acute and chronic virus infections is not influenced by age. PLoS Pathog. 2012;8:e1003076 pubmed publisher
  774. van der Waart A, van der Velden W, van Halteren A, Leenders M, Feuth T, Blijlevens N, et al. Decreased levels of circulating IL17-producing CD161+CCR6+ T cells are associated with graft-versus-host disease after allogeneic stem cell transplantation. PLoS ONE. 2012;7:e50896 pubmed publisher
  775. Wong W, Sigvardsson M, Astrand Grundström I, Hogge D, Larsson J, Qian H, et al. Expression of integrin ?2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2R?(c) null mice. Stem Cells. 2013;31:360-71 pubmed publisher
  776. Reuter M, Yuan S, Marx P, Kutzler M, Weiner D, Betts M. DNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells. Hum Vaccin Immunother. 2012;8:1648-53 pubmed publisher
  777. He Y, He X, Guo P, Du M, Shao J, Li M, et al. The decidual stromal cells-secreted CCL2 induces and maintains decidual leukocytes into Th2 bias in human early pregnancy. Clin Immunol. 2012;145:161-73 pubmed publisher
  778. Shaw J, Hunt P, Critchfield J, McConnell D, Garcia J, Pollard R, et al. Short communication: HIV+ viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation. AIDS Res Hum Retroviruses. 2013;29:172-7 pubmed publisher
  779. Jalah R, Patel V, Kulkarni V, Rosati M, Alicea C, Ganneru B, et al. IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques. Hum Vaccin Immunother. 2012;8:1620-9 pubmed publisher
  780. Koreth J, Stevenson K, Kim H, McDonough S, Bindra B, Armand P, et al. Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation. J Clin Oncol. 2012;30:3202-8 pubmed publisher
  781. Wolff M, Leung J, Davenport M, Poles M, Cho I, Loke P. TH17, TH22 and Treg cells are enriched in the healthy human cecum. PLoS ONE. 2012;7:e41373 pubmed publisher
  782. Prabowo A, Anink J, Lammens M, Nellist M, van den Ouweland A, Adle Biassette H, et al. Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation. Brain Pathol. 2013;23:45-59 pubmed publisher
  783. Takahashi A, Torigoe T, Tamura Y, Kanaseki T, Tsukahara T, Sasaki Y, et al. Heat shock enhances the expression of cytotoxic granule proteins and augments the activities of tumor-associated antigen-specific cytotoxic T lymphocytes. Cell Stress Chaperones. 2012;17:757-63 pubmed publisher
  784. Qi Y, Operario D, Georas S, Mosmann T. The acute environment, rather than T cell subset pre-commitment, regulates expression of the human T cell cytokine amphiregulin. PLoS ONE. 2012;7:e39072 pubmed publisher
  785. Xu H, Wang X, Liu D, Moroney Rasmussen T, Lackner A, Veazey R. IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques. Mucosal Immunol. 2012;5:658-69 pubmed publisher
  786. Carney E, Srinivasan V, Moss P, Taylor A. Classical ataxia telangiectasia patients have a congenitally aged immune system with high expression of CD95. J Immunol. 2012;189:261-8 pubmed publisher
  787. Hartigan O Connor D, Abel K, Van Rompay K, Kanwar B, McCune J. SIV replication in the infected rhesus macaque is limited by the size of the preexisting TH17 cell compartment. Sci Transl Med. 2012;4:136ra69 pubmed publisher
  788. Klatt N, Estes J, Sun X, Ortiz A, Barber J, Harris L, et al. Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol. 2012;5:646-57 pubmed publisher
  789. Hobo W, Norde W, Schaap N, Fredrix H, Maas F, Schellens K, et al. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation. J Immunol. 2012;189:39-49 pubmed publisher
  790. Li X, Miao H, Henn A, Topham D, Wu H, Zand M, et al. Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination. Vaccine. 2012;30:4581-4 pubmed publisher
  791. Vanderford T, Slichter C, Rogers K, Lawson B, Obaede R, Else J, et al. Treatment of SIV-infected sooty mangabeys with a type-I IFN agonist results in decreased virus replication without inducing hyperimmune activation. Blood. 2012;119:5750-7 pubmed publisher
  792. Schmueck M, Fischer A, Hammoud B, Brestrich G, Fuehrer H, Luu S, et al. Preferential expansion of human virus-specific multifunctional central memory T cells by partial targeting of the IL-2 receptor signaling pathway: the key role of CD4+ T cells. J Immunol. 2012;188:5189-98 pubmed publisher
  793. Frahm M, Picking R, Kuruc J, McGee K, Gay C, Eron J, et al. CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection. J Immunol. 2012;188:4289-96 pubmed publisher
  794. Puronen C, Thompson W, Imamichi H, Beq S, Hodge J, Rehm C, et al. Decreased interleukin 7 responsiveness of T lymphocytes in patients with idiopathic CD4 lymphopenia. J Infect Dis. 2012;205:1382-90 pubmed publisher
  795. Jankowska M, Marszałł M, Debska Slizien A, Carrero J, Lindholm B, Czarnowski W, et al. Vitamin B6 and the immunity in kidney transplant recipients. J Ren Nutr. 2013;23:57-64 pubmed publisher
  796. Hutnick N, Myles D, Hirao L, Scott V, Ferraro B, Khan A, et al. An optimized SIV DNA vaccine can serve as a boost for Ad5 and provide partial protection from a high-dose SIVmac251 challenge. Vaccine. 2012;30:3202-8 pubmed publisher
  797. Friberg H, Bashyam H, Toyosaki Maeda T, Potts J, Greenough T, Kalayanarooj S, et al. Cross-reactivity and expansion of dengue-specific T cells during acute primary and secondary infections in humans. Sci Rep. 2011;1:51 pubmed publisher
  798. Phadwal K, Alegre Abarrategui J, Watson A, Pike L, Anbalagan S, Hammond E, et al. A novel method for autophagy detection in primary cells: impaired levels of macroautophagy in immunosenescent T cells. Autophagy. 2012;8:677-89 pubmed publisher
  799. Man S, Tucky B, Cotleur A, Drazba J, Takeshita Y, Ransohoff R. CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier. Sci Transl Med. 2012;4:119ra14 pubmed publisher
  800. Zeng M, Southern P, Reilly C, Beilman G, Chipman J, Schacker T, et al. Lymphoid tissue damage in HIV-1 infection depletes naïve T cells and limits T cell reconstitution after antiretroviral therapy. PLoS Pathog. 2012;8:e1002437 pubmed publisher
  801. West N, Milne K, Truong P, MacPherson N, Nelson B, Watson P. Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. Breast Cancer Res. 2011;13:R126 pubmed publisher
  802. Koreth J, Matsuoka K, Kim H, McDonough S, Bindra B, Alyea E, et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med. 2011;365:2055-66 pubmed publisher
  803. Wang X, Xu H, Alvarez X, Pahar B, Moroney Rasmussen T, Lackner A, et al. Distinct expression patterns of CD69 in mucosal and systemic lymphoid tissues in primary SIV infection of rhesus macaques. PLoS ONE. 2011;6:e27207 pubmed publisher
  804. Vogl B, Fagin U, Nerbas L, Schlenke P, Lamprecht P, Jabs W. Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation. J Med Virol. 2012;84:119-31 pubmed publisher
  805. Taaffe J, Bosinger S, Del Prete G, Else J, Ratcliffe S, Ward C, et al. CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques. J Med Primatol. 2012;41:24-42 pubmed publisher
  806. Vargas Inchaustegui D, Demberg T, Robert Guroff M. A CD8?(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities. Immunology. 2011;134:326-40 pubmed publisher
  807. Crawford T, Ndhlovu L, Tan A, Carvidi A, Hecht F, Sinclair E, et al. HIV-1 infection abrogates CD8+ T cell mitogen-activated protein kinase signaling responses. J Virol. 2011;85:12343-50 pubmed publisher
  808. Meeths M, Chiang S, Wood S, Entesarian M, Schlums H, Bang B, et al. Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D. Blood. 2011;118:5783-93 pubmed publisher
  809. Shaw J, Hunt P, Critchfield J, McConnell D, Garcia J, Pollard R, et al. Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers. J Virol. 2011;85:11422-34 pubmed publisher
  810. Luiza Silva M, Campi Azevedo A, Batista M, Martins M, Avelar R, da Silveira Lemos D, et al. Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody. J Infect Dis. 2011;204:873-83 pubmed publisher
  811. Caramori G, Lasagna L, Casalini A, Adcock I, Casolari P, Contoli M, et al. Immune response to Mycobacterium tuberculosis infection in the parietal pleura of patients with tuberculous pleurisy. PLoS ONE. 2011;6:e22637 pubmed publisher
  812. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed publisher
  813. Preijers F, Huys E, Leenders M, Nieto L, Gautherot E, Moshaver B. The new violet laser dye, Krome Orange, allows an optimal polychromatic immunophenotyping based on CD45-KO gating. J Immunol Methods. 2011;372:42-51 pubmed publisher
  814. Bohmer R, Bandala Sanchez E, Harrison L. Forward light scatter is a simple measure of T-cell activation and proliferation but is not universally suited for doublet discrimination. Cytometry A. 2011;79:646-52 pubmed publisher
  815. West N, Panet Raymond V, Truong P, Alexander C, Babinszky S, Milne K, et al. Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR). Breast Cancer (Auckl). 2011;5:105-15 pubmed publisher
  816. Lumsden J, Pichyangkul S, Srichairatanakul U, Yongvanitchit K, Limsalakpetch A, Nurmukhambetova S, et al. Evaluation of the safety and immunogenicity in rhesus monkeys of a recombinant malaria vaccine for Plasmodium vivax with a synthetic Toll-like receptor 4 agonist formulated in an emulsion. Infect Immun. 2011;79:3492-500 pubmed publisher
  817. Das A, Veazey R, Wang X, Lackner A, Xu H, Pahar B. Simian immunodeficiency virus infection in rhesus macaques induces selective tissue specific B cell defects in double positive CD21+CD27+ memory B cells. Clin Immunol. 2011;140:223-8 pubmed publisher
  818. Foster B, Foroughi S, Yin Y, Prussin C. Effect of anti-IgE therapy on food allergen specific T cell responses in eosinophil associated gastrointestinal disorders. Clin Mol Allergy. 2011;9:7 pubmed publisher
  819. Gadiot J, Hooijkaas A, Kaiser A, Van Tinteren H, van Boven H, Blank C. Overall survival and PD-L1 expression in metastasized malignant melanoma. Cancer. 2011;117:2192-201 pubmed publisher
  820. Zhang L, Jiang Q, Li G, Jeffrey J, Kovalev G, Su L. Efficient infection, activation, and impairment of pDCs in the BM and peripheral lymphoid organs during early HIV-1 infection in humanized rag2?/?? C?/? mice in vivo. Blood. 2011;117:6184-92 pubmed publisher
  821. Lee J, Hayman E, Pegram H, Santos E, Heller G, Sadelain M, et al. In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy. Cancer Res. 2011;71:2871-81 pubmed publisher
  822. Hardie D, Baldwin M, Naylor A, Haworth O, Hou T, Lax S, et al. The stromal cell antigen CD248 (endosialin) is expressed on naive CD8+ human T cells and regulates proliferation. Immunology. 2011;133:288-95 pubmed publisher
  823. Petrilli G, Lorenzi L, Paracchini R, Ubiali A, Schumacher R, Cabassa P, et al. Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature. Int J Surg Pathol. 2014;22:712-21 pubmed publisher
  824. Pankewycz O, Leca N, Kohli R, Wallace P, Said M, Feng L, et al. Low-dose rabbit antithymocyte globulin induction therapy results in prolonged selective lymphocyte depletion irrespective of maintenance immunosuppression. Transplant Proc. 2011;43:462-5 pubmed publisher
  825. Das A, Xu H, Wang X, Yau C, Veazey R, Pahar B. Double-positive CD21+CD27+ B cells are highly proliferating memory cells and their distribution differs in mucosal and peripheral tissues. PLoS ONE. 2011;6:e16524 pubmed publisher
  826. Theorell J, Schlums H, Chiang S, Huang T, Tattermusch A, Wood S, et al. Sensitive and viable quantification of inside-out signals for LFA-1 activation in human cytotoxic lymphocytes by flow cytometry. J Immunol Methods. 2011;366:106-18 pubmed publisher
  827. de Almeida C, de Lima T, Castro D, Torres K, da Silva Braga W, Peruhype Magalhães V, et al. Immunological/virological peripheral blood biomarkers and distinct patterns of sleeping quality in chronic hepatitis C patients. Scand J Immunol. 2011;73:486-95 pubmed publisher
  828. Scheible K, Zhang G, Baer J, Azadniv M, Lambert K, Pryhuber G, et al. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. Vaccine. 2011;29:2159-68 pubmed publisher
  829. Comin Anduix B, Sazegar H, Chodon T, Matsunaga D, Jalil J, von Euw E, et al. Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanoma. PLoS ONE. 2010;5:e12711 pubmed publisher
  830. Mehra S, Pahar B, Dutta N, Conerly C, Philippi Falkenstein K, Alvarez X, et al. Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas. PLoS ONE. 2010;5:e12266 pubmed publisher
  831. Demotte N, Wieërs G, Van Der Smissen P, Moser M, Schmidt C, Thielemans K, et al. A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice. Cancer Res. 2010;70:7476-88 pubmed publisher
  832. von Gegerfelt A, Valentin A, Alicea C, Van Rompay K, Marthas M, Montefiori D, et al. Emergence of simian immunodeficiency virus-specific cytotoxic CD4+ T cells and increased humoral responses correlate with control of rebounding viremia in CD8-depleted macaques infected with Rev-independent live-attenuated simian immunodeficiency vir. J Immunol. 2010;185:3348-58 pubmed publisher
  833. Autissier P, Soulas C, Burdo T, Williams K. Immunophenotyping of lymphocyte, monocyte and dendritic cell subsets in normal rhesus macaques by 12-color flow cytometry: clarification on DC heterogeneity. J Immunol Methods. 2010;360:119-28 pubmed publisher
  834. Elsner L, Flügge P, Lozano J, Muppala V, Eiz Vesper B, Demiroglu S, et al. The endogenous danger signals HSP70 and MICA cooperate in the activation of cytotoxic effector functions of NK cells. J Cell Mol Med. 2010;14:992-1002 pubmed publisher
  835. Hong H, Eberhard J, Keudel P, Bollmann B, Ahmad F, Ballmaier M, et al. Phenotypically and functionally distinct subsets contribute to the expansion of CD56-/CD16+ natural killer cells in HIV infection. AIDS. 2010;24:1823-34 pubmed publisher
  836. Markley J, Sadelain M. IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice. Blood. 2010;115:3508-19 pubmed publisher
  837. Autissier P, Soulas C, Burdo T, Williams K. Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans. Cytometry A. 2010;77:410-9 pubmed publisher
  838. Gordon S, Weissman A, Cecchinato V, Fenizia C, Ma Z, Lee T, et al. Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques. J Virol. 2010;84:3043-58 pubmed publisher
  839. Jacobi A, Huang W, Wang T, Freimuth W, Sanz I, Furie R, et al. Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum. 2010;62:201-10 pubmed publisher
  840. Cernea S, Herold K. Monitoring of antigen-specific CD8 T cells in patients with type 1 diabetes treated with antiCD3 monoclonal antibodies. Clin Immunol. 2010;134:121-9 pubmed publisher
  841. Zamai L, Galeotti L, Del Zotto G, Canonico B, Mirandola P, Papa S. Identification of a NCR+/NKG2D+/LFA-1(low)/CD94(-) immature human NK cell subset. Cytometry A. 2009;75:893-901 pubmed publisher
  842. Kagina B, Abel B, Bowmaker M, Scriba T, Gelderbloem S, Smit E, et al. Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine. 2009;27:5488-95 pubmed publisher
  843. Hadrup S, Bakker A, Shu C, Andersen R, van Veluw J, Hombrink P, et al. Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat Methods. 2009;6:520-6 pubmed publisher
  844. Park C, Majeti R, Weissman I. In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood. Nat Protoc. 2008;3:1932-40 pubmed publisher
  845. Karagoz B, Bilgi O, Gumus M, Erikci A, Sayan O, Turken O, et al. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Med Oncol. 2010;27:29-33 pubmed publisher
  846. Contreras X, Schweneker M, Chen C, McCune J, Deeks S, Martin J, et al. Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. J Biol Chem. 2009;284:6782-9 pubmed publisher
  847. Milne K, Barnes R, Girardin A, Mawer M, Nesslinger N, Ng A, et al. Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer. PLoS ONE. 2008;3:e3409 pubmed publisher
  848. Chattopadhyay P, Melenhorst J, Ladell K, Gostick E, Scheinberg P, Barrett A, et al. Techniques to improve the direct ex vivo detection of low frequency antigen-specific CD8+ T cells with peptide-major histocompatibility complex class I tetramers. Cytometry A. 2008;73:1001-9 pubmed publisher
  849. Wang X, Das A, Lackner A, Veazey R, Pahar B. Intestinal double-positive CD4+CD8+ T cells of neonatal rhesus macaques are proliferating, activated memory cells and primary targets for SIVMAC251 infection. Blood. 2008;112:4981-90 pubmed publisher
  850. Morgan A, Guillen C, Symon F, Birring S, Campbell J, Wardlaw A. CXCR6 identifies a putative population of retained human lung T cells characterised by co-expression of activation markers. Immunobiology. 2008;213:599-608 pubmed publisher
  851. Sodsai P, Hirankarn N, Avihingsanon Y, Palaga T. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity. Lupus. 2008;17:645-53 pubmed publisher
  852. Gurer C, Strowig T, Brilot F, Pack M, Trumpfheller C, Arrey F, et al. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood. 2008;112:1231-9 pubmed publisher
  853. Chaise C, Buchan S, Rice J, Marquet J, Rouard H, Kuentz M, et al. DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance. Blood. 2008;112:2956-64 pubmed publisher
  854. Stolte Leeb N, Bieler K, Kostler J, Heeney J, Haaft P, Suh Y, et al. Better protective effects in rhesus macaques by combining systemic and mucosal application of a dual component vector vaccine after rectal SHIV89.6P challenge compared to systemic vaccination alone. Viral Immunol. 2008;21:235-46 pubmed publisher
  855. Schweneker M, Favre D, Martin J, Deeks S, McCune J. HIV-induced changes in T cell signaling pathways. J Immunol. 2008;180:6490-500 pubmed
  856. Mageed A, Pietryga D, DeHeer D, West R. Isolation of large numbers of mesenchymal stem cells from the washings of bone marrow collection bags: characterization of fresh mesenchymal stem cells. Transplantation. 2007;83:1019-26 pubmed
  857. Zhu J, Koelle D, Cao J, Vazquez J, Huang M, Hladik F, et al. Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J Exp Med. 2007;204:595-603 pubmed
  858. Pahar B, Cantu M, Zhao W, Kuroda M, Veazey R, Montefiori D, et al. Single epitope mucosal vaccine delivered via immuno-stimulating complexes induces low level of immunity against simian-HIV. Vaccine. 2006;24:6839-49 pubmed
  859. Yaddanapudi K, Palacios G, Towner J, Chen I, Sariol C, Nichol S, et al. Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses. FASEB J. 2006;20:2519-30 pubmed publisher
  860. Jamieson C, Gotlib J, Durocher J, Chao M, Mariappan M, Lay M, et al. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci U S A. 2006;103:6224-9 pubmed
  861. Pahar B, Lackner A, Veazey R. Intestinal double-positive CD4+CD8+ T cells are highly activated memory cells with an increased capacity to produce cytokines. Eur J Immunol. 2006;36:583-92 pubmed
  862. Barsov E, Andersen H, Coalter V, Carrington M, Lifson J, Ott D. Capture of antigen-specific T lymphocytes from human blood by selective immortalization to establish long-term T-cell lines maintaining primary cell characteristics. Immunol Lett. 2006;105:26-37 pubmed
  863. Marei A, Ghaemmaghami A, Renshaw P, Wiselka M, Barer M, Carr M, et al. Superior T cell activation by ESAT-6 as compared with the ESAT-6-CFP-10 complex. Int Immunol. 2005;17:1439-46 pubmed
  864. Siliciano J, Siliciano R. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals. Methods Mol Biol. 2005;304:3-15 pubmed
  865. Taylor J, Ordway D, Troudt J, Gonzalez Juarrero M, Basaraba R, Orme I. Factors associated with severe granulomatous pneumonia in Mycobacterium tuberculosis-infected mice vaccinated therapeutically with hsp65 DNA. Infect Immun. 2005;73:5189-93 pubmed
  866. Schwendemann J, Choi C, Schirrmacher V, Beckhove P. Dynamic differentiation of activated human peripheral blood CD8+ and CD4+ effector memory T cells. J Immunol. 2005;175:1433-9 pubmed
  867. Humphreys T, Baldridge L, Billings S, Campbell J, Spinola S. Trafficking pathways and characterization of CD4 and CD8 cells recruited to the skin of humans experimentally infected with Haemophilus ducreyi. Infect Immun. 2005;73:3896-902 pubmed
  868. Lozza L, Lilleri D, Percivalle E, Fornara C, Comolli G, Revello M, et al. Simultaneous quantification of human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells. Eur J Immunol. 2005;35:1795-804 pubmed
  869. Mittag A, Lenz D, Gerstner A, Sack U, Steinbrecher M, Koksch M, et al. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets. Cytometry A. 2005;65:103-15 pubmed
  870. Hodara V, Velasquillo M, Parodi L, Giavedoni L. Expression of CD154 by a simian immunodeficiency virus vector induces only transitory changes in rhesus macaques. J Virol. 2005;79:4679-90 pubmed
  871. Heit A, Schmitz F, O Keeffe M, Staib C, Busch D, Wagner H, et al. Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines. J Immunol. 2005;174:4373-80 pubmed
  872. Contamin H, Loizon S, Bourreau E, Michel J, Garraud O, Mercereau Puijalon O, et al. Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey). J Immunol Methods. 2005;297:61-71 pubmed
  873. Crough T, Burrows J, Fazou C, Walker S, Davenport M, Khanna R. Contemporaneous fluctuations in T cell responses to persistent herpes virus infections. Eur J Immunol. 2005;35:139-49 pubmed
  874. Frost P, Hubbard G, Dammann M, Snider C, Moore C, Hodara V, et al. White monkey syndrome in infant baboons (Papio species). J Med Primatol. 2004;33:197-213 pubmed
  875. Asin S, Fanger M, Wildt Perinic D, Ware P, Wira C, Howell A. Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts. J Infect Dis. 2004;190:236-45 pubmed
  876. Kumar P, Uchil P, Sulochana P, Nirmala G, Chandrashekar R, Haridattatreya M, et al. Screening for T cell-eliciting proteins of Japanese encephalitis virus in a healthy JE-endemic human cohort using recombinant baculovirus-infected insect cell preparations. Arch Virol. 2003;148:1569-91 pubmed
  877. Braun R, Foerster M, Grahmann P, Haefner D, Workalemahu G, Kroegel C. Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases. Cytometry B Clin Cytom. 2003;54:19-27 pubmed
  878. Stacchini A, Demurtas A, Godio L, Martini G, Antinoro V, Palestro G. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B Clin Cytom. 2003;54:10-8 pubmed
  879. Amrolia P, Muccioli Casadei G, Yvon E, Huls H, Sili U, Wieder E, et al. Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses. Blood. 2003;102:2292-9 pubmed
  880. Erickson M, Morkowski S, Lehar S, Gillard G, Beers C, Dooley J, et al. Regulation of thymic epithelium by keratinocyte growth factor. Blood. 2002;100:3269-78 pubmed
  881. Loza M, Perussia B. Peripheral immature CD2-/low T cell development from type 2 to type 1 cytokine production. J Immunol. 2002;169:3061-8 pubmed
  882. Manz M, Miyamoto T, Akashi K, Weissman I. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A. 2002;99:11872-7 pubmed
  883. Bueno C, Rodriguez Caballero A, Garcia Montero A, Pandiella A, Almeida J, Orfao A. A new method for detecting TNF-alpha-secreting cells using direct-immunofluorescence surface membrane stainings. J Immunol Methods. 2002;264:77-87 pubmed
  884. Koelle D, Liu Z, McClurkan C, Topp M, Riddell S, Pamer E, et al. Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus. J Clin Invest. 2002;110:537-48 pubmed
  885. Kim C, Johnston B, Butcher E. Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood. 2002;100:11-6 pubmed
  886. Otsu M, Hershfield M, Tuschong L, Muul L, Onodera M, Ariga T, et al. Flow cytometry analysis of adenosine deaminase (ADA) expression: a simple and reliable tool for the assessment of ADA-deficient patients before and after gene therapy. Hum Gene Ther. 2002;13:425-32 pubmed
  887. Venkatesan S, Petrovic A, Van Ryk D, Locati M, Weissman D, Murphy P. Reduced cell surface expression of CCR5 in CCR5Delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration. J Biol Chem. 2002;277:2287-301 pubmed
  888. Venkatesan S, Petrovic A, Locati M, Kim Y, Weissman D, Murphy P. A membrane-proximal basic domain and cysteine cluster in the C-terminal tail of CCR5 constitute a bipartite motif critical for cell surface expression. J Biol Chem. 2001;276:40133-45 pubmed
  889. Giavedoni L, Imhoof J, Velasquillo M, Parodi L, Hodara V. Expression of the interleukin-18 gene from rhesus macaque by the simian immunodeficiency virus does not result in increased viral replication. J Interferon Cytokine Res. 2001;21:173-80 pubmed
  890. Telford W, Moss M, Morseman J, Allnutt F. Cryptomonad algal phycobiliproteins as fluorochromes for extracellular and intracellular antigen detection by flow cytometry. Cytometry. 2001;44:16-23 pubmed
  891. Sharron M, Pohlmann S, Price K, Lolis E, Tsang M, Kirchhoff F, et al. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. Blood. 2000;96:41-9 pubmed
  892. Converso M, Bertero M, Vallario A, Caligaris Cappio F. Analysis of T-cell clones in systemic lupus erythematosus. Haematologica. 2000;85:118-23 pubmed
  893. Giavedoni L, Velasquillo M, Parodi L, Hubbard G, Hodara V. Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J Virol. 2000;74:1648-57 pubmed
  894. Le Cleach L, Delaire S, Boumsell L, Bagot M, Bourgault Villada I, Bensussan A, et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol. 2000;119:225-30 pubmed
  895. Paz Miguel J, Flores R, Sanchez Velasco P, Ocejo Vinyals G, Escribano de Diego J, López de Rego J, et al. Reactive oxygen intermediates during programmed cell death induced in the thymus of the Ts(1716)65Dn mouse, a murine model for human Down's syndrome. J Immunol. 1999;163:5399-410 pubmed
  896. Lee B, Sharron M, Montaner L, Weissman D, Doms R. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999;96:5215-20 pubmed
  897. Waterfall M, Black A, Riley E. Gammadelta+ T cells preferentially respond to live rather than killed malaria parasites. Infect Immun. 1998;66:2393-8 pubmed
  898. Kim C, Pelus L, White J, Applebaum E, Johanson K, Broxmeyer H. CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells. J Immunol. 1998;160:2418-24 pubmed